supp.fit

Folic Acid: study protocols

1,135 study groups say how much Folic Acid participants took a day. These are the doses the studies gave. They are not a recommendation.

Folic Acid: what the research found →

Dose per serving from products

16,813 products in our catalogue print how much Folic Acid a serving holds.

Most common: 250 mcg to 500 mcg, 38% of 16,813 products.

Dose per servingProducts
50 mcg or less
707
50 mcg to 100 mcg
834
100 mcg to 250 mcg
2,522
250 mcg to 500 mcg
6,381
500 mcg to 1 mg
4,774
1 mg to 2.5 mg
939
over 2.5 mg
656

Dose per serving from research

1,135 study groups in 700 studies say how much Folic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mcg to 500 mcg, 38% of 1,135 study groups.

Daily doseStudy groups
100 mcg or less
52
100 mcg to 250 mcg
93
250 mcg to 500 mcg
430
500 mcg to 1 mg
212
1 mg to 2.5 mg
69
2.5 mg to 5 mg
200
5 mg to 10 mg
28
over 10 mg
51

Commonly used together

635 of 1,135 study groups took Folic Acid with something else. Shown: what 3 or more different studies gave. The 10 most common of 40.

What was given together, not what works together.

Taken withStudy groups
Iron
284
Vitamin B12
252
Vitamin B6
162
Zinc
67
Vitamin C
51
Vitamin A
41
Vitamin E
41
Inositol
33
Vitamin D
32
Riboflavin
29

1,135 study groups

Study
Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial
2015 · Enalapril-folic acid group · Adults with hypertension in China, without a history of stroke or myocardial infarction
800 mcg1644 days10,348
Effect of folic acid supplementation on cancer risk among adults with hypertension in China: A randomized clinical trial
2017 · enalapril-folic acid group · Adults with hypertension in China without a history of stroke or myocardial infarction; age and sex not specified
800 mcg1643 days10,348
Folic acid therapy reduces the risk of mortality associated with heavy proteinuria among hypertensive patients
2017 · Enalapril-folic acid group · Hypertensive patients without a history of major cardiovascular diseases
800 mcg1644 days10,348
Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease: The Renal Substudy of the China Stroke Primary Prevention Trial
2016 · Enalapril-folic acid group · Chinese adults aged 45–75 with hypertension, with baseline kidney function ranging from normal to moderate chronic kidney disease
800 mcg1606 days7,545
Effects of Folic Acid Therapy on the New-Onset Proteinuria in Chinese Hypertensive Patients: A Post Hoc Analysis of the Renal Substudy of CSPPT (China Stroke Primary Prevention Trial)
2017 · enalapril-folic acid group · Chinese adults with hypertension and no proteinuria at baseline; some had diabetes mellitus
800 mcg1606 days6,511
Platelet Count Affects Efficacy of Folic Acid in Preventing First Stroke
2018 · 10 mg enalapril and 0.8 mg folic acid · Chinese hypertensive adults, mean age 59.5 years, 38% male, with no history of stroke or myocardial infarction
800 mcg219 weeks5,408
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial
2007 · folic acid · Men and women with a recent history of colorectal adenomas and no previous invasive large intestine carcinoma
1 mg2922 days516
Folic acid supplementation and risk of colorectal neoplasia during long-term follow-up of a randomized clinical trial
2019 · Folic acid · Adults recently diagnosed with colorectal adenomas
1 mg—516
Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas
2018 · 1 mg/d folic acid · Adults aged 21–80 recently diagnosed with colorectal adenomas
1 mg6 years443
Methyltetrahydrofolate vs Folic Acid Supplementation in Idiopathic Recurrent Miscarriage with Respect to Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms: A Randomized Controlled Trial
2015 · folic acid group · Women with three or more idiopathic recurrent abortions and no identified antiphospholipid, anatomic, cytogenetic, hormonal, or infectious cause
1 mg—110
The influence of folic acid supplement on the outcome of pregnancies in the county of Funen in Denmark. Part I
1999 · 1.0 mg folic acid group · Women of childbearing age who became pregnant; age range and health status not specified
1 mg1187 days—
Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study
2001 · folic acid group · Adults with active rheumatoid arthritis
1 mg48 weeks—
Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation
2008 · folic acid group · Adults with a previous history of at least one colorectal adenoma; age and sex not restricted
1 mg995 days—
Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels
2008 · folic acid treatment group · Adults with a history of colorectal adenomas; age and sex ranges are not specified.
1 mg6 years—
Folic acid prevents the initial occurrence of sporadic colorectal adenoma in Chinese older than 50 years of age: a randomized clinical trial
2013 · folic acid group · Adults older than 50 years with no adenomas
1 mg3 years—
Folic Acid Therapy Reduces the First Stroke Risk Associated With Hypercholesterolemia Among Hypertensive Patients
2016 · Enalapril-folic acid group · Hypertensive adults without a history of major cardiovascular disease
800 mcg1644 days—
Homocysteine and Stroke Risk: Modifying Effect of Methylenetetrahydrofolate Reductase C677T Polymorphism and Folic Acid Intervention
2017 · 10-mg enalapril and 0.8-mg folic acid group · Chinese hypertensive adults
800 mcg1643 days—
Effect of Smoking and Folate Levels on the Efficacy of Folic Acid Therapy in Prevention of Stroke in Hypertensive Men
2018 · enalapril 10-mg and folic acid 0.8-mg tablet group · men with hypertension; age range not reported
800 mcg1643 days—
Effect of Vitamin B(12) Levels on the Association Between Folic Acid Treatment and CKD Progression: A Post Hoc Analysis of a Folic Acid Interventional Trial
2020 · Enalapril and folic acid · Hypertensive adults with mild to moderate chronic kidney disease
800 mcg1607 days—
Estimated Stroke-Free Survival of Folic Acid Therapy for Hypertensive Adults: Projection Based on the CSPPT
2020 · enalapril-folic acid group · Adults aged 45–75 with hypertension and no history of stroke or myocardial infarction
800 mcg1643 days—
Interaction of serum vitamin B(12) and folate with MTHFR genotypes on risk of ischemic stroke
2020 · enalapril and folic acid group · hypertensive adults; age and sex not specified
800 mcg1644 days—
Effects of prenatal micronutrients supplementation timing on pregnancy-induced hypertension: Secondary analysis of a double-blind randomized controlled trial
2021 · FA group · Pregnant nulliparous Chinese women aged 20 or older, enrolled before 20 gestational weeks, with haemoglobin above 10.0 g/dl
400 mcg—6,261
Micronutrient supplementation during pregnancy and the risk of pregnancy-induced hypertension: A randomized clinical trial
2019 · FA group · Nulliparous pregnant women aged 20 years or older, enrolled before 20 weeks of gestation, with hemoglobin at least 10.0 g/dL
400 mcg—5,923
Effects of Prenatal Micronutrient Supplementation on Spontaneous Preterm Birth: A Double-Blind Randomized Controlled Trial in China
2017 · FA group · Pregnant women aged 20 years or older, nulliparous, enrolled before 20 gestational weeks, with hemoglobin above 10.0 g/dL
400 mcg—5,888
Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial
2008 · Folic acid · Pregnant women resident in disadvantaged rural counties in Shaanxi Province, China; eligible women enrolled before 28 weeks’ gestation
400 mcg—2,017
High dosage folic acid supplementation, oral cleft recurrence and fetal growth
2013 · 4 mg folic acid · Women aged 16–45 with an oral cleft themselves or who had a previous child with an oral cleft; not pregnant at enrollment
4 mg3 years1,257
High dosage folic acid supplementation, oral cleft recurrence and fetal growth
2013 · 0.4 mg folic acid · Women aged 16–45 with an oral cleft themselves or who had a previous child with an oral cleft; not pregnant at enrollment
400 mcg3 years1,251
Effect of high dose folic acid supplementation in pregnancy on pre-eclampsia (FACT): double blind, phase III, randomised controlled, international, multicentre trial
2018 · folic acid group · Pregnant women at 8–16 completed weeks of gestation with at least one risk factor for pre-eclampsia
4 mg—1,228
Excess risk of preterm birth with periconceptional iron supplementation in a malaria endemic area: analysis of secondary data on birth outcomes in a double blind randomized controlled safety trial in Burkina Faso
2019 · folic acid alone · Nulliparous, non-pregnant women aged 15–24 years in a malaria-endemic area of Burkina Faso who became pregnant during or shortly after supplementation
400 mcg548 days979
Risk of malaria in young children after periconceptional iron supplementation
2021 · Control · Nulliparous young women in Burkina Faso; age range and sex beyond female are not specified; no diagnosed condition stated
400 mcg548 days979
The effect of folic acid throughout pregnancy among pregnant women at high risk of pre-eclampsia: A randomized clinical trial
2020 · low dose (LD) group · Pregnant women with a history of pre-eclampsia or eclampsia in their last pregnancy
400 mcg—788
The effect of folic acid throughout pregnancy among pregnant women at high risk of pre-eclampsia: A randomized clinical trial
2020 · high dose (HD) group · Pregnant women with a history of pre-eclampsia or eclampsia in their last pregnancy
4 mg—788
A randomised trial to evaluate the effects of low-dose aspirin in gestation and reproduction: design and baseline characteristics
2013 · Placebo group · Healthy women aged 18–40 trying to conceive, with one or two prior pregnancy losses and no known infertility diagnosis
400 mcg—606
Efficacy of 4.0 mg versus 0.4 mg Folic Acid Supplementation on the Reproductive Outcomes: A Randomized Controlled Trial
2021 · 0.4 mg FA group · Women aged 18–44 planning a pregnancy within 12 months; women with specified conditions including epilepsy, diabetes, obesity and megaloblastic anemia were excluded
400 mcg1 year531
Efficacy of 4.0 mg versus 0.4 mg Folic Acid Supplementation on the Reproductive Outcomes: A Randomized Controlled Trial
2021 · 4.0 mg FA group · Women aged 18–44 planning a pregnancy within 12 months; women with specified conditions including epilepsy, diabetes, obesity and megaloblastic anemia were excluded
4 mg1 year529
Low-Molecular-Weight Heparin for the Treatment of Unexplained Recurrent Miscarriage With Negative Antiphospholipid Antibodies: A Randomized Controlled Trial
2017 · Study group · Women with three or more unexplained recurrent miscarriages and negative antiphospholipid antibodies, who became pregnant
500 mcg20 weeks150
Low-Molecular-Weight Heparin for the Treatment of Unexplained Recurrent Miscarriage With Negative Antiphospholipid Antibodies: A Randomized Controlled Trial
2017 · Control group · Women with three or more unexplained recurrent miscarriages and negative antiphospholipid antibodies, who became pregnant
500 mcg20 weeks150
Periconceptional use of folic acid and risk of miscarriage - findings of the Oral Cleft Prevention Program in Brazil
2013 · 4.0 mg group · Women aged 16–45 with nonsyndromic orofacial cleft themselves or a previous child with nonsyndromic orofacial cleft
4 mg—141
Periconceptional iron supplementation does not reduce anemia or improve iron status among pregnant women in rural Bangladesh
2009 · folic acid (FA) · Married, nulliparous women in rural Bangladesh, followed until pregnancy or the end of 9 months
400 mcg274 days138
Periconceptional use of folic acid and risk of miscarriage - findings of the Oral Cleft Prevention Program in Brazil
2013 · 0.4 mg group · Women aged 16–45 with nonsyndromic orofacial cleft themselves or a previous child with nonsyndromic orofacial cleft
400 mcg—127
Folic acid supplementation prevents phenytoin-induced gingival overgrowth in children
2011 · folic acid arm · Children aged 6–15 years with epilepsy starting phenytoin monotherapy
500 mcg26 weeks62
Sex and menopausal status influence human dietary requirements for the nutrient choline
2007 · Folic acid supplement group · Healthy men and women aged 18–70 years; participants were not selected for a diagnosed condition or nutrient deficiency
400 mcg—26
The influence of folic acid supplement on the outcome of pregnancies in the county of Funen in Denmark. Part I
1999 · 2.5 mg folic acid group · Women of childbearing age who became pregnant; age range and health status not specified
2.5 mg1187 days—
Folate supplements prevent recurrence of neural tube defects
1992 · Folate supplementation · Women with a previous neural tube defect pregnancy; age not reported
4 mg——
Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors
2007 · Homocysteine-lowering group · Myocardial infarction survivors
2 mg6 years—
Modifying effects of maternal Hb concentration on infant birth weight in women receiving prenatal iron-containing supplements: a randomised controlled trial
2016 · FA group · Pregnant women aged at least 20 years, nulliparous, with Hb concentration ≥100 g/L and enrolled before 20 weeks of gestation
400 mcg——
Prenatal iron containing supplements provided to Chinese women with no or mild anemia had no effect on hemoglobin concentration in post-partum women or their infants at 6 and 12 months of age
2019 · FA · Nulliparous pregnant women with hemoglobin concentration >100 g/L and no or mild anemia
400 mcg——
Interaction of serum calcium and folic acid treatment on first stroke in hypertensive males
2021 · enalapril and folic acid · Chinese hypertensive adults; male and female participants
800 mcg1643 days—
The effect of myo-inositol supplementation on the prevention of gestational diabetes in overweight pregnant women: a randomized, double-blind, controlled trial
2023 · control group · Overweight pregnant women at 12–14 weeks of gestation
400 mcg10 weeks—
Folic acid supplementation improves cognitive function in participants with cerebral small vascular disease-related cognitive impairment: a randomized controlled trial
2026 · FA group · Adults aged 40–80 years with cerebral small vessel disease and cognitive impairment; men and women
800 mcg26 weeks110
Folic Acid Supplementation Mitigates Alzheimer's Disease by Reducing Inflammation: A Randomized Controlled Trial
2016 · folic acid supplementation group · Adults aged 40–90 with newly diagnosed mild-to-moderate possible or probable Alzheimer's disease and normocytic anemia
1.25 mg26 weeks81
Cognitive Benefits of Folic Acid, Docosahexaenoic Acid, and a Combination of Both Nutrients in Mild Cognitive Impairment: Possible Alterations through Mitochondrial Function and DNA Damage
2024 · FA · Adults aged 60 years and older with mild cognitive impairment
800 mcg1 year70
Comparison of two different folic acid doses with methotrexate--a randomized controlled trial (FOLVARI Study)
2015 · FA10 group · Adults aged 18–75 with active rheumatoid arthritis
1.43 mg24 weeks51
Effect of folic acid supplementation on nerve conduction velocity in diabetic polyneuropathy patients
2019 · folic acid group · Patients with diabetic polyneuropathy; age and sex not specified
1 mg16 weeks40
A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease
2008 · folic acid · Adults with probable Alzheimer's disease treated concurrently with a cholinesterase inhibitor
1 mg26 weeks23
A randomized double-blind comparison of fluoxetine augmentation by high and low dosage folic acid in patients with depressive episodes
2013 · Group I · Female out-patients with moderate or severe depressive episodes, without psychotic symptoms
1.5 mg6 weeks23
Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy
2000 · Folic acid 1 mg (40-week phase) · Adults on maintenance dialysis with end-stage renal disease and hyperhomocysteinemia
1 mg40 weeks—
Effects of folic acid supplementation on hearing in older adults: a randomized, controlled trial
2007 · folic acid group · Older men and women with plasma total homocysteine concentrations of at least 13 micromol/L and serum vitamin B12 concentrations of at least 200 pmol/L at screening
800 mcg3 years—
Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial
2007 · folic acid group · Men and women aged 50–70 years with raised plasma total homocysteine and normal serum vitamin B12 at screening
800 mcg3 years—
Effects of folic acid on preschool children's appetite: randomized triple-blind clinical trial
2007 · folic acid · Children aged 3–5 years with low weight-for-age and weight-for-height ratios and parent-reported poor appetite
1 mg20 days—
Folate supplementation in schizophrenia: a possible role for MTHFR genotype
2011 · folate · stable adult outpatients with schizophrenia
2 mg12 weeks—
Effect of folic acid combined with docosahexaenoic acid intervention on mild cognitive impairment in elderly: a randomized double-blind, placebo-controlled trial
2021 · FA · Elderly people with mild cognitive impairment (MCI); age range and sex not specified
800 mcg26 weeks—
Positive effects of folic acid supplementation on cognitive aging are dependent on ω-3 fatty acid status: a post hoc analysis of the FACIT trial
2021 · folic acid · Adults aged 50–70 years with plasma total homocysteine 13–26 µmol/L and serum vitamin B12 ≥200 pmol/L
800 mcg3 years—
Effects of Folic Acid Combined with DHA Supplementation on Cognitive Function and Amyloid-β-Related Biomarkers in Older Adults with Mild Cognitive Impairment by a Randomized, Double Blind, Placebo-Controlled Trial
2021 · folic acid · Adults aged over 60 years with mild cognitive impairment
800 mcg26 weeks—
Effects of prenatal micronutrients supplementation timing on pregnancy-induced hypertension: Secondary analysis of a double-blind randomized controlled trial
2021 · IFA group · Pregnant nulliparous Chinese women aged 20 or older, enrolled before 20 gestational weeks, with haemoglobin above 10.0 g/dl
400 mcg—6,252
Micronutrient supplementation during pregnancy and the risk of pregnancy-induced hypertension: A randomized clinical trial
2019 · IFA group · Nulliparous pregnant women aged 20 years or older, enrolled before 20 weeks of gestation, with hemoglobin at least 10.0 g/dL
400 mcg—5,933
Effects of Prenatal Micronutrient Supplementation on Spontaneous Preterm Birth: A Double-Blind Randomized Controlled Trial in China
2017 · IFA group · Pregnant women aged 20 years or older, nulliparous, enrolled before 20 gestational weeks, with hemoglobin above 10.0 g/dL
400 mcg—5,920
Micronutrient supplementation during pregnancy and the risk of pregnancy-induced hypertension: A randomized clinical trial
2019 · MMN group · Nulliparous pregnant women aged 20 years or older, enrolled before 20 weeks of gestation, with hemoglobin at least 10.0 g/dL
400 mcg—5,914
Effects of Prenatal Micronutrient Supplementation on Spontaneous Preterm Birth: A Double-Blind Randomized Controlled Trial in China
2017 · MMN group · Pregnant women aged 20 years or older, nulliparous, enrolled before 20 gestational weeks, with hemoglobin above 10.0 g/dL
400 mcg—5,910
B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial
2010 · B vitamins · Patients with recent stroke or transient ischaemic attack within the past 7 months
2 mg1241 days4,089
Treatment with B vitamins and incidence of cancer in patients with previous stroke or transient ischemic attack: results of a randomized placebo-controlled trial
2012 · B vitamins · Patients with recent stroke or transient ischemic attack
2 mg1241 days4,082
Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial
2012 · B-vitamins group · Adults with a stroke or transient ischaemic attack within the previous 7 months; men and women, age not restricted
2 mg1241 days4,040
Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial
2008 · Active treatment · Women aged 40 years or older with a history of cardiovascular disease or at least three cardiovascular risk factors
2.5 mg2665 days2,721
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study
2009 · folic acid/B6/B12 group · Women at high risk of cardiovascular disease, with preexisting cardiovascular disease or at least three coronary risk factors; women included in these AMD analyses had no AMD diagnosis at baseline.
2.5 mg2665 days2,607
Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial
2009 · Active treatment · Women aged 45 years or older at high risk for cardiovascular disease, without diabetes at baseline
2.5 mg2665 days2,132
Folic Acid, Vitamin B6, and Vitamin B12 in Combination and Age-Related Cataract in a Randomized Trial of Women
2016 · combination treatment group · Women with preexisting cardiovascular disease or at least three coronary risk factors; ages 40 and older
2.5 mg2665 days1,969
Effect of prenatal multiple micronutrient supplements and medium-quantity lipid-based nutritional supplements on maternal weight gain and infant birth weight in rural Niger: a cluster-randomised trial
2025 · MQ-LNS · Pregnant women in rural Niger enrolled at up to 30 weeks' gestation
400 mcg—1,144
Effect of prenatal multiple micronutrient supplements and medium-quantity lipid-based nutritional supplements on maternal weight gain and infant birth weight in rural Niger: a cluster-randomised trial
2025 · MMN · Pregnant women in rural Niger enrolled at up to 30 weeks' gestation
400 mcg—1,083
Excess risk of preterm birth with periconceptional iron supplementation in a malaria endemic area: analysis of secondary data on birth outcomes in a double blind randomized controlled safety trial in Burkina Faso
2019 · weekly iron and folic acid · Nulliparous, non-pregnant women aged 15–24 years in a malaria-endemic area of Burkina Faso who became pregnant during or shortly after supplementation
400 mcg548 days980
Risk of malaria in young children after periconceptional iron supplementation
2021 · Iron · Nulliparous young women in Burkina Faso; age range and sex beyond female are not specified; no diagnosed condition stated
400 mcg548 days980
Cost-effectiveness of invitation to food supplementation early in pregnancy combined with multiple micronutrients on infant survival: analysis of data from MINIMat randomized trial, Bangladesh
2015 · EMMS · Pregnant women in rural Bangladesh, irrespective of nutritional status
400 mcg—740
A randomised trial to evaluate the effects of low-dose aspirin in gestation and reproduction: design and baseline characteristics
2013 · LDA group · Healthy women aged 18–40 trying to conceive, with one or two prior pregnancy losses and no known infertility diagnosis
400 mcg—606
Nutrient supplementation during the first 1000 days and growth of infants born to pregnant adolescents
2020 · IFA-MNP · Pregnant adolescents under 20 years of age and their children
400 mcg—388
Nutrient supplementation during the first 1000 days and growth of infants born to pregnant adolescents
2020 · IFA-Control · Pregnant adolescents under 20 years of age
400 mcg—378
Nutrient supplementation during the first 1000 days and growth of infants born to pregnant adolescents
2020 · IFA-LNS · Pregnant adolescents under 20 years of age and their children
400 mcg—361
Multivitamin and iron supplementation to prevent periconceptional anemia in rural tanzanian women: a randomized, controlled trial
2015 · Folic acid + iron · Non-pregnant women and adolescent girls aged 15–29 years in rural Tanzania
400 mcg26 weeks267
B vitamins to enhance treatment response to antidepressants in middle-aged and older adults: results from the B-VITAGE randomised, double-blind, placebo-controlled trial
2014 · vitamins · Community-dwelling adults aged 50 years or over with DSM-IV-TR major depression
2 mg52 weeks77
Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study
2007 · TEGAFOX · Adults aged 18–75 with previously untreated metastatic colorectal cancer
90 mg—73
Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study
2007 · TEGAFIRI · Adults aged 18–75 with previously untreated metastatic colorectal cancer
90 mg—68
Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial
2008 · folic acid group · Patients with colorectal adenomas
5 mg3 years49
The Effects of Folic Acid Supplementation on Recurrence and Metabolic Status in Endometrial Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial
2018 · folic acid group · Women diagnosed with endometrial hyperplasia
5 mg12 weeks30
The effect of Myo-inositol on fertility rates in poor ovarian responder in women undergoing assisted reproductive technique: a randomized clinical trial
2021 · Control group · Infertile women aged 20–43 with poor ovarian response, defined by antral follicle count below 7 or AMH below 1.2 ng/ml
400 mg12 weeks30
Effects of folate supplementation on recurrence and metabolic status of cervical intraepithelial neoplasia grade 2/3 in overweight and obese women: a randomized double-blind placebo-controlled trial
2022 · intervention group · Overweight or obese women with CIN2/3
5 mg12 weeks30
Effects of long-term folate supplementation on metabolic status and regression of cervical intraepithelial neoplasia: A randomized, double-blind, placebo-controlled trial
2016 · folate group · Women aged 18–55 with cervical intraepithelial neoplasia grade 1 (CIN1)
5 mg26 weeks29
Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study
2001 · folinic acid group · Adults with active rheumatoid arthritis
357 mcg48 weeks—
Homocysteine lowering with folic acid and B vitamins in vascular disease
2006 · active-treatment group · Patients aged 55 years or older with vascular disease or diabetes
2.5 mg5 years—
Long-term effect of folic acid therapy in heart transplant recipients: follow-up analysis of a randomized study
2008 · Folic acid therapy · Heart transplant recipients; age and sex not specified
15 mg1 year—
Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial
2008 · combined folic acid/vitamin B6/vitamin B12 treatment · Women aged 40 years or older with a history of cardiovascular disease or at least three coronary risk factors
2.5 mg2666 days—
Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial
2009 · vitamin therapy group · Adults with known cardiovascular disease
2.5 mg5 years—
B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trial
2010 · B-vitamins · Stroke survivors; age and sex not specified
2 mg383 days—
Equity in adherence to and effect of prenatal food and micronutrient supplementation on child mortality: results from the MINIMat randomized trial, Bangladesh
2014 · EFe30F (early food invitation; 30 mg iron + 400 μg folic acid) · Pregnant women in rural Bangladesh, enrolled before 14 weeks’ gestation
400 mcg——
Equity in adherence to and effect of prenatal food and micronutrient supplementation on child mortality: results from the MINIMat randomized trial, Bangladesh
2014 · UFe30F (usual food invitation; 30 mg iron + 400 μg folic acid) · Pregnant women in rural Bangladesh, enrolled before 14 weeks’ gestation
400 mcg——
Effect of daily vitamin B-12 and folic acid supplementation on fracture incidence in elderly individuals with an elevated plasma homocysteine concentration: B-PROOF, a randomized controlled trial
2014 · vitamin B-12 plus folic acid group · Adults aged 65 years or older with elevated plasma homocysteine concentrations (12–50 μmol/L)
400 mcg2 years—
Modifying effects of maternal Hb concentration on infant birth weight in women receiving prenatal iron-containing supplements: a randomised controlled trial
2016 · IFA group · Pregnant women aged at least 20 years, nulliparous, with Hb concentration ≥100 g/L and enrolled before 20 weeks of gestation
400 mcg——
Effects of long-term weekly iron and folic acid supplementation on lower genital tract infection - a double blind, randomised controlled trial in Burkina Faso
2017 · control · Healthy nulliparous, non-pregnant women aged 15–24 years at enrolment; some became pregnant during follow-up
400 mcg548 days—
Folic Acid and Vitamin B12 Supplementation and the Risk of Cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial
2019 · B vitamins · B-PROOF trial participants; age and specific condition not stated in the abstract
400 mcg3 years—
The effect of myo-inositol supplementation on the prevention of gestational diabetes in overweight pregnant women: a randomized, double-blind, controlled trial
2023 · myo-inositol group · Overweight pregnant women at 12–14 weeks of gestation
400 mcg10 weeks—
Predictors of adherence to micronutrient supplementation before and during pregnancy in Vietnam
2017 · FA (folic acid) preconception group · Women of reproductive age in Vietnam intending to become pregnant
400 mcg400 days1,459
Impact of preconceptional micronutrient supplementation on maternal mental health during pregnancy and postpartum: results from a randomized controlled trial in Vietnam
2017 · Folic acid (FA) · Women aged 18–40 planning pregnancy; reproductive-age women without a stated diagnosed condition
400 mcg56 weeks572
Preconception micronutrient supplementation positively affects child intellectual functioning at 6 y of age: A randomized controlled trial in Vietnam
2021 · FA (folic acid) group · Women of reproductive age receiving preconception supplementation; offspring were assessed at ages 6–7 years
400 mcg201 days472
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study
2013 · Innovator infliximab 3 mg/kg group · Adults with active rheumatoid arthritis and an inadequate response to methotrexate
714 mcg30 weeks304
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study
2013 · CT-P13 3 mg/kg group · Adults with active rheumatoid arthritis and an inadequate response to methotrexate
714 mcg30 weeks302
Computerized counseling for folate knowledge and use: a randomized controlled trial
2008 · Intervention group · English-speaking women aged 18–45 years eligible to become pregnant
400 mcg—223
The dihydrofolate reductase 19-bp deletion modifies the beneficial effect of B-vitamin therapy in mild cognitive impairment: pooled study of two randomized placebo-controlled trials
2022 · Active treatment, VITACOG (UK) · Older adults with mild cognitive impairment; mean age about 77 years; sex not restricted
800 mcg2 years133
Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy (and folic acid vs placebo) in patients with bipolar depression (CEQUEL)
2018 · Folic acid · People aged 16 years or older with bipolar disorder type I or II and a current depressive episode requiring new pharmacological treatment
500 mcg52 weeks91
Effects of folic acid supplementation on cognitive function and Aβ-related biomarkers in mild cognitive impairment: a randomized controlled trial
2019 · intervention group · Adults with mild cognitive impairment; age and sex not stated
400 mcg2 years90
Effects of 6-Month Folic Acid Supplementation on Cognitive Function and Blood Biomarkers in Mild Cognitive Impairment: A Randomized Controlled Trial in China
2016 · oral folic acid group · Adults aged 65 years and older with mild cognitive impairment
400 mcg26 weeks80
Biochemical and genetic predictors and correlates of response to lamotrigine and folic acid in bipolar depression: Analysis of the CEQUEL clinical trial
2017 · Folic acid (FA) · Adults with bipolar disorder type I or II
500 mcg12 weeks67
Effect of continued folic acid supplementation beyond the first trimester of pregnancy on cognitive performance in the child: a follow-up study from a randomized controlled trial (FASSTT Offspring Trial)
2019 · Folic acid · Healthy pregnant women aged 18–35 with a singleton pregnancy who had taken 400 μg/day folic acid during the first trimester
400 mcg26 weeks59
Effects of maternal folic acid supplementation during the second and third trimesters of pregnancy on neurocognitive development in the child: an 11-year follow-up from a randomised controlled trial
2021 · Folic acid · Healthy pregnant women aged 18–35 years with singleton pregnancies who had taken 400 μg/day folic acid in the first trimester
400 mcg26 weeks37
Probiotic effects on sexual function in women with polycystic ovary syndrome: a double blinded randomized controlled trial
2022 · Letrozole group (Group B) · Women aged 18–38 with PCOS and infertility
400 mcg8 weeks20
The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis
2008 · treatment arm A: MTX plus FA phase · Adults aged 35–70 with moderate-to-severe plaque psoriasis
2.86 mg16 weeks10
The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis
2008 · treatment arm B: MTX plus FA phase · Adults aged 35–70 with moderate-to-severe plaque psoriasis
2.86 mg16 weeks10
Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial
2000 · fluoxetine plus folic acid group · Patients meeting DSM-III-R criteria for major depression with baseline 17-item Hamilton Rating Scale score of 20 or more; age and sex distribution not fully specified
500 mcg10 weeks—
Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages
2002 · folate · healthy younger, middle-aged and older women
750 mcg5 weeks—
Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease
2007 · low-dose folic acid · Patients with coronary artery disease; age and sex not reported
400 mcg7 weeks—
The administration of folic acid to institutionalized epileptic adults with phenytoin-induced gingival hyperplasia. A double-blind, randomized, placebo-controlled, parallel study
1991 · folic acid group · Institutionalized adults with severe intellectual disability, epilepsy, and phenytoin-induced gingival hyperplasia; age and sex not specified
3 mg16 weeks—
Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial
2011 · Group B · Women with polycystic ovary syndrome undergoing IVF
400 mcg90 days—
A Pilot Randomized Controlled Double-Blind Trial of High- Versus Low-Dose Weekly Folic Acid in People With Rheumatoid Arthritis Receiving Methotrexate
2019 · high-dose group · People with active rheumatoid arthritis receiving stable-dose methotrexate
714 mcg24 weeks—
Effects of antenatal micronutrient supplementation regimens on adolescent emotional and behavioral problems: A 14-year follow-up of a double-blind, cluster-randomized controlled trial
2023 · Folic acid (FA) · Pregnant females in rural western China; age and health condition not reported
400 mcg——
Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial
1994 · 5 mg folic acid each week · People aged 19–78 with rheumatoid arthritis receiving methotrexate
714 mcg——
Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial
1994 · 27.5 mg folic acid each week · People aged 19–78 with rheumatoid arthritis receiving methotrexate
3.93 mg——
Effects of individualized administration of folic acid on prothrombotic state and vascular endothelial function with H-type hypertension: A double-blinded, randomized clinical cohort study
2022 · Intervention group, second treatment phase, CC genotype · Adults with H-type hypertension, hyperhomocysteinemia and a prothrombotic state; MTHFR C677T CC genotype
800 mcg12 weeks9
[Efficacy and safety of Enalapril-Folate acid tablets in lowering blood pressure and plasma homocysteine]
2007 · Group 3 · People with mild-to-moderate hypertension; age and sex not specified
800 mcg8 weeks—
Efficacy of folic acid and enalapril combined therapy on reduction of blood pressure and plasma glucose: a multicenter, randomized, double-blind, parallel-controlled, clinical trial
2008 · high-FA group · Chinese adults aged 27–75 with mild to moderate hypertension; some participants had baseline hyperglycemia
800 mcg8 weeks—
[Efficacy of enalapril combined with folic acid in lowering blood pressure and plasma homocysteine level]
2009 · high-dose group · People with essential hypertension; age and sex not specified
800 mcg8 weeks—
Elevated Homocysteine Concentrations Decrease the Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitors in Hypertensive Patients
2017 · Enalapril (10 mg) and folic acid (0.8 mg) · Previously untreated hypertensive patients; age and sex not specified
800 mcg1643 days—
Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial
2008 · Multiple micronutrients · Pregnant women resident in disadvantaged rural counties in Shaanxi Province, China; eligible women enrolled before 28 weeks’ gestation
400 mcg—1,899
Equity in adherence to and effect of prenatal food and micronutrient supplementation on child mortality: results from the MINIMat randomized trial, Bangladesh
2014 · EMMS (early food invitation; multiple micronutrients) · Pregnant women in rural Bangladesh, enrolled before 14 weeks’ gestation
400 mcg——
Equity in adherence to and effect of prenatal food and micronutrient supplementation on child mortality: results from the MINIMat randomized trial, Bangladesh
2014 · UMMS (usual food invitation; multiple micronutrients) · Pregnant women in rural Bangladesh, enrolled before 14 weeks’ gestation
400 mcg——
Modifying effects of maternal Hb concentration on infant birth weight in women receiving prenatal iron-containing supplements: a randomised controlled trial
2016 · MMN group · Pregnant women aged at least 20 years, nulliparous, with Hb concentration ≥100 g/L and enrolled before 20 weeks of gestation
400 mcg——
[Prevention of the first occurrence of anencephaly and spina bifida with periconceptional multivitamin supplementation (conclusion)]
1994 · multivitamin supplement · Women planning a pregnancy
800 mcg—2,471
Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation
1992 · vitamin supplement · Women planning a pregnancy, in most cases their first
800 mcg—2,104
Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial
2008 · Iron-folic acid · Pregnant women resident in disadvantaged rural counties in Shaanxi Province, China; eligible women enrolled before 28 weeks’ gestation
400 mcg—1,912
Effect of prenatal multiple micronutrient supplements and medium-quantity lipid-based nutritional supplements on maternal weight gain and infant birth weight in rural Niger: a cluster-randomised trial
2025 · IFA · Pregnant women in rural Niger enrolled at up to 30 weeks' gestation
400 mcg—1,105
Prenatal fortified balanced energy-protein supplementation and birth outcomes in rural Burkina Faso: A randomized controlled efficacy trial
2022 · Control (IFA only) · Pregnant women aged 15–40 years in rural Burkina Faso
400 mcg—909
Prenatal fortified balanced energy-protein supplementation and birth outcomes in rural Burkina Faso: A randomized controlled efficacy trial
2022 · Intervention (IFA plus fortified BEP) · Pregnant women aged 15–40 years in rural Burkina Faso
400 mcg—879
Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial
2008 · folic acid plus vitamin B12 plus vitamin B6 · Adults undergoing coronary angiography with coronary artery disease or aortic valve stenosis
800 mcg165 weeks772
Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial
2008 · folic acid plus vitamin B12 · Adults undergoing coronary angiography with coronary artery disease or aortic valve stenosis
800 mcg165 weeks772
Cost-effectiveness of invitation to food supplementation early in pregnancy combined with multiple micronutrients on infant survival: analysis of data from MINIMat randomized trial, Bangladesh
2015 · UFe60F · Pregnant women in rural Bangladesh, irrespective of nutritional status
400 mcg—738
Association between prenatal provision of lipid-based nutrient supplements and caesarean delivery: Findings from a randomised controlled trial in Malawi
2022 · IFA group · Pregnant women aged 15 years or older, enrolled before 20 completed gestational weeks, without chronic health conditions, in Malawi
400 mcg—420
Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial
2002 · homocysteine-lowering therapy · Patients with coronary artery disease after successful percutaneous coronary intervention; age and sex not specified
1 mg26 weeks272
Impact of weekly iron folic acid supplementation with and without vitamin B12 on anaemic adolescent girls: a randomised clinical trial
2016 · Group B · Anaemic adolescent girls aged 11–18 years
71.4 mcg26 weeks224
Impact of weekly iron folic acid supplementation with and without vitamin B12 on anaemic adolescent girls: a randomised clinical trial
2016 · Group A · Anaemic adolescent girls aged 11–18 years
71.4 mcg26 weeks222
Randomized control trial comparing effectiveness of weekly versus daily antenatal oral iron supplementation in preventing anemia during pregnancy
2018 · weekly supplementation group · Non-anemic pregnant women at 14–22 weeks’ gestation
429 mcg—149
Randomized control trial comparing effectiveness of weekly versus daily antenatal oral iron supplementation in preventing anemia during pregnancy
2018 · daily supplementation group · Non-anemic pregnant women at 14–22 weeks’ gestation
1 mg—143
Periconceptional iron supplementation does not reduce anemia or improve iron status among pregnant women in rural Bangladesh
2009 · iron and folic acid (IFA) · Married, nulliparous women in rural Bangladesh, followed until pregnancy or the end of 9 months
400 mcg274 days134
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial
2015 · myo-inositol · Pregnant obese women (prepregnancy BMI 30 or greater)
400 mcg—110
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial
2016 · myo-inositol group · Pregnant overweight, non-obese women with pre-pregnancy BMI ≥25 and <30 kg/m²
400 mcg—110
Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: an open-label, randomized controlled trial
2024 · MI group · Pregnant women at 11–13+6 weeks of gestation
400 mcg—100
Multimicronutrient supplementation for undernourished pregnant women and the birth size of their offspring: a double-blind, randomized, placebo-controlled trial
2007 · micronutrient supplementation group · Undernourished pregnant women enrolled at 24–32 weeks of gestation, with BMI <18.5 and/or hemoglobin 7–9 g/dL
500 mcg58 days99
Weekly vs daily iron and folic acid supplementation in adolescent Nepalese girls
2002 · Group A · Healthy adolescent girls in Nepal; median age 15 years
1.5 mg100 days70
Weekly vs daily iron and folic acid supplementation in adolescent Nepalese girls
2002 · Group B · Healthy adolescent girls in Nepal; median age 15 years
214 mcg14 weeks67
Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
2010 · MYO plus folic acid, with r-FSH added if no pregnancy occurred · Women with polycystic ovary syndrome, menstrual irregularities, chronic anovulation, and female infertility; ages not reported
400 mcg—60
Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial
2000 · early group · Premature infants with birth weight <1250 g
2 mg8 weeks57
Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial
2000 · late group · Premature infants with birth weight <1250 g
2 mg8 weeks57
Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer
2018 · Supplemented patients · Adults aged at least 18 years with advanced metastatic or locally advanced unresectable esophagogastric carcinoma
450 mcg22 weeks41
Effect of Lipid-Based Multiple Micronutrients Supplementation in Underweight Primigravida Pre-Eclamptic Women on Maternal and Pregnancy Outcomes: Randomized Clinical Trial
2022 · Group 1 · Pregnant primigravida women aged 15–35 with pre-eclampsia and underweight for gestational age
400 mcg48 days30
Effect of Lipid-Based Multiple Micronutrients Supplementation in Underweight Primigravida Pre-Eclamptic Women on Maternal and Pregnancy Outcomes: Randomized Clinical Trial
2022 · Group 2 · Pregnant primigravida women aged 15–35 with pre-eclampsia and underweight for gestational age
400 mcg62 days30
Albendazole therapy and reduced decline in haemoglobin concentration during pregnancy (Sierra Leone)
2001 · albendazole plus iron-folate supplements · Pregnant women in Sierra Leone
5 mg——
Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal
2003 · Folic acid · Pregnant women in rural Nepal
400 mcg——
Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal
2003 · Folic acid + iron · Pregnant women in rural Nepal
400 mcg——
Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial
2005 · daily oral treatment with folate and mecobalamin · Adults aged 65 years or older with residual hemiplegia at least 1 year after a first ischemic stroke
5 mg2 years—
Effect of routine prophylactic supplementation with iron and folic acid on preschool child mortality in southern Nepal: community-based, cluster-randomised, placebo-controlled trial
2006 · iron and folic acid · Children aged 1–36 months in southern Nepal
50 mcg——
Effect of routine prophylactic supplementation with iron and folic acid on preschool child mortality in southern Nepal: community-based, cluster-randomised, placebo-controlled trial
2006 · iron and folic acid with zinc · Children aged 1–36 months in southern Nepal
50 mcg——
Daily intake of 100 mg ascorbic acid as urinary tract infection prophylactic agent during pregnancy
2007 · Group A · Pregnant women
5 mg90 days—
Daily intake of 100 mg ascorbic acid as urinary tract infection prophylactic agent during pregnancy
2007 · Group B · Pregnant women
5 mg90 days—
5-methyltetrahydrofolate administration is associated with prolonged survival and reduced inflammation in ESRD patients
2008 · group B · Hemodialysis patients with end-stage renal disease; age and sex not reported
5 mg——
Treatment and prevention of anemia with ferrous sulfate plus folic acid in children attending daycare centers in Goiânia, Goiás State, Brazil: a randomized controlled trial
2008 · Treatment group receiving ferrous sulfate plus folic acid · Children aged 6–24 months with anemia attending municipal daycare centers in Goiânia, Brazil
50 mcg90 days—
Treatment and prevention of anemia with ferrous sulfate plus folic acid in children attending daycare centers in Goiânia, Goiás State, Brazil: a randomized controlled trial
2008 · Prevention group receiving ferrous sulfate plus folic acid · Non-anemic children aged 6–24 months attending municipal daycare centers in Goiânia, Brazil
50 mcg90 days—
Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial
2012 · standard multivitamin with high doses of folic acid, vitamin B6 and vitamin B12 · Men and women aged 35–75 years, at least 6 months after kidney transplant, with stable kidney function and elevated serum homocysteine
5 mg——
myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study
2013 · myo-inositol group · Pregnant women recruited at 12–13 weeks’ gestation with a first-degree relative with type 2 diabetes, prepregnancy BMI <30 kg/m², and no pregestational diabetes or PCOS
400 mcg——
Equity in adherence to and effect of prenatal food and micronutrient supplementation on child mortality: results from the MINIMat randomized trial, Bangladesh
2014 · EFe60F (early food invitation; 60 mg iron + 400 μg folic acid) · Pregnant women in rural Bangladesh, enrolled before 14 weeks’ gestation
400 mcg——
Equity in adherence to and effect of prenatal food and micronutrient supplementation on child mortality: results from the MINIMat randomized trial, Bangladesh
2014 · UFe60F (usual food invitation; 60 mg iron + 400 μg folic acid) · Pregnant women in rural Bangladesh, enrolled before 14 weeks’ gestation
400 mcg——
Effectiveness of homocysteine lowering vitamins in prevention of thrombotic tendency at high altitude area: A randomized field trial
2015 · intervention · Indian soldiers freshly inducted to a high-altitude area
5 mg2 years—
Effects of long-term weekly iron and folic acid supplementation on lower genital tract infection - a double blind, randomised controlled trial in Burkina Faso
2017 · iron · Healthy nulliparous, non-pregnant women aged 15–24 years at enrolment; some became pregnant during follow-up
400 mcg548 days—
Prevention of congenital abnormalities by periconceptional multivitamin supplementation
1993 · multivitamin group · Women in the Hungarian family planning programme around conception; age and health condition not stated
800 mcg——
The higher rate of multiple births after periconceptional multivitamin supplementation: an analysis of causes
1994 · multivitamin group · Women receiving periconceptional supplementation; pregnancy
800 mcg——
Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation
1996 · multivitamin group · Women receiving periconceptional supplementation; age and health condition not specified
800 mcg——
Predictors of adherence to micronutrient supplementation before and during pregnancy in Vietnam
2017 · IFA (iron and folic acid) preconception group · Women of reproductive age in Vietnam intending to become pregnant
400 mcg400 days1,489
Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis
2013 · B-vitamins · Patients with previous stroke or transient ischemic attack who were cognitively unimpaired at the cognitive assessment
2 mg1241 days1,110
Evaluation of multiple micronutrient supplementation and medium-quantity lipid-based nutrient supplementation in pregnancy on child development in rural Niger: A secondary analysis of a cluster randomized controlled trial
2022 · MMS · Pregnant women under 30 weeks’ gestation at enrollment, without the specified chronic health conditions or pregnancy complications
400 mcg—1,083
Effect of a randomised exclusive breastfeeding counselling intervention nested into the MINIMat prenatal nutrition trial in Bangladesh
2017 · Fe30 · Pregnant women in rural Bangladesh, enrolled before 14 weeks of gestation
400 mcg—917
Effect of a randomised exclusive breastfeeding counselling intervention nested into the MINIMat prenatal nutrition trial in Bangladesh
2017 · MMS · Pregnant women in rural Bangladesh, enrolled before 14 weeks of gestation
400 mcg—914
Impact of preconceptional micronutrient supplementation on maternal mental health during pregnancy and postpartum: results from a randomized controlled trial in Vietnam
2017 · Iron and folic acid (IFA) · Women aged 18–40 planning pregnancy; reproductive-age women without a stated diagnosed condition
400 mcg56 weeks526
Impact of preconceptional micronutrient supplementation on maternal mental health during pregnancy and postpartum: results from a randomized controlled trial in Vietnam
2017 · Multiple micronutrients (MM) · Women aged 18–40 planning pregnancy; reproductive-age women without a stated diagnosed condition
400 mcg56 weeks518
Prenatal and postnatal lipid-based nutrient supplementation and cognitive, social-emotional, and motor function in preschool-aged children in Ghana: a follow-up of a randomized controlled trial
2019 · multiple micronutrients (MMN) group · Pregnant women aged 18 years or older, enrolled at up to 20 weeks of gestation; supplementation continued postpartum
400 mcg—439
Preconception micronutrient supplementation positively affects child intellectual functioning at 6 y of age: A randomized controlled trial in Vietnam
2021 · IFA (iron and folic acid) group · Women of reproductive age receiving preconception supplementation; offspring were assessed at ages 6–7 years
400 mcg194 days427
Preconception micronutrient supplementation positively affects child intellectual functioning at 6 y of age: A randomized controlled trial in Vietnam
2021 · MM (multiple micronutrient) group · Women of reproductive age receiving preconception supplementation; offspring were assessed at ages 6–7 years
400 mcg200 days422
Lipid-based nutrient supplement increases the birth size of infants of primiparous women in Ghana
2015 · IFA · Pregnant women in Ghana, aged 20 years or younger in pregnancy (≤20 weeks); primiparous subgroup reported
400 mcg—349
Effects of prenatal food and micronutrient supplementation on child growth from birth to 54 months of age: a randomized trial in Bangladesh
2011 · Early invitation food supplementation + Fe60F · Pregnant women in rural Bangladesh; fetal viability and gestational age under 14 weeks; all eligible maternal nutritional statuses
400 mcg—291
Effects of prenatal food and micronutrient supplementation on child growth from birth to 54 months of age: a randomized trial in Bangladesh
2011 · Early invitation food supplementation + MMS · Pregnant women in rural Bangladesh; fetal viability and gestational age under 14 weeks; all eligible maternal nutritional statuses
400 mcg—290
Effects of prenatal food and micronutrient supplementation on child growth from birth to 54 months of age: a randomized trial in Bangladesh
2011 · Usual invitation food supplementation + Fe60F · Pregnant women in rural Bangladesh; fetal viability and gestational age under 14 weeks; all eligible maternal nutritional statuses
400 mcg—275
Effects of prenatal food and micronutrient supplementation on child growth from birth to 54 months of age: a randomized trial in Bangladesh
2011 · Usual invitation food supplementation + Fe30F · Pregnant women in rural Bangladesh; fetal viability and gestational age under 14 weeks; all eligible maternal nutritional statuses
400 mcg—260
Effects of prenatal food and micronutrient supplementation on child growth from birth to 54 months of age: a randomized trial in Bangladesh
2011 · Usual invitation food supplementation + MMS · Pregnant women in rural Bangladesh; fetal viability and gestational age under 14 weeks; all eligible maternal nutritional statuses
400 mcg—260
Effects of prenatal food and micronutrient supplementation on child growth from birth to 54 months of age: a randomized trial in Bangladesh
2011 · Early invitation food supplementation + Fe30F · Pregnant women in rural Bangladesh; fetal viability and gestational age under 14 weeks; all eligible maternal nutritional statuses
400 mcg—258
The dihydrofolate reductase 19-bp deletion modifies the beneficial effect of B-vitamin therapy in mild cognitive impairment: pooled study of two randomized placebo-controlled trials
2022 · Active treatment, Hong Kong trial · Older adults with mild cognitive impairment; mean age about 77 years; sex not restricted
400 mcg2 years131
Vitamin B12 and Folic Acid Improve Gross Motor and Problem-Solving Skills in Young North Indian Children: A Randomized Placebo-Controlled Trial
2015 · Folic acid · Children aged 6–30 months from low- to middle-socioeconomic-class families in New Delhi, India
150 mcg26 weeks107
Folate and Vitamin B(12)-Related Biomarkers in Relation to Brain Volumes
2016 · B-vitamin group · Adults aged 65 years or older with mildly elevated plasma homocysteine (12–50 µmol/L)
400 mcg2 years106
DHA status influences effects of B-vitamin supplementation on cognitive ageing: a post-hoc analysis of the B-proof trial
2022 · B-vitamin group · Men and women aged 65 years and older with elevated plasma homocysteine levels (12–50 µmol/L), cognitively healthy
400 mcg2 years94
Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?
2001 · folic acid · Patients with coronary artery disease; age and sex not reported
5 mg6 weeks52
Comparison of two different folic acid doses with methotrexate--a randomized controlled trial (FOLVARI Study)
2015 · FA30 group · Adults aged 18–75 with active rheumatoid arthritis
4.29 mg24 weeks49
Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term?
2000 · FA 5 mg daily · Adults with rheumatoid arthritis established on methotrexate and folic acid
5 mg1 year38
Folic acid improves endothelial function in children and adolescents with type 1 diabetes
2004 · Folic acid · Children and adolescents with type 1 diabetes; mean age 13.6 years (SD 2.6)
5 mg8 weeks36
Folic acid does not improve endothelial function in healthy hyperhomocysteinaemic subjects
2004 · folic acid · Healthy adults with hyperhomocysteinaemia and no additional coronary artery disease risk factors; age range not stated
5 mg8 weeks26
Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo-controlled trial
1999 · folic acid treatment · Adults with familial hypercholesterolemia; age and sex not specified
5 mg4 weeks20
Folic acid improves endothelial dysfunction in type 2 diabetes--an effect independent of homocysteine-lowering
2006 · folic acid · patients with type 2 diabetes without vascular disease
10 mg2 weeks19
A randomized double-blind comparison of fluoxetine augmentation by high and low dosage folic acid in patients with depressive episodes
2013 · Group II · Female out-patients with moderate or severe depressive episodes, without psychotic symptoms
5 mg6 weeks19
Oral folate enhances endothelial function in hyperhomocysteinaemic subjects
1999 · oral folic acid · healthy adults with mild hyperhomocysteinaemia (entry homocysteine >13 micromol L-1)
5 mg6 weeks18
Folic acid improves arterial endothelial function in adults with hyperhomocystinemia
1999 · folic acid · Adults aged 44–64 with fasting total homocystine levels above the 75th percentile (hyperhomocystinemia), without the listed cardiovascular risk conditions
10 mg8 weeks17
Short-Term Effects of Folate Supplementation in Combination With Vitamin B6 for Treating Acute Manic Episodes in Bipolar I Disorder: A Randomized Controlled Trial
2025 · Folate group · Adults aged 18–45 with bipolar I disorder in an acute manic episode
5 mg6 weeks15
High-dose folic acid acutely improves coronary vasodilator function in patients with coronary artery disease
2005 · folate · adult men and women with coronary artery disease and normal serum homocysteine
30 mg1 day14
Folic acid supplementation increases cutaneous vasodilator sensitivity to sympathetic nerve activity in older adults
2017 · folic acid · Older adults, mean age 66 ± 1 years; 8 male and 6 female; no specific condition stated
5 mg6 weeks14
Pyridoxine improves endothelial function in cardiac transplant recipients
2001 · folate · Cardiac transplant recipients; age and sex not specified
5 mg10 weeks12
[Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study]
2005 · study group · Patients with epilepsy treated with phenytoin, carbamazepine, or both
5 mg26 weeks9
Effect of folic acid on recurrence of phenytoin-induced gingival overgrowth following gingivectomy
1991 · treatment group · Residents of an institution for people with developmental disabilities with phenytoin-induced gingival overgrowth following gingivectomy
5 mg26 weeks4
Influence of folic acid on postprandial endothelial dysfunction
2000 · folic acid · Healthy volunteers aged 18–33 years
10 mg2 weeks—
Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy
2000 · Folic acid 5 mg daily, without betaine (12-week phase) · Adults on maintenance dialysis with end-stage renal disease and hyperhomocysteinemia
5 mg12 weeks—
Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy
2000 · Folic acid 5 mg (40-week phase) · Adults on maintenance dialysis with end-stage renal disease and hyperhomocysteinemia
5 mg40 weeks—
Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure?
2000 · folic acid group · Adults with predialysis chronic renal failure; mean age 62 years; 67 men across the study
5 mg12 weeks—
A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease
2001 · folic acid group · Adults aged 46–79 years with coronary artery disease; 79 of the 90 participants were men
5 mg12 weeks—
Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study
2001 · folic acid · healthy men aged 19 to 32 years
10 mg7 days—
Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering
2002 · folic acid · Patients with coronary artery disease; age and sex not reported
5 mg6 weeks—
Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial
2002 · folic acid and placebo · Fertile and subfertile men
5 mg26 weeks—
Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial
2002 · folic acid · Healthy adult cigarette smokers; mean age 37.8 years
5 mg4 weeks—
C677T methylenetetrahydrofolate reductase polymorphism interferes with the effects of folic acid and zinc sulfate on sperm concentration
2003 · folic acid group · fertile and subfertile males
5 mg26 weeks—
Folic Acid improves baroreceptor sensitivity in hypertension
2005 · folic acid group · male patients with hypertension
5 mg1 day—
Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes
2005 · oral folic acid · Adults with type 2 diabetes, mean age 56.5 years, with no history of cardiovascular disease
5 mg4 weeks—
Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial
2006 · FA group · Patients with psoriasis stable on long-term methotrexate doses and not receiving folic acid
5 mg12 weeks—
Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus
2006 · Folate · Children with type 1 diabetes mellitus; age and sex not specified
5 mg8 weeks—
Effect of folic acid on endothelial function following acute myocardial infarction
2007 · group A · Patients after acute myocardial infarction referred for coronary intervention; 16 had normal homocysteine and 24 had elevated homocysteine across the study
10 mg6 weeks—
Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease
2007 · high-dose folic acid · Patients with coronary artery disease; age and sex not reported
5 mg7 weeks—
The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people
2007 · cobalamin plus folic acid group · Dutch elderly people; no diagnosed condition stated
400 mcg24 weeks—
Effect of folic acid combined with fluoxetine in patients with major depression on plasma homocysteine and vitamin B12, and serotonin levels in lymphocytes
2008 · fluoxetine and folic acid · Patients with major depression; age and sex not reported
10 mg6 weeks—
A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease
2008 · B vitamin group · Women aged 65 years or older with cardiovascular disease or at least three coronary risk factors; female health professionals
2.5 mg2411 days—
Assessment of the efficacy of combination therapy with folic acid and tadalafil for the management of erectile dysfunction in men with type 2 diabetes mellitus
2013 · Group A · Men with type 2 diabetes mellitus and erectile dysfunction
5 mg90 days—
Effects of pre- and postnatal nutrition interventions on child growth and body composition: the MINIMat trial in rural Bangladesh
2013 · Fe30F · Pregnant women enrolled before 14 weeks’ gestation; age 14–50 years
400 mcg——
Effects of pre- and postnatal nutrition interventions on child growth and body composition: the MINIMat trial in rural Bangladesh
2013 · MMS · Pregnant women enrolled before 14 weeks’ gestation; age 14–50 years
400 mcg——
Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT
2014 · B-vitamin group · Adults aged 65 years and older with homocysteine levels of 12–50 µmol/L
400 mcg2 years—
Folic acid supplementation improves microvascular function in older adults through nitric oxide-dependent mechanisms
2015 · Folic acid treatment · Healthy young and older adults; age ranges and arm size not stated
5 mg6 weeks—
Effects of 2-year vitamin B12 and folic acid supplementation in hyperhomocysteinemic elderly on arterial stiffness and cardiovascular outcomes within the B-PROOF trial
2015 · B-vitamin supplementation · Adults aged at least 65 years with hyperhomocysteinemia (12–50 μmol/l)
400 mcg2 years—
Comparative Study of the Effects of Tamoxifen Citrate and Folate on Semen Quality of the Infertile Male with Semen Abnormality
2015 · Tamoxifen citrate plus Folate · Infertile men with semen abnormalities
5 mg90 days—
Effects of Two-Year Vitamin B(12) and Folic Acid Supplementation on Depressive Symptoms and Quality of Life in Older Adults with Elevated Homocysteine Concentrations: Additional Results from the B-PROOF Study, an RCT
2016 · intervention group · Adults aged 65 years or older from the general population with elevated homocysteine concentrations (12–50 µmol/L)
400 mcg2 years—
The effects of folic acid and pyridoxine supplementation on characteristics of migraine attacks in migraine patients with aura: A double-blind, randomized placebo-controlled, clinical trial
2017 · folic acid alone · Adults aged 18–65 with migraine with aura
5 mg90 days—
Preconception Micronutrient Supplementation with Iron and Folic Acid Compared with Folic Acid Alone Affects Linear Growth and Fine Motor Development at 2 Years of Age: A Randomized Controlled Trial in Vietnam
2017 · IFA group · Women in Vietnam receiving preconception supplementation; age and health status not stated
400 mcg——
A Pilot Randomized Controlled Double-Blind Trial of High- Versus Low-Dose Weekly Folic Acid in People With Rheumatoid Arthritis Receiving Methotrexate
2019 · low-dose group · People with active rheumatoid arthritis receiving stable-dose methotrexate
114 mcg24 weeks—
B-vitamins and body composition: integrating observational and experimental evidence from the B-PROOF study
2020 · intervention group · Adults aged 65 years and older with elevated homocysteine levels (12–50 µmol/L)
400 mcg2 years—
A randomized placebo-controlled trial of using B vitamins to prevent cognitive decline in older mild cognitive impairment patients
2020 · B vitamins supplementation · Adults aged 65 years or older with mild cognitive impairment and serum homocysteine ≥10.0 μmol/L
400 mcg2 years—
Folic acid supplementation in postmenopausal women with hot flushes: phase III randomised double-blind placebo-controlled trial
2021 · folic acid group · Postmenopausal women experiencing at least 50 hot flushes weekly
5 mg12 weeks—
B Vitamin Supplementation Slows Cognitive Decline in Mild Cognitive Impairment Patients with Frontal Lobe Atrophy
2022 · B vitamin supplementation · Mild cognitive impairment outpatients; age and sex not specified
400 mcg2 years—
Effects of antenatal micronutrient supplementation regimens on adolescent emotional and behavioral problems: A 14-year follow-up of a double-blind, cluster-randomized controlled trial
2023 · Multiple micronutrient (MMN) · Pregnant females in rural western China; age and health condition not reported
400 mcg——
Prenatal and postnatal small-quantity lipid-based nutrient supplements and children's social-emotional difficulties at ages 9-11 y in Ghana: follow-up of a randomized controlled trial
2023 · multiple micronutrient (MMN) group · Pregnant women in Ghana; children were followed through infancy and assessed at ages 9–11 years
400 mcg——
Effect of folic acid on the sexual function of postmenopausal women: a triple-blind randomized controlled trial
2023 · folic acid group · Postmenopausal women; mean age 53.2 years
5 mg8 weeks—
Thiamine and folate treatment of chronic epileptic patients: a controlled study with the Wechsler IQ scale
1993 · second group · Patients with epilepsy receiving phenytoin alone or with phenobarbital for more than 4 years; age and sex not reported
5 mg26 weeks—
Effects of individualized administration of folic acid on prothrombotic state and vascular endothelial function with H-type hypertension: A double-blinded, randomized clinical cohort study
2022 · Intervention group, second treatment phase, CT genotype · Adults with H-type hypertension, hyperhomocysteinemia and a prothrombotic state; MTHFR C677T CT genotype
2.5 mg12 weeks14
[Efficacy and safety of Enalapril-Folate acid tablets in lowering blood pressure and plasma homocysteine]
2007 · Group 2 · People with mild-to-moderate hypertension; age and sex not specified
400 mcg8 weeks—
Efficacy of folic acid and enalapril combined therapy on reduction of blood pressure and plasma glucose: a multicenter, randomized, double-blind, parallel-controlled, clinical trial
2008 · low-FA group · Chinese adults aged 27–75 with mild to moderate hypertension; some participants had baseline hyperglycemia
400 mcg8 weeks—
[Efficacy of enalapril combined with folic acid in lowering blood pressure and plasma homocysteine level]
2009 · low-dose group · People with essential hypertension; age and sex not specified
400 mcg8 weeks—
A pilot study of D-chiro-inositol plus folic acid in overweight patients with type 1 diabetes
2017 · control group · Overweight or obese patients with type 1 diabetes receiving intensive insulin therapy
400 mcg24 weeks—
Multivitamin and iron supplementation to prevent periconceptional anemia in rural tanzanian women: a randomized, controlled trial
2015 · Folic acid, iron, multivitamins · Non-pregnant women and adolescent girls aged 15–29 years in rural Tanzania
400 mcg26 weeks267
The effect of myo-inositol, vitamin D3 and melatonin on the oocyte quality and pregnancy in in vitro fertilization: a randomized prospective controlled trial
2020 · Study group · Women undergoing ICSI
600 mcg26 weeks50
Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly
2004 · special nutritional formula · Healthy adults aged 70 years or older with Mini Mental score ≥22
400 mcg1 year30
Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal
2003 · Folic acid + iron + zinc · Pregnant women in rural Nepal
400 mcg——
Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal
2003 · Multiple micronutrients · Pregnant women in rural Nepal
400 mcg——
Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension
2005 · Multivitamin plus vitamin A · HIV-positive pregnant Tanzanian women
800 mcg——
Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension
2005 · Multivitamin without vitamin A · HIV-positive pregnant Tanzanian women
800 mcg——
Randomized, double-blind, placebo-controlled trial of selenium supplements among HIV-infected pregnant women in Tanzania: effects on maternal and child outcomes
2008 · selenium group · Infants born to women with HIV in the selenium group; follow-up after birth
1.05 mg——
Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary atherosclerosis
2013 · AGE-S · Subjects evaluated for coronary artery calcium; age, sex, and specific condition are not stated
300 mcg1 year—
Predictors of adherence to micronutrient supplementation before and during pregnancy in Vietnam
2017 · MM (multiple micronutrients) preconception group · Women of reproductive age in Vietnam intending to become pregnant
400 mcg54 weeks1,469
Effects of antenatal multiple micronutrient supplementation on children's weight and size at 2 years of age in Nepal: follow-up of a double-blind randomised controlled trial
2008 · intervention group · Pregnant women enrolled at no earlier than 12 weeks’ gestation, with singleton pregnancies and gestation up to 20 completed weeks
400 mcg—600
Effect of antenatal multiple micronutrient supplementation on anthropometry and blood pressure in mid-childhood in Nepal: follow-up of a double-blind randomised controlled trial
2014 · intervention group (multiple micronutrient supplement) · Pregnant women attending antenatal care in Nepal; no specific age range or deficiency criterion stated
400 mcg—600
Assessing the adherence and acceptability to iron and folic acid compared with multiple micronutrient supplements during pregnancy: a cluster-randomized noninferiority trial in Cambodia
2025 · MMS-180 · Healthy pregnant individuals aged 18–45 years, in the first 14 weeks of a low-risk singleton pregnancy
400 mcg180 days516
Assessing the adherence and acceptability to iron and folic acid compared with multiple micronutrient supplements during pregnancy: a cluster-randomized noninferiority trial in Cambodia
2025 · MMS-90 · Healthy pregnant individuals aged 18–45 years, in the first 14 weeks of a low-risk singleton pregnancy
400 mcg180 days515
Adherence in a pragmatic randomized controlled trial on prophylactic iron supplementation during pregnancy in Maputo, Mozambique
2015 · routine Fe · Pregnant women aged 18 years or older with non-high-risk pregnancies, at least 12 weeks’ gestation, attending prenatal care in Maputo, Mozambique
400 mcg—2,184
Adherence in a pragmatic randomized controlled trial on prophylactic iron supplementation during pregnancy in Maputo, Mozambique
2015 · selective Fe · Pregnant women aged 18 years or older with non-high-risk pregnancies, at least 12 weeks’ gestation, attending prenatal care in Maputo, Mozambique
1 mg—2,142
Evaluation of multiple micronutrient supplementation and medium-quantity lipid-based nutrient supplementation in pregnancy on child development in rural Niger: A secondary analysis of a cluster randomized controlled trial
2022 · IFA (routine care) · Pregnant women under 30 weeks’ gestation at enrollment, without the specified chronic health conditions or pregnancy complications
400 mcg—1,105
Effect of a randomised exclusive breastfeeding counselling intervention nested into the MINIMat prenatal nutrition trial in Bangladesh
2017 · Fe60 · Pregnant women in rural Bangladesh, enrolled before 14 weeks of gestation
400 mcg—958
Prevalence of morbidity symptoms among pregnant and postpartum women receiving different nutrient supplements in Ghana and Malawi: A secondary outcome analysis of two randomised controlled trials
2023 · IFA supplement group · Pregnant women aged 18 years or older in Ghana and pregnant women aged 15 years or older in Malawi; supplementation began by 20 weeks of pregnancy, with follow-up through lactation
400 mcg—904
Effects of antenatal multiple micronutrient supplementation on children's weight and size at 2 years of age in Nepal: follow-up of a double-blind randomised controlled trial
2008 · control group · Pregnant women enrolled at no earlier than 12 weeks’ gestation, with singleton pregnancies and gestation up to 20 completed weeks
400 mcg—600
Assessing the adherence and acceptability to iron and folic acid compared with multiple micronutrient supplements during pregnancy: a cluster-randomized noninferiority trial in Cambodia
2025 · IFA-90 · Healthy pregnant individuals aged 18–45 years, in the first 14 weeks of a low-risk singleton pregnancy
400 mcg90 days515
The effect of blister packaging Iron and Folate on adherence to medication and hemoglobin levels among pregnant women at National Referral Hospital antenatal clinics in a low to middle income country: a Randomised Controlled Trial (The IFAd Trial)
2022 · IFA in blister packaging · Pregnant women in their second trimester up to 28 weeks, aged 15–43 years, eligible for iron and folic acid supplementation
400 mcg8 weeks478
The effect of blister packaging Iron and Folate on adherence to medication and hemoglobin levels among pregnant women at National Referral Hospital antenatal clinics in a low to middle income country: a Randomised Controlled Trial (The IFAd Trial)
2022 · IFA in loose packaging · Pregnant women in their second trimester up to 28 weeks, aged 15–43 years, eligible for iron and folic acid supplementation
400 mcg8 weeks474
Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in community-dwelling older adults with depressive symptoms--the Beyond Ageing Project: a randomized controlled trial
2012 · daily oral folic acid + vitamin B-12 supplementation · Adults aged 60–74 with elevated psychological distress
400 mcg2 years450
Small-quantity, lipid-based nutrient supplements provided to women during pregnancy and 6 mo postpartum and to their infants from 6 mo of age increase the mean attained length of 18-mo-old children in semi-urban Ghana: a randomized controlled trial
2016 · IFA · Pregnant women aged 18 years or older enrolled at up to 20 weeks of gestation; their infants received no supplement
400 mcg—441
Maternal Supplementation with Small-Quantity Lipid-Based Nutrient Supplements Compared with Multiple Micronutrients, but Not with Iron and Folic Acid, Reduces the Prevalence of Low Gestational Weight Gain in Semi-Urban Ghana: A Randomized Controlled Trial
2017 · IFA group · Pregnant women aged 18 years or older, enrolled at 20 weeks’ gestation or earlier; semi-urban Ghana
400 mcg—441
Prenatal and postnatal lipid-based nutrient supplementation and cognitive, social-emotional, and motor function in preschool-aged children in Ghana: a follow-up of a randomized controlled trial
2019 · iron and folic acid (IFA) group · Pregnant women aged 18 years or older, enrolled at up to 20 weeks of gestation
400 mcg—441
Effect of prenatal micronutrient-fortified balanced energy-protein supplementation on maternal and newborn body composition: A sub-study from the MISAME-III randomized controlled efficacy trial in rural Burkina Faso
2023 · Intervention · Pregnant women aged 15–40 years, enrolled before 21 completed weeks of gestation; maternal and newborn body composition were assessed postpartum
400 mcg—440
Sustained effects of small-quantity lipid-based nutrient supplements provided during the first 1000 days on child growth at 9-11 y in a randomized controlled trial in Ghana
2024 · daily IFA tablets · Pregnant females aged 18 years or older enrolled at up to 20 weeks of gestation; their children received no infant supplementation
400 mcg—440
Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study
2009 · vitamin group · Adults aged 21 years or older with advanced chronic kidney disease or end-stage renal disease and high plasma homocysteine
40 mg1128 days339
Maternal zinc supplementation and growth in Peruvian infants
2008 · zinc group · Pregnant women enrolled at 10–24 weeks of gestation; low-risk pregnancy
250 mcg—273
Maternal zinc supplementation and growth in Peruvian infants
2008 · control group · Pregnant women enrolled at 10–24 weeks of gestation; low-risk pregnancy
250 mcg—273
High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial
2009 · B-vitamin group · Men and postmenopausal women aged 40 years or older with fasting total homocysteine ≥8.5 μmol/L and no clinical signs or symptoms of cardiovascular disease
5 mg1132 days254
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial
2008 · high-dose supplement group · Adults over 50 with mild to moderate probable Alzheimer disease and normal vitamin B12 and folate levels
5 mg548 days240
Associations of maternal nutrition during pregnancy and post-partum with maternal cognition and caregiving
2018 · IFA · Pregnant women enrolled at ≤20 weeks’ gestation in Malawi, followed through 6 months postpartum
400 mcg1 year238
Association of prenatal lipid-based nutritional supplementation with fetal growth in rural Gambia
2017 · MMN · Pregnant women aged 18–45 years in rural Gambia, enrolled at 10–20 weeks’ gestation
400 mcg—164
Association of prenatal lipid-based nutritional supplementation with fetal growth in rural Gambia
2017 · PE · Pregnant women aged 18–45 years in rural Gambia, enrolled at 10–20 weeks’ gestation
400 mcg—151
Vitamins B12, B6, and folic acid for onset of depressive symptoms in older men: results from a 2-year placebo-controlled randomized trial
2008 · treatment with vitamins · Men aged 75 years and older, free of clinically significant depression at baseline
2 mg2 years150
Association of prenatal lipid-based nutritional supplementation with fetal growth in rural Gambia
2017 · FeFol · Pregnant women aged 18–45 years in rural Gambia, enrolled at 10–20 weeks’ gestation
400 mcg—146
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial
2012 · B-vitamin group · Adults aged 70 years or older with mild cognitive impairment
800 mcg2 years133
Effect of Picture-based health education and counselling on knowledge and adherence to preconception Iron-folic acid supplementation among women planning to be pregnant in Eastern Ethiopia: a randomized controlled trial
2022 · Intervention group · Women aged 18–45 planning pregnancy after stopping contraception or following spontaneous abortion
400 mcg90 days122
Effect of Picture-based health education and counselling on knowledge and adherence to preconception Iron-folic acid supplementation among women planning to be pregnant in Eastern Ethiopia: a randomized controlled trial
2022 · Control group · Women aged 18–45 planning pregnancy after stopping contraception or following spontaneous abortion
400 mcg90 days122
Vitamin B12 and Folic Acid Improve Gross Motor and Problem-Solving Skills in Young North Indian Children: A Randomized Placebo-Controlled Trial
2015 · Vitamin B12 & Folic Acid · Children aged 6–30 months from low- to middle-socioeconomic-class families in New Delhi, India
150 mcg26 weeks101
Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia
2013 · folate plus B12 · Adults aged 18–68 with schizophrenia, stable on antipsychotic treatment and with persistent symptoms
2 mg16 weeks94
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
2010 · Active treatment group · Adults aged 70 years or older with mild cognitive impairment
800 mcg2 years85
Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial
2000 · treatment group · Healthy siblings of patients with premature atherothrombotic disease
5 mg2 years78
Cognitive Benefits of Folic Acid, Docosahexaenoic Acid, and a Combination of Both Nutrients in Mild Cognitive Impairment: Possible Alterations through Mitochondrial Function and DNA Damage
2024 · FA + DHA · Adults aged 60 years and older with mild cognitive impairment
800 mcg1 year70
Effects of Folic Acid and Vitamin B12 Supplementation on Cognitive Impairment and Inflammation in Patients with Alzheimer's Disease: A Randomized, Single-Blinded, Placebo-Controlled Trial
2021 · Folate and vitB12 group · Adults older than 45 years with probable Alzheimer's disease, MoCA score below 22, receiving dementia medication
1.2 mg26 weeks60
Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine
2000 · Folic acid and vitamin B(12) · Men aged 39–67 years with coronary heart disease
5 mg8 weeks59
Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS
2007 · myo-inositol plus folic acid · Women with oligomenorrhea and polycystic ovaries
400 mcg14 weeks45
Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease
2012 · combined therapy · Patients with cardiovascular disease at high cardiovascular risk; age and sex not reported
1 mg6 weeks36
Folate and vitamin B12 supplementation in patients with schizophrenia and low serum folate level: A 24-week randomized, double-blind, placebo-controlled study
2026 · folate group · Patients with schizophrenia and serum folate levels lower than 6 mg/L
5 mg24 weeks36
Acute autonomic effects of vitamins and fats in male smokers
2009 · moderate vitamins · Male smokers, mean age 34.2 years (SD 6.9)
1 mg1 day30
Acute autonomic effects of vitamins and fats in male smokers
2009 · high doses of vitamins · Male smokers, mean age 34.2 years (SD 6.9)
5 mg1 day30
A pilot study of thiamin and folic acid in hemodialysis patients with cognitive impairment
2021 · Treatment group · Adults aged 18–80 with end-stage kidney disease receiving maintenance hemodialysis for at least 3 months and cognitive impairment
30 mg96 weeks25
Effect of folic acid supplementation on mood and serotonin response in healthy males
2005 · Folic acid intervention · Healthy, folate-replete males; age not reported
300 mcg12 weeks23
Probiotic effects on sexual function in women with polycystic ovary syndrome: a double blinded randomized controlled trial
2022 · Probiotic plus letrozole group (Group A) · Women aged 18–38 with PCOS and infertility
400 mcg8 weeks20
Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease
2012 · group V · Patients with cardiovascular disease at high cardiovascular risk; age and sex not reported
1 mg6 weeks18
Integrating Calcium Into Antenatal Iron-Folic Acid Supplementation in Ethiopia: Women's Experiences, Perceptions of Acceptability, and Strategies to Support Calcium Supplement Adherence
2020 · 3-event regimen · Healthy pregnant women aged 16 years or older, 12–28 weeks’ gestation, in rural Ethiopia
400 mcg6 weeks17
Integrating Calcium Into Antenatal Iron-Folic Acid Supplementation in Ethiopia: Women's Experiences, Perceptions of Acceptability, and Strategies to Support Calcium Supplement Adherence
2020 · 2-event regimen · Healthy pregnant women aged 16 years or older, 12–28 weeks’ gestation, in rural Ethiopia
400 mcg6 weeks16
Integrating Calcium Into Antenatal Iron-Folic Acid Supplementation in Ethiopia: Women's Experiences, Perceptions of Acceptability, and Strategies to Support Calcium Supplement Adherence
2020 · 4-event regimen · Healthy pregnant women aged 16 years or older, 12–28 weeks’ gestation, in rural Ethiopia
400 mcg6 weeks15
Short-Term Effects of Folate Supplementation in Combination With Vitamin B6 for Treating Acute Manic Episodes in Bipolar I Disorder: A Randomized Controlled Trial
2025 · Folate/vitamin B6 group · Adults aged 18–45 with bipolar I disorder in an acute manic episode
5 mg6 weeks14
[Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition]
2012 · diet, metformin and MYO (D+M+I) · Overweight or obese women with polycystic ovary syndrome; age not reported
400 mcg90 days9
Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy
2000 · Folic acid 5 mg daily with betaine 4 g per day (12-week phase) · Adults on maintenance dialysis with end-stage renal disease and hyperhomocysteinemia
5 mg12 weeks—
Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial
2002 · zinc sulfate and folic acid · Fertile and subfertile men
5 mg26 weeks—
C677T methylenetetrahydrofolate reductase polymorphism interferes with the effects of folic acid and zinc sulfate on sperm concentration
2003 · folic acid and zinc sulfate group · fertile and subfertile males
5 mg26 weeks—
Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study
2005 · Vitamin therapy · Community-dwelling elderly adults, median age 76 years; both sexes; vitamin deficiencies were present in a subset
800 mcg120 days—
Does folic acid and zinc sulphate intervention affect endocrine parameters and sperm characteristics in men?
2006 · Folic acid and zinc sulphate intervention · Fertile and subfertile males
5 mg26 weeks—
Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus
2006 · Folate/vitamin B6 · Children with type 1 diabetes mellitus; age and sex not specified
5 mg8 weeks—
Combined iron and folic acid supplementation with or without zinc reduces time to walking unassisted among Zanzibari infants 5- to 11-mo old
2006 · iron+folic acid (FeFA) · Children aged 5–11 months at the start of supplementation, nutritionally at risk, in Pemba, Zanzibar
50 mcg1 year—
Combined iron and folic acid supplementation with or without zinc reduces time to walking unassisted among Zanzibari infants 5- to 11-mo old
2006 · iron+folic acid+zinc (FeFA+Zn) · Children aged 5–11 months at the start of supplementation, nutritionally at risk, in Pemba, Zanzibar
50 mcg1 year—
Myoinositol/folic acid combination for the treatment of erectile dysfunction in type 2 diabetes men: a double-blind, randomized, placebo-controlled study
2006 · myoinositol/folic acid combination · men with type 2 diabetes and erectile dysfunction
400 mcg——
Clinical trial: B vitamins improve health in patients with coeliac disease living on a gluten-free diet
2009 · B vitamin supplementation · Adults aged 45–64 years with longstanding coeliac disease, on a strict gluten-free diet for several years
800 mcg26 weeks—
A study of the treatment of Rett syndrome with folate and betaine
2009 · Folate–betaine combination, participants weighing less than 30 kg · Females aged 1.2–28.9 years with Rett syndrome and a MECP2 gene mutation; participants in this dose subgroup weighed less than 30 kg
15 mg1 year—
A study of the treatment of Rett syndrome with folate and betaine
2009 · Folate–betaine combination, participants weighing more than 30 kg · Females aged 1.2–28.9 years with Rett syndrome and a MECP2 gene mutation; participants in this dose subgroup weighed more than 30 kg
15 mg1 year—
The effects of iron and/or zinc supplementation on maternal reports of sleep in infants from Nepal and Zanzibar
2009 · iron–folic acid · Infants aged 4–18 months in Pemba Island, Zanzibar, or Sarlahi District, Nepal
50 mcg1 year—
The effects of iron and/or zinc supplementation on maternal reports of sleep in infants from Nepal and Zanzibar
2009 · iron–folic acid and zinc · Infants aged 4–18 months in Pemba Island, Zanzibar, or Sarlahi District, Nepal
50 mcg1 year—
Physical work capacity of young underprivileged school girls impact of daily vs intermittent iron folic acid supplementation: a randomized controlled trial
2009 · daily IFA group · Schoolgirls aged 9–13 years from underprivileged communities
500 mcg1 year—
Maternal zinc supplementation reduces diarrheal morbidity in peruvian infants
2010 · zinc · Pregnant women in a periurban slum of Lima, Peru
250 mcg——
Daily supplementation with iron plus folic acid, zinc, and their combination is not associated with younger age at first walking unassisted in malnourished preschool children from a deficient population in rural Nepal
2010 · iron+folic acid · Malnourished children aged 1–36 months in a deficient population in rural Nepal
50 mcg——
Daily supplementation with iron plus folic acid, zinc, and their combination is not associated with younger age at first walking unassisted in malnourished preschool children from a deficient population in rural Nepal
2010 · zinc+iron+folic acid · Malnourished children aged 1–36 months in a deficient population in rural Nepal
50 mcg——
A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people
2011 · supplement group · Older people with mild to moderate Alzheimer disease or vascular dementia
5 mg2 years—
Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12
2011 · Folic acid and vitamin B12, without vitamin B6 · Adults with stable coronary artery disease; mean age 57.8 years; sex not specified
800 mcg2 years—
Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12
2011 · Folic acid and vitamin B12 plus vitamin B6 · Adults with stable coronary artery disease; mean age 57.8 years; sex not specified
800 mcg2 years—
Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial
2011 · Group A · Women with polycystic ovary syndrome undergoing IVF
400 mcg90 days—
Developmental effects of micronutrient supplementation and malaria in Zanzibari children
2013 · FeFA alone · Zanzibari children aged 5–14 months at baseline
50 mcg——
Developmental effects of micronutrient supplementation and malaria in Zanzibari children
2013 · FeFA with zinc · Zanzibari children aged 5–14 months at baseline
50 mcg——
Effects of pre- and postnatal nutrition interventions on child growth and body composition: the MINIMat trial in rural Bangladesh
2013 · Fe60F · Pregnant women enrolled before 14 weeks’ gestation; age 14–50 years
400 mcg——
The effects of folic acid and pyridoxine supplementation on characteristics of migraine attacks in migraine patients with aura: A double-blind, randomized placebo-controlled, clinical trial
2017 · folic acid plus pyridoxine · Adults aged 18–65 with migraine with aura
5 mg90 days—
B-Vitamin Therapy for Kidney Transplant Recipients Lowers Homocysteine and Improves Selective Cognitive Outcomes in the Randomized FAVORIT Ancillary Cognitive Trial
2017 · treatment group (high-dose vitamin group) · Men and women aged 35–75 with stable kidney function for at least 6 months after kidney transplantation and elevated plasma homocysteine
5 mg2008 days—
The Vitamins in Psychosis Study: A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Vitamins B(12), B(6), and Folic Acid on Symptoms and Neurocognition in First-Episode Psychosis
2019 · B-vitamin supplement group · Patients with first-episode psychosis; age and sex not specified
5 mg12 weeks—
The myo-inositol effect on the oocyte quality and fertilization rate among women with polycystic ovary syndrome undergoing assisted reproductive technology cycles: a randomized clinical trial
2019 · study group · infertile women with PCOS undergoing assisted reproductive technology cycles; age not reported
400 mg30 days—
Effect of folic acid combined with docosahexaenoic acid intervention on mild cognitive impairment in elderly: a randomized double-blind, placebo-controlled trial
2021 · FA + DHA · Elderly people with mild cognitive impairment (MCI); age range and sex not specified
800 mcg26 weeks—
The impact of myo-inositol supplementation on sleep quality in pregnant women: a randomized, double-blind, placebo-controlled study
2022 · myo-inositol supplementation · Pregnant women with low-risk singleton pregnancies, at least 14 weeks’ gestation
200 mcg10 weeks—
Effects of Folic Acid Combined with DHA Supplementation on Cognitive Function and Amyloid-β-Related Biomarkers in Older Adults with Mild Cognitive Impairment by a Randomized, Double Blind, Placebo-Controlled Trial
2021 · folic acid + DHA · Adults aged over 60 years with mild cognitive impairment
800 mcg26 weeks—
Effects of antenatal micronutrient supplementation regimens on adolescent emotional and behavioral problems: A 14-year follow-up of a double-blind, cluster-randomized controlled trial
2023 · Iron-folic acid (IFA) · Pregnant females in rural western China; age and health condition not reported
400 mcg——
Fortified balanced energy-protein supplementation during pregnancy and lactation and infant growth in rural Burkina Faso: A 2 × 2 factorial individually randomized controlled trial
2023 · Prenatal BEP and IFA supplementation · Pregnant women aged 15–40 years in rural Burkina Faso
400 mcg——
Fortified balanced energy-protein supplementation during pregnancy and lactation and infant growth in rural Burkina Faso: A 2 × 2 factorial individually randomized controlled trial
2023 · Postnatal BEP and IFA supplementation · Women in rural Burkina Faso who had given birth; maternal ages 15–40 years at enrollment
400 mcg26 weeks—
Fortified balanced energy-protein supplementation during pregnancy and lactation and infant growth in rural Burkina Faso: A 2 × 2 factorial individually randomized controlled trial
2023 · Prenatal and postnatal BEP and IFA supplementation · Pregnant women aged 15–40 years in rural Burkina Faso who continued into lactation
400 mcg——
Prenatal and postnatal small-quantity lipid-based nutrient supplements and children's social-emotional difficulties at ages 9-11 y in Ghana: follow-up of a randomized controlled trial
2023 · iron and folic acid (IFA) group · Pregnant women in Ghana; children were followed through infancy and assessed at ages 9–11 years
400 mcg——
Preconception Micronutrient Supplementation Affects Maternal BMI and Body Composition Postpartum: A Randomized Controlled Trial in Vietnam
2024 · Folic acid only (FA) · Females in Vietnam receiving preconception supplementation who later delivered live offspring; age and health condition not specified
400 mcg——
Effect of Early-Life Lipid-Based Nutrient Supplement and Home Environment on Autonomic Nervous System Regulation at 9-11 Years: A Follow-Up of a Randomized Controlled Trial
2025 · Iron and folic acid (IFA) group · Pregnant women; their offspring received no supplementation
400 mcg——
Improvement in biochemical manifestations of the serum and follicular fluid and ICSI outcomes in PCOS patients with myo-inositol administration: prospective randomized research
2025 · MI group · Infertile women with PCOS undergoing ovulation induction for ICSI; age not reported
2 mg6 weeks—
Thiamine and folate treatment of chronic epileptic patients: a controlled study with the Wechsler IQ scale
1993 · fourth group · Patients with epilepsy receiving phenytoin alone or with phenobarbital for more than 4 years; age and sex not reported
5 mg26 weeks—
Adding zinc to prenatal iron and folate tablets improves fetal neurobehavioral development
1999 · iron and folate without zinc · Pregnant women in a Peruvian population; gestational age not otherwise specified
250 mcg——
Adding zinc to prenatal iron and folate tablets improves fetal neurobehavioral development
1999 · iron, folate, and zinc · Pregnant women in a Peruvian population; gestational age not otherwise specified
250 mcg——
Maternal Blood Pressure in Relation to Prenatal Lipid-Based Nutrient Supplementation and Adverse Birth Outcomes in a Ghanaian Cohort: A Randomized Controlled Trial and Cohort Analysis
2021 · MMN group · Pregnant Ghanaian women aged 18 years or older, enrolled by 20 weeks of gestation
400 mcg—354
Maternal Blood Pressure in Relation to Prenatal Lipid-Based Nutrient Supplementation and Adverse Birth Outcomes in a Ghanaian Cohort: A Randomized Controlled Trial and Cohort Analysis
2021 · LNS group · Pregnant Ghanaian women aged 18 years or older, enrolled by 20 weeks of gestation
400 mcg—354
Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype
2005 · folic acid · asymptomatic men with normal or high-normal ambulatory blood pressure
5 mg3 weeks41
Effects of individualized administration of folic acid on prothrombotic state and vascular endothelial function with H-type hypertension: A double-blinded, randomized clinical cohort study
2022 · Intervention group, second treatment phase, TT genotype · Adults with H-type hypertension, hyperhomocysteinemia and a prothrombotic state; MTHFR C677T TT genotype
5 mg12 weeks32
Folic acid and vitamin B12 supplementation in subjects with type 2 diabetes mellitus: A multi-arm randomized controlled clinical trial
2020 · Group A · Patients with type 2 diabetes mellitus on stable oral antidiabetic drugs
5 mg8 weeks20
A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH)
2000 · combination group · Patients with primary hypercholesterolaemia; age and sex not reported
2 mg6 weeks—
Effect of folic acid supplementation on biochemical indices in overweight and obese men with type 2 diabetes
2011 · folic acid group · Overweight and obese men aged about 58 years with type 2 diabetes, receiving metformin
5 mg8 weeks—
Combined food and micronutrient supplements during pregnancy have limited impact on child blood pressure and kidney function in rural Bangladesh
2013 · Fe30F · Pregnant women in rural Bangladesh; age range not specified
400 mcg——
Combined food and micronutrient supplements during pregnancy have limited impact on child blood pressure and kidney function in rural Bangladesh
2013 · MMS · Pregnant women in rural Bangladesh; age range not specified
400 mcg——
A pilot study of D-chiro-inositol plus folic acid in overweight patients with type 1 diabetes
2017 · treated group · Overweight or obese patients with type 1 diabetes receiving intensive insulin therapy
400 mcg24 weeks—
Folic acid supplementation in children with sickle cell disease: a randomized double-blind noninferiority cross-over trial
2025 · Folic acid · Children aged 2–19 years with sickle cell disease who had routinely received daily folic acid for at least 12 weeks before enrolment
1 mg85 days25
Ethnicity and race influence the folate status response to controlled folate intakes in young women
2004 · 800 μg DFE/d repletion group · Women aged 18–45 with the MTHFR 677 CC genotype; Mexican American, African American, and Caucasian (7 of each)
800 mcg7 weeks21
Folic acid improves phenytoin pharmacokinetics
1995 · treatment 2 · Six fertile women receiving phenytoin therapy for epilepsy
1 mg—6
A prospective study of serum folate levels in patients with solid tumors treated with olaparib
2025 · Folic acid supplementation · Adult women with stage III–IV solid tumors, including breast or ovarian cancer, who developed folate deficiency with concomitant anemia while receiving olaparib
1 mg—2
Kinetics of folate turnover in pregnant women (second trimester) and nonpregnant controls during folic acid supplementation: stable-isotopic labeling of plasma folate, urinary folate and folate catabolites shows subtle effects of pregnancy on turnover of folate pools
2001 · 1.93 micromol/d total folate intake · Second-trimester pregnant women and nonpregnant controls; exact allocation to this intake level is not stated
850 mcg12 weeks—
Effect of folic Acid supplementation on the folate status of buccal mucosa and lymphocytes
2004 · folic acid group · Adults aged 20–60 years with red-cell folate concentrations between 200 and 650 nmol/L
1.2 mg12 weeks—
Effect of different dosage and administration schedules of folic acid on blood folate levels in a population of Honduran women of reproductive age
2008 · 1 mg/d group · Women factory workers aged 18 to 49 years in Honduras
1 mg12 weeks—
Gender and body size affect the response of erythrocyte folate to folic acid treatment
2008 · 800 microg/d folic acid, 3-y trial · men and women; age and health condition not reported
800 mcg3 years—
Gender and body size affect the response of erythrocyte folate to folic acid treatment
2008 · 800 microg/d folic acid, 12-wk trial · men and women; age and health condition not reported
800 mcg12 weeks—
Steady state folate concentrations achieved with 5 compared with 1.1 mg folic acid supplementation among women of childbearing age
2009 · 1.1 mg folic acid group · Nonpregnant women aged 18–45 years who did not take folic acid supplements
1.1 mg30 weeks—
Effects of folic acid supplementation on serum folate and plasma homocysteine concentrations in older adults: a dose-response trial
2010 · 1,000 μg/day folic acid · Adults aged 60–90 years; healthy older adults
1 mg6 weeks—
Effects of folic acid supplementation on serum folate and plasma homocysteine concentrations in older adults: a dose-response trial
2010 · 2,000 μg/day folic acid · Adults aged 60–90 years; healthy older adults
2 mg6 weeks—
Effect of folic acid intervention on the change of serum folate level in hypertensive Chinese adults: do methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms affect therapeutic responses?
2012 · high-FA group · Chinese adults with mild or moderate essential hypertension
800 mcg8 weeks—
Differences in erythrocyte folate concentrations in older adults reached steady-state within one year in a two-year, controlled, 1 mg/d folate supplementation trial
2012 · folate-supplemented group · Adults aged 65 years or older
1 mg2 years—
Pregnancy-induced changes in the long-term pharmacokinetics of 1.1 mg vs. 5 mg folic acid: a randomized clinical trial
2015 · 1.1 mg (regular dose) · Pregnant women who were not previously taking folic acid
1.1 mg——
l-5-Methyltetrahydrofolate Supplementation Increases Blood Folate Concentrations to a Greater Extent than Folic Acid Supplementation in Malaysian Women
2018 · folic acid group · Healthy Malaysian women aged 20–45 years
1 mg12 weeks—
Maternal folate status during extended lactation and the effect of supplemental folic acid
1999 · 1 mg folic acid/d · Lactating women; age and health condition not specified
1 mg26 weeks—
Small-quantity, lipid-based nutrient supplements provided to women during pregnancy and 6 mo postpartum and to their infants from 6 mo of age increase the mean attained length of 18-mo-old children in semi-urban Ghana: a randomized controlled trial
2016 · LNS (women and infants) · Pregnant women aged 18 years or older enrolled at up to 20 weeks of gestation, and their infants from 6 to 18 months of age
80 mcg1 year440
Prenatal and postnatal lipid-based nutrient supplementation and cognitive, social-emotional, and motor function in preschool-aged children in Ghana: a follow-up of a randomized controlled trial
2019 · LNS group · Pregnant women aged 18 years or older and their children, from pregnancy through the child's age of 18 months
480 mcg—440
Associations of maternal nutrition during pregnancy and post-partum with maternal cognition and caregiving
2018 · MMN · Pregnant women enrolled at ≤20 weeks’ gestation in Malawi, followed through 6 months postpartum
400 mcg1 year239
Associations of maternal nutrition during pregnancy and post-partum with maternal cognition and caregiving
2018 · LNS · Pregnant women enrolled at ≤20 weeks’ gestation in Malawi, followed through 6 months postpartum
400 mcg1 year234
Association of prenatal lipid-based nutritional supplementation with fetal growth in rural Gambia
2017 · PE + MMN · Pregnant women aged 18–45 years in rural Gambia, enrolled at 10–20 weeks’ gestation
400 mcg—159
Acceptability of multiple micronutrient powders and iron syrup in Bihar, India
2018 · multiple micronutrient powder (MNP) · Children aged 6–23 months in rural Bihar, not currently taking iron supplements
160 mcg30 days100
Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial
2025 · intervention group · Chinese adults with mild cognitive impairment; mean age 67.95 years; 70 male and 120 female
180 mcg1 year95
Enhanced physical and cognitive performance in active duty Airmen: evidence from a randomized multimodal physical fitness and nutritional intervention
2020 · exercise plus nutritional supplement group · Active-duty Air Force Airmen aged 18–45; no qualifying disease or deficiency was stated
200 mcg12 weeks70
A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia
2010 · NF group, 3-month blinded trial · Community-dwelling adults aged 18–86 years, both sexes, without dementia or clinical memory difficulties
400 mcg90 days59
Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients
2007 · mecobalamin (B12) + multivitamin supplement · Taiwanese men and women aged over 50 with mild to moderate Alzheimer's disease and normal folic acid and vitamin B12 concentrations
1 mg26 weeks45
L-Arginine and B vitamins improve endothelial function in subjects with mild to moderate blood pressure elevation
2018 · Nutritional intervention group · Men and postmenopausal women aged 40–65 with slightly to moderately elevated blood pressure
400 mcg26 weeks40
L-Arginine and B vitamins improve endothelial function in subjects with mild to moderate blood pressure elevation
2018 · Placebo group receiving open-label TAP in follow-up · Men and postmenopausal women aged 40–65 with slightly to moderately elevated blood pressure
400 mcg13 weeks40
Effects of Low-Dose Dairy Protein Plus Micronutrient Supplementation during Resistance Exercise on Muscle Mass and Physical Performance in Older Adults: A Randomized, Controlled Trial
2018 · ExPM (resistance exercise plus low-dose dairy protein and micronutrient supplementation) · Adults aged 65–80 years, non-disabled and not exercising regularly
200 mcg12 weeks40
A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia
2010 · Open-label NF group, separate 6-month trial · Community-dwelling adults, both sexes, without dementia or clinical memory difficulties
400 mcg26 weeks38
Effects of ingesting a pre-workout dietary supplement with and without synephrine for 8 weeks on training adaptations in resistance-trained males
2017 · PWS · Apparently healthy, resistance-trained males; mean age about 21 years
50 mg8 weeks27
Effects of ingesting a pre-workout dietary supplement with and without synephrine for 8 weeks on training adaptations in resistance-trained males
2017 · PWS + S · Apparently healthy, resistance-trained males; mean age about 22 years
50 mg8 weeks26
Effects of acute ingestion of a pre-workout dietary supplement with and without p-synephrine on resting energy expenditure, cognitive function and exercise performance
2017 · PWS · Resistance-trained healthy adults; 20 men and 5 women, mean age 21.7 years
50 mg1 day25
Effects of acute ingestion of a pre-workout dietary supplement with and without p-synephrine on resting energy expenditure, cognitive function and exercise performance
2017 · PWS + S · Resistance-trained healthy adults; 20 men and 5 women, mean age 21.7 years
50 mg1 day25
Effects of an L-arginine-based multi ingredient product on endothelial function in subjects with mild to moderate hypertension and hyperhomocysteinemia - a randomized, double-blind, placebo-controlled, cross-over trial
2017 · AbMIP (vasoLoges® protect) · Men and postmenopausal women aged 40–65 with elevated systolic blood pressure and homocysteine ≥10 μmol/L
600 mcg4 weeks25
Short-Term Effects of a Ready-to-Drink Pre-Workout Beverage on Exercise Performance and Recovery
2017 · RTD · Recreationally active men and women aged 18–40 years with at least six months of resistance-training experience
325 mcg7 days25
Opicapone in Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study
2025 · addOPC group · Adults with Parkinson's disease receiving levodopa-carbidopa intestinal gel and experiencing nocturnal, morning, or afternoon akinesia
400 mcg1 year11
Opicapone in Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study
2025 · nOPC group · Adults with Parkinson's disease receiving levodopa-carbidopa intestinal gel and experiencing nocturnal, morning, or afternoon akinesia
400 mcg1 year11
Micronutrient supplementation may reduce symptoms of depression in Guatemalan women
2009 · weekly 5,000 microg folic acid group · Women in Guatemala; age range and health condition not specified
714 mcg12 weeks—
Micronutrient supplementation may reduce symptoms of depression in Guatemalan women
2009 · weekly 2,800 microg folic acid group · Women in Guatemala; age range and health condition not specified
400 mcg12 weeks—
Micronutrient supplementation may reduce symptoms of depression in Guatemalan women
2009 · daily 400 microg folic acid group · Women in Guatemala; age range and health condition not specified
400 mcg12 weeks—
Micronutrient supplementation may reduce symptoms of depression in Guatemalan women
2009 · daily 200 microg folic acid group · Women in Guatemala; age range and health condition not specified
200 mcg12 weeks—
A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia
2010 · NF group, 2-week blinded trial · Community-dwelling adults, both sexes, without dementia or clinical memory difficulties
400 mcg2 weeks—
Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation
2011 · Group MVB · Patients with type 2 diabetes
1 mg120 days—
Three-month B vitamin supplementation in pre-school children affects folate status and homocysteine, but not cognitive performance
2014 · B vitamin supplementation group · Healthy preschool children selected for low urinary folate-status ranking
220 mcg90 days—
Low-dose B vitamins supplementation ameliorates cardiovascular risk: a double-blind randomized controlled trial in healthy Chinese elderly
2015 · treatment group · Healthy adults aged 60–74 years
400 mcg1 year—
Preconception Micronutrient Supplementation Affects Maternal BMI and Body Composition Postpartum: A Randomized Controlled Trial in Vietnam
2024 · Iron and folic acid (IFA) · Females in Vietnam receiving preconception supplementation who later delivered live offspring; age and health condition not specified
400 mcg——
Folic acid therapy reduces serum uric acid in hypertensive patients: a substudy of the China Stroke Primary Prevention Trial (CSPPT)
2017 · enalapril-folic acid group · hypertensive adults; age and sex not specified
800 mcg1606 days7,685
Interaction of neutrophil counts and folic acid treatment on new-onset proteinuria in hypertensive patients
2021 · enalapril and folic acid · Adults with hypertension; mean age 59.5 years
800 mcg1606 days4,101
Optimal folic acid dosage in lowering homocysteine: Precision Folic Acid Trial to lower homocysteine (PFAT-Hcy)
2024 · 2.0 mg folic acid group · Chinese men and women aged 45–75 with hypertension and elevated total homocysteine
2 mg8 weeks337
Higher baseline global leukocyte DNA methylation is associated with MTX non-response in early RA patients
2019 · All MTX treatment groups · Adults with treatment-naive early rheumatoid arthritis
1.43 mg90 days336
Optimal folic acid dosage in lowering homocysteine: Precision Folic Acid Trial to lower homocysteine (PFAT-Hcy)
2024 · 0.8 mg folic acid group · Chinese men and women aged 45–75 with hypertension and elevated total homocysteine
800 mcg8 weeks336
Optimal folic acid dosage in lowering homocysteine: Precision Folic Acid Trial to lower homocysteine (PFAT-Hcy)
2024 · 1.2 mg folic acid group · Chinese men and women aged 45–75 with hypertension and elevated total homocysteine
1.2 mg8 weeks336
Optimal folic acid dosage in lowering homocysteine: Precision Folic Acid Trial to lower homocysteine (PFAT-Hcy)
2024 · 1.6 mg folic acid group · Chinese men and women aged 45–75 with hypertension and elevated total homocysteine
1.6 mg8 weeks336
Betaine and choline status modify the effects of folic acid and creatine supplementation on arsenic methylation in a randomized controlled trial of Bangladeshi adults
2021 · 800FA · Adults aged 24–55 in Bangladesh exposed to arsenic through household drinking water
800 mcg12 weeks154
Folic Acid and Creatine as Therapeutic Approaches to Lower Blood Arsenic: A Randomized Controlled Trial
2015 · FA800, first phase · Adults aged 20–65 in Bangladesh selected for drinking from a well with arsenic above 50 μg/L; both folate-deficient and folate-sufficient participants
800 mcg12 weeks151
Protective Effect of Folic Acid on Oxidative DNA Damage: A Randomized, Double-Blind, and Placebo Controlled Clinical Trial
2015 · high-FA group · Adults aged 18–79 chronically exposed to arsenic in drinking water
800 mcg8 weeks150
The Folic Acid and Creatine Trial: Treatment Effects of Supplementation on Arsenic Methylation Indices and Metabolite Concentrations in Blood in a Bangladeshi Population
2023 · 800FA · Adults aged 20–65 years in Bangladesh exposed to arsenic in drinking water; men and women, recruited independent of folate status
800 mcg12 weeks150
MTHFR C677T and MTR A2756G polymorphisms and the homocysteine lowering efficacy of different doses of folic acid in hypertensive Chinese adults
2012 · High FA group · Chinese adults with mild or moderate hypertension; mean age approximately 57 years; men and women
800 mcg8 weeks146
Combined use of amlodipine and folic acid are significantly more efficacious than amlodipine alone in lowering plasma homocysteine and blood pressure among hypertensive patients with hyperhomocysteinemia and intolerance to ACEI: A multicenter, randomized, double-blind, parallel-controlled clinical trial
2023 · B group (amlodipine 5 mg/FA 0.8 mg) · Chinese adults with hypertension, hyperhomocysteinemia, and intolerance to ACE inhibitors; mean age 62.9 years in this arm; men and women
800 mcg8 weeks118
Increasing the number of SNP loci does not necessarily improve prediction power at least in the comparison of MTHFR SNP and haplotypes
2008 · folic acid group · Healthy Japanese men; age range not stated
1 mg90 days101
Folic Acid and Creatine as Therapeutic Approaches to Lower Blood Arsenic: A Randomized Controlled Trial
2015 · FA800 continued, second phase · Adults aged 20–65 in Bangladesh selected for drinking from a well with arsenic above 50 μg/L; both folate-deficient and folate-sufficient participants
800 mcg24 weeks77
Effects of individualized administration of folic acid on prothrombotic state and vascular endothelial function with H-type hypertension: A double-blinded, randomized clinical cohort study
2022 · Intervention group, first treatment phase · Adults over 18 with H-type hypertension, hyperhomocysteinemia and a prothrombotic state
800 mcg12 weeks55
Effects of polymorphisms in endothelial nitric oxide synthase and folate metabolizing genes on the concentration of serum nitrate, folate, and plasma total homocysteine after folic acid supplementation: a double-blind crossover study
2015 · Folic acid · Healthy individuals; age and sex not specified
800 mcg2 weeks52
Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans
2005 · Study 3 folic acid group · Healthy adults aged 50–70 years with plasma total homocysteine below 26 μmol/L
800 mcg6 weeks40
Effect of different doses of folic acid on serum homocysteine level in patients on hemodialysis
2011 · 2 mg/d folic acid · Adults on maintenance hemodialysis; mean age 57.6 years; 17 women and 14 men completed all phases
2 mg4 weeks31
The impact of folate status and folic acid supplementation on the micronucleus frequency in human erythrocytes
2006 · folic acid supplementation group · Both-sex participants without folate deficiency; age not reported
1 mg7 days30
Sensitivity of markers of DNA stability and DNA repair activity to folate supplementation in healthy volunteers
2006 · folic acid group · Healthy men and women aged 20–60 years, with red cell folate 250–650 nmol/L and no folate deficiency
1.2 mg12 weeks30
Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial
2014 · Folate-1 · Women aged 18–40 years with obesity and polycystic ovary syndrome
1 mg8 weeks27
Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial
2017 · folic acid · children with epilepsy and antiepileptic drug-induced liver injury
1 mg30 days26
The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial
2014 · folate-1 · Women aged 18–40 with polycystic ovary syndrome who were overweight or obese
1 mg8 weeks23
Effect of folic acid on bone metabolism: a randomized double blind clinical trial in postmenopausal osteoporotic women
2014 · folic acid · Postmenopausal women with osteoporosis; age range not stated
1 mg26 weeks17
Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans
2005 · Study 1 folic acid group · Healthy adults aged 30–50 years with plasma total homocysteine below 25 μmol/L
800 mcg6 weeks12
Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation
2005 · folic acid supplementation · Children with hyperhomocysteinemia receiving antiepileptic drugs
1 mg90 days10
Impact of folic acid supplementation on the epigenetic profile in healthy unfortified individuals - a randomized intervention trial
2024 · 800 μg folic acid · Healthy men aged 23–61 years with normal baseline folate levels
800 mcg8 weeks7
Effect of folate supplementation on mucosal cell proliferation in high risk patients for colon cancer
2002 · treatment group · 11 patients with recurrent adenomatous polyps of the colon; age and sex not reported
2 mg90 days6
Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients
1999 · Folic acid 1 mg daily · Adults with end-stage renal disease receiving maintenance haemodialysis
1 mg40 weeks—
Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients
2000 · control group · Critically ill anemic adults admitted to a multidisciplinary intensive care unit
1 mg——
Randomized trial of folic acid supplementation and serum homocysteine levels
2001 · 0.8 mg/d folic acid · Patients with ischemic heart disease; age and sex not specified
800 mcg90 days—
Randomized trial of folic acid supplementation and serum homocysteine levels
2001 · 1.0 mg/d folic acid · Patients with ischemic heart disease; age and sex not specified
1 mg90 days—
Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease
2002 · 2.0 mg folic acid · People with a history of myocardial infarction or unstable angina
2 mg——
Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study
2003 · 800 micro g folic acid · Healthy men and women aged 50–75 years
800 mcg12 weeks—
Assessment of tailor-made prevention of atherosclerosis with folic acid supplementation: randomized, double-blind, placebo-controlled trials in each MTHFR C677T genotype
2005 · folic acid group · healthy Japanese men
1 mg90 days—
Effect of lowering of homocysteine levels on inflammatory markers: a randomized controlled trial
2005 · folic acid group · men and postmenopausal women with homocysteine concentrations of at least 13 micromol/L at screening
800 mcg1 year—
No effect of folic acid supplementation in the course of 1 year on haemostasis markers and C-reactive protein in older adults
2005 · folic acid group · Older adults with plasma total homocysteine concentrations above 13 mM at screening
800 mcg1 year—
Effects of short-term folic acid and/or riboflavin supplementation on serum folate and plasma total homocysteine concentrations in young Japanese male subjects
2006 · FA group · Healthy Japanese men aged 20–29 years
800 mcg2 weeks—
Effect of folate supplementation on N-terminal pro-brain natriuretic peptide
2007 · 1.0 mg FA daily · Healthy adults, median age 57 years
1 mg8 weeks—
Blood folate status and expression of proteins involved in immune function, inflammation, and coagulation: biochemical and proteomic changes in the plasma of humans in response to long-term synthetic folic acid supplementation
2010 · 1.2 mg folic acid daily · Human subjects; age, sex, and health status not specified
1.2 mg12 weeks—
A dose-finding trial of the effect of long-term folic acid intervention: implications for food fortification policy
2011 · 0.8 mg/d folic acid · Patients with ischemic heart disease and healthy volunteers; ages and sex not specified
800 mcg26 weeks—
Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa
2010 · folic acid group · Adults with a history of at least one colorectal adenoma, mean age 57.8 years; both sexes
1 mg3 years—
Effect of folic acid intervention on ALT concentration in hypertensives without known hepatic disease: a randomized, double-blind, controlled trial
2012 · high FA group · Chinese adults with mild or moderate essential hypertension and no known hepatic disease
800 mcg8 weeks—
Effects of combined enalapril and folic acid therapy on the serum uric acid levels in hypertensive patients: a multicenter, randomized, double-blind, parallel-controlled clinical trial
2015 · high-FA group · Adults aged 27–75 with mild to moderate hypertension in China
800 mcg8 weeks—
Supplementation with Folic Acid, but Not Creatine, Increases Plasma Betaine, Decreases Plasma Dimethylglycine, and Prevents a Decrease in Plasma Choline in Arsenic-Exposed Bangladeshi Adults
2016 · FA800 · Arsenic-exposed adults aged 24–55 in Bangladesh
800 mcg12 weeks—
MTHFR Gene and Serum Folate Interaction on Serum Homocysteine Lowering: Prospect for Precision Folic Acid Treatment
2018 · 10-mg enalapril+0.8-mg folic acid · Chinese adults with hypertension
800 mcg1643 days—
Folic acid supplementation enhances arsenic methylation: results from a folic acid and creatine supplementation randomized controlled trial in Bangladesh
2019 · 800 μg folic acid group · Bangladeshi participants exposed to arsenic through drinking water; the majority were folate sufficient
800 mcg24 weeks—
Relationship of visceral adiposity index with new-onset proteinuria in hypertensive patients
2021 · 10 mg enalapril and 0.8 mg folic acid · Hypertensive patients without proteinuria at baseline and without major cardiovascular diseases
800 mcg1606 days—
No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients
1998 · 1 mg folic acid (phase 2) · Haemodialysis patients with hyperhomocysteinaemia; age and sex not reported
1 mg40 weeks—
Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy
1998 · 1 mg folic acid daily · Peritoneal dialysis patients with hyperhomocysteinemia
1 mg40 weeks—
Maternal Blood Pressure in Relation to Prenatal Lipid-Based Nutrient Supplementation and Adverse Birth Outcomes in a Ghanaian Cohort: A Randomized Controlled Trial and Cohort Analysis
2021 · IFA group · Pregnant Ghanaian women aged 18 years or older, enrolled by 20 weeks of gestation
400 mcg—349
Alendronate in rheumatoid arthritis patients treated with methotrexate and glucocorticoids
2001 · Alendronate+calcium group · 25 female patients with rheumatoid arthritis
2.5 mg26 weeks25
Alendronate in rheumatoid arthritis patients treated with methotrexate and glucocorticoids
2001 · Calcium-only group · 25 female patients with rheumatoid arthritis
2.5 mg26 weeks25
Folic acid and vitamin B12 supplementation in subjects with type 2 diabetes mellitus: A multi-arm randomized controlled clinical trial
2020 · Group C · Patients with type 2 diabetes mellitus on stable oral antidiabetic drugs
5 mg8 weeks20
Nitrate-Rich Beetroot Juice Reduces Blood Pressure in Tanzanian Adults with Elevated Blood Pressure: A Double-Blind Randomized Controlled Feasibility Trial
2020 · N + F (combined intervention) · Adults aged 50–70 years in Tanzania with elevated blood pressure; nonsmokers with systolic blood pressure 130–170 mm Hg
5 mg60 days16
Cardiovascular effects of oral Supplementation of vitamin C, E and folic acid in young healthy males
2004 · vitamin intervention · 31 young healthy male adults; 14 received the vitamin intervention
10 mg12 weeks14
Lowering homocysteine with B vitamins has no effect on blood pressure in older adults
2007 · Vitamins group · Healthy adults aged 65 years or older with homocysteine concentrations of at least 13 micromol/L
1 mg2 years—
Combined food and micronutrient supplements during pregnancy have limited impact on child blood pressure and kidney function in rural Bangladesh
2013 · Fe60F · Pregnant women in rural Bangladesh; age range not specified
400 mcg——
Low daily dose of 3 mg monacolin K from RYR reduces the concentration of LDL-C in a randomized, placebo-controlled intervention
2016 · supplement group with RYR · Adults with hypercholesterolemia who were not treated with statins
200 mcg12 weeks—
Impact of Preconception Micronutrient Supplementation on Anemia and Iron Status during Pregnancy and Postpartum: A Randomized Controlled Trial in Rural Vietnam
2016 · Folic acid (FA control) · Women aged 18–40 planning pregnancy in rural Vietnam; no specific diagnosed condition required
400 mcg56 weeks555
Methylenetetrahydrofolate reductase 677C-->T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial
2002 · supplement · Healthy adults with MTHFR 677 TT, CT, or CC genotypes
400 mcg120 days126
School-administered weekly iron-folate supplements improve hemoglobin and ferritin concentrations in Malaysian adolescent girls
1999 · Folic acid only · Otherwise healthy adolescent girls with hemoglobin 120–130 g/L (group B, borderline anemia)
714 mcg22 weeks90
Evidence from a Randomized Trial That Exposure to Supplemental Folic Acid at Recommended Levels during Pregnancy Does Not Lead to Increased Unmetabolized Folic Acid Concentrations in Maternal or Cord Blood
2016 · placebo group · Pregnant women aged 18–35 years who had taken 400 μg folic acid daily during the first trimester
400 mcg—67
Impact of continuing folic acid after the first trimester of pregnancy: findings of a randomized trial of Folic Acid Supplementation in the Second and Third Trimesters
2013 · 400 μg FA/d treatment group · Pregnant women aged 18–35 with singleton uncomplicated pregnancies who had taken folic acid supplements in the first trimester
400 mcg22 weeks59
Evidence from a Randomized Trial That Exposure to Supplemental Folic Acid at Recommended Levels during Pregnancy Does Not Lead to Increased Unmetabolized Folic Acid Concentrations in Maternal or Cord Blood
2016 · folic acid group · Pregnant women aged 18–35 years who had taken 400 μg folic acid daily during the first trimester
400 mcg—59
Long-term effect of low-dose folic acid intake: potential effect of mandatory fortification on the prevention of neural tube defects
2011 · 400 μg folic acid group · Women aged 18–40 years; reproductive-aged women
400 mcg40 weeks48
Folate status of reproductive age women and neural tube defect risk: the effect of long-term folic acid supplementation at doses of 140 µg and 400 µg per day
2011 · 400 μg folic acid/day · Healthy reproductive-age women aged 18–40 years; not pregnant or lactating and not planning pregnancy in the next 12 months
400 mcg40 weeks48
Folic acid fortified milk increases blood folate to concentrations associated with a very low risk of neural tube defects in Singaporean women of childbearing age
2016 · fortified milk (FM) group · Non-pregnant women aged 21–35 years
400 mcg12 weeks35
Folic acid causes higher prevalence of detectable unmetabolized folic acid in serum than B-complex: a randomized trial
2016 · FA · Elderly people
400 mcg23 days31
Optimum dose of oral folic acid supplementation in transfusion-dependent thalassemia: a randomized controlled trial
2022 · Group 2 · Children aged 5–18 years with transfusion-dependent thalassemia
2.5 mg39 weeks30
Optimum dose of oral folic acid supplementation in transfusion-dependent thalassemia: a randomized controlled trial
2022 · Group 3 · Children aged 5–18 years with transfusion-dependent thalassemia
714 mcg39 weeks30
Folate-status response to a controlled folate intake in nonpregnant, pregnant, and lactating women
2012 · Lactating women · Lactating women 5–15 weeks postpartum
750 mcg11 weeks28
Homocysteine metabolism and effects of folic acid supplementation in patients affected with spina bifida
2000 · Folic acid intervention · Patients with spina bifida (n=12) and disabled control patients (n=15)
500 mcg4 weeks27
Choline deficiency increases lymphocyte apoptosis and DNA damage in humans
2006 · dietary folate supplemented with 400 μg folic acid/d · Healthy men and women aged 18–70 years
400 mcg6 weeks26
Folate-status response to a controlled folate intake in nonpregnant, pregnant, and lactating women
2012 · Pregnant women · Third-trimester pregnant women
750 mcg11 weeks26
[6S]-5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the homozygous or wild-type 677C-->T polymorphism of methylenetetrahydrofolate reductase
2009 · folic acid · healthy females with either the homozygous (TT) or wild-type (CC) MTHFR 677C→T genotype
400 mcg1 day24
Pharmacokinetics of Sodium and Calcium Salts of (6S)-5-Methyltetrahydrofolic Acid Compared to Folic Acid and Indirect Comparison of the Two Salts
2020 · Folic acid · Healthy men and women aged 18–50 years
400 mcg1 day24
Ethnicity and race influence the folate status response to controlled folate intakes in young women
2004 · 400 μg DFE/d repletion group · Women aged 18–45 with the MTHFR 677 CC genotype; Mexican American, African American, and Caucasian (7 of each)
400 mcg7 weeks21
Folate-status response to a controlled folate intake in nonpregnant, pregnant, and lactating women
2012 · Nonpregnant women · Nonpregnant women of childbearing age
750 mcg11 weeks21
Impact of high-dose folic acid supplementation in pregnancy on biomarkers of folate status and 1-carbon metabolism: An ancillary study of the Folic Acid Clinical Trial (FACT)
2021 · high-dose FA · Pregnant women randomized at 8–16 gestational weeks; maternal folate and 1-carbon metabolism biomarkers were assessed at 24–26 gestational weeks.
4 mg—19
Aleurone flour increases red-cell folate and lowers plasma homocyst(e)ine substantially in man
2005 · FA · Free-living healthy individuals, mean age 46–52 years; sex not specified
640 mcg16 weeks18
Relative bioavailability of iron and folic acid from a new powdered supplement compared to a traditional tablet in pregnant women
2009 · Tablet Supplement (Materna®) · Healthy pregnant women aged 18–45 years, at 24–32 weeks’ gestation
1 mg1 day18
Folic Acid Supplementation in Postpolypectomy Patients in a Randomized Controlled Trial Increases Tissue Folate Concentrations and Reduces Aberrant DNA Biomarkers in Colonic Tissues Adjacent to the Former Polyp Site
2016 · folic acid · Adults with adenomatous polyps after initial colonoscopy and polypectomy; mean age 64.3 years
600 mcg26 weeks12
Availability of food folate in humans
1999 · meal C · healthy volunteers; age and sex not reported
400 mcg1 day—
Kinetics of folate turnover in pregnant women (second trimester) and nonpregnant controls during folic acid supplementation: stable-isotopic labeling of plasma folate, urinary folate and folate catabolites shows subtle effects of pregnancy on turnover of folate pools
2001 · 1.02 micromol/d total folate intake · Second-trimester pregnant women and nonpregnant controls; exact allocation to this intake level is not stated
450 mcg12 weeks—
Effects of once-a-week or daily folic acid supplementation on red blood cell folate concentrations in women
2004 · once-a-week folic acid group · Nonpregnant women aged 18–40 years with screening red blood cell folate concentrations of 295–905 nmol/L
400 mcg12 weeks—
Effects of once-a-week or daily folic acid supplementation on red blood cell folate concentrations in women
2004 · daily folic acid group · Nonpregnant women aged 18–40 years with screening red blood cell folate concentrations of 295–905 nmol/L
400 mcg12 weeks—
The short-term bioavailabilities of [6S]-5-methyltetrahydrofolate and folic acid are equivalent in men
2004 · 500 micro g FA capsule · Men presaturated with folic acid
500 mcg1 day—
[6S]-5-Methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation
2006 · Folic acid reference group · Pregnant women enrolled at 36 weeks gestation who were healthy Canadian women during lactation
400 mcg16 weeks—
Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age
2006 · 400 microg folic acid group · Healthy women aged 19–33 years
400 mcg24 weeks—
Milk folate secretion is not impaired during iron deficiency in humans
2006 · multivitamin without iron · Breast-feeding mothers; age not reported
400 mcg——
Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial
2007 · MTHF · Pregnant women from gestation week 22 until delivery
400 mcg——
Effect of different dosage and administration schedules of folic acid on blood folate levels in a population of Honduran women of reproductive age
2008 · 5 mg/week group · Women factory workers aged 18 to 49 years in Honduras
714 mcg12 weeks—
Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability
2008 · 0.4 mg folic acid with water · Healthy volunteers; age and sex not specified
400 mcg1 day—
Gender and body size affect the response of erythrocyte folate to folic acid treatment
2008 · 400 microg/d folic acid, 12-wk trial · men and women; age and health condition not reported
400 mcg12 weeks—
Gender and body size affect the response of erythrocyte folate to folic acid treatment
2008 · 600 microg/d folic acid, 12-wk trial · men and women; age and health condition not reported
600 mcg12 weeks—
Folate status and homocysteine response to folic acid doses and withdrawal among young Chinese women in a large-scale randomized double-blind trial
2008 · 400 microg 1 time/d · Young Chinese women not exposed to other sources of folic acid
400 mcg26 weeks—
Folate status and homocysteine response to folic acid doses and withdrawal among young Chinese women in a large-scale randomized double-blind trial
2008 · 100 microg 4 times/d · Young Chinese women not exposed to other sources of folic acid
400 mcg26 weeks—
Folate status and homocysteine response to folic acid doses and withdrawal among young Chinese women in a large-scale randomized double-blind trial
2008 · 4000 microg 1 time/d · Young Chinese women not exposed to other sources of folic acid
4 mg26 weeks—
Folate status and homocysteine response to folic acid doses and withdrawal among young Chinese women in a large-scale randomized double-blind trial
2008 · 4000 microg 1 time/wk · Young Chinese women not exposed to other sources of folic acid
571 mcg26 weeks—
Unmetabolized folic acid and total folate concentrations in breast milk are unaffected by low-dose folate supplements
2009 · folic acid · Lactating women enrolled within 1 week postpartum
400 mcg16 weeks—
Effects of folic acid supplementation on serum folate and plasma homocysteine concentrations in older adults: a dose-response trial
2010 · 400 μg/day folic acid · Adults aged 60–90 years; healthy older adults
400 mcg6 weeks—
MTHFR 677C->T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation
2011 · 400 μg/d folic acid · Northern Chinese women of childbearing age
400 mcg26 weeks—
MTHFR 677C->T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation
2011 · 4000 μg/d folic acid · Northern Chinese women of childbearing age
4 mg26 weeks—
MTHFR 677C->T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation
2011 · 4000 μg/wk folic acid · Northern Chinese women of childbearing age
571 mcg26 weeks—
Effect of folic acid intervention on the change of serum folate level in hypertensive Chinese adults: do methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms affect therapeutic responses?
2012 · low-FA group · Chinese adults with mild or moderate essential hypertension
400 mcg8 weeks—
Response of serum and red blood cell folate concentrations to folic acid supplementation depends on methylenetetrahydrofolate reductase C677T genotype: results from a crossover trial
2013 · 400 μg folic acid · Adults aged 18–69 years without chronic disease or diseases known to interfere with folate metabolism
400 mcg12 weeks—
Wheat rolls fortified with microencapsulated L-5-methyltetrahydrofolic acid or equimolar folic acid increase blood folate concentrations to a similar extent in healthy men and women
2013 · folic acid wheat roll group · Healthy men and women aged 18–45 years
400 mcg16 weeks—
Relative bioavailability of 13C5-folic acid in pectin-coated folate fortified rice in humans using stable isotope techniques
2017 · Trial 1: aqueous 13C5-PteGlu · Healthy volunteers aged 18–39
400 mcg1 day—
Relative bioavailability of 13C5-folic acid in pectin-coated folate fortified rice in humans using stable isotope techniques
2017 · Trial 2: cooked white rice with 13C5-PteGlu · Healthy volunteers aged 18–39
400 mcg1 day—
Relative bioavailability of 13C5-folic acid in pectin-coated folate fortified rice in humans using stable isotope techniques
2017 · Trial 3: pectin-coated fortified cooked rice · Healthy volunteers aged 18–39
400 mcg1 day—
Supplementation with (6S)-5-methyltetrahydrofolic acid appears as effective as folic acid in maintaining maternal folate status while reducing unmetabolised folic acid in maternal plasma: a randomised trial of pregnant women in Canada
2024 · Folic acid group · Pregnant individuals at 8–21 weeks’ gestation
600 mcg16 weeks—
Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects
1996 · folic acid supplement (group I) · Women recruited from university staff and students; no condition stated
400 mcg90 days—
Minimum effective dose of folic acid for food fortification to prevent neural-tube defects
1997 · 400 micrograms/day group · Women with red-cell folate concentrations between 150 and 400 micrograms/L
400 mcg26 weeks—
Folate status response to controlled folate intake in pregnant women
1997 · 730 microg/d synthetic folic acid group · Pregnant women in their second trimester and nonpregnant women; the abstract does not give the number in this dose group
730 mcg12 weeks—
Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention
1998 · 5 mg folic acid supplementation per week · Patients with rheumatoid arthritis taking low-dose methotrexate; age and sex not reported
714 mcg1 year—
Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention
1998 · 27.5 mg folic acid supplementation per week · Patients with rheumatoid arthritis taking low-dose methotrexate; age and sex not reported
3.93 mg1 year—
A 2-Year Randomized Controlled Trial With Low-Dose B-Vitamin Supplementation Shows Benefits on Bone Mineral Density in Adults With Lower B12 Status
2022 · B-vitamin treatment · Community-dwelling adults aged 50 years or older; men and women; no specific diagnosed condition, and not currently taking B-vitamin supplements at screening
200 mcg2 years103
Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial
2015 · Combination A · Adults aged 18–70 with hypercholesterolemia not requiring statins or statin-intolerant
200 mcg4 weeks23
Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial
2009 · AGE+S · Intermediate-risk adults, mean age 60 ± 9 years; 79% male
300 mcg1 year—
Optimal folic acid dosage in lowering homocysteine: Precision Folic Acid Trial to lower homocysteine (PFAT-Hcy)
2024 · 2.4 mg folic acid group · Chinese men and women aged 45–75 with hypertension and elevated total homocysteine
2.4 mg8 weeks339
Optimal folic acid dosage in lowering homocysteine: Precision Folic Acid Trial to lower homocysteine (PFAT-Hcy)
2024 · 0.4 mg folic acid group · Chinese men and women aged 45–75 with hypertension and elevated total homocysteine
400 mcg8 weeks338
Optimal folic acid dosage in lowering homocysteine: Precision Folic Acid Trial to lower homocysteine (PFAT-Hcy)
2024 · 0.6 mg folic acid group · Chinese men and women aged 45–75 with hypertension and elevated total homocysteine
600 mcg8 weeks336
Sex-Specific Associations between One-Carbon Metabolism Indices and Posttranslational Histone Modifications in Arsenic-Exposed Bangladeshi Adults
2017 · 400 µg FA/day · Adults aged 20–65 exposed to household well-water arsenic ≥50 µg/L
400 mcg12 weeks156
Betaine and choline status modify the effects of folic acid and creatine supplementation on arsenic methylation in a randomized controlled trial of Bangladeshi adults
2021 · 400FA · Adults aged 24–55 in Bangladesh exposed to arsenic through household drinking water
400 mcg12 weeks156
Folic Acid and Creatine as Therapeutic Approaches to Lower Blood Arsenic: A Randomized Controlled Trial
2015 · FA400, first phase · Adults aged 20–65 in Bangladesh selected for drinking from a well with arsenic above 50 μg/L; both folate-deficient and folate-sufficient participants
400 mcg12 weeks153
Low-Dose Creatine Supplementation Lowers Plasma Guanidinoacetate, but Not Plasma Homocysteine, in a Double-Blind, Randomized, Placebo-Controlled Trial
2015 · FA group · Bangladeshi adults
400 mcg12 weeks153
The Folic Acid and Creatine Trial: Treatment Effects of Supplementation on Arsenic Methylation Indices and Metabolite Concentrations in Blood in a Bangladeshi Population
2023 · 400FA · Adults aged 20–65 years in Bangladesh exposed to arsenic in drinking water; men and women, recruited independent of folate status
400 mcg12 weeks153
Protective Effect of Folic Acid on Oxidative DNA Damage: A Randomized, Double-Blind, and Placebo Controlled Clinical Trial
2015 · low-FA group · Adults aged 18–79 chronically exposed to arsenic in drinking water
400 mcg8 weeks150
MTHFR C677T and MTR A2756G polymorphisms and the homocysteine lowering efficacy of different doses of folic acid in hypertensive Chinese adults
2012 · Low FA group · Chinese adults with mild or moderate hypertension; mean age approximately 57 years; men and women
400 mcg8 weeks147
Combined use of amlodipine and folic acid are significantly more efficacious than amlodipine alone in lowering plasma homocysteine and blood pressure among hypertensive patients with hyperhomocysteinemia and intolerance to ACEI: A multicenter, randomized, double-blind, parallel-controlled clinical trial
2023 · A group (amlodipine 5 mg/FA 0.4 mg) · Chinese adults with hypertension, hyperhomocysteinemia, and intolerance to ACE inhibitors; mean age 63.4 years in this arm; men and women
400 mcg8 weeks116
Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh
2006 · folic acid group · Bangladeshi men and women aged 18–65 years with low plasma folate, exposed to arsenic in drinking water
400 mcg12 weeks97
A randomized controlled trial of folic acid intervention in pregnancy highlights a putative methylation-regulated control element at ZFP57
2019 · folic acid · Pregnant women recruited at approximately 14 weeks of gestation, with singleton pregnancies
400 mcg22 weeks96
Folic acid intervention during pregnancy alters DNA methylation, affecting neural target genes through two distinct mechanisms
2022 · FA group · Women with singleton pregnancies who had taken folic acid in the first trimester; age not specified
400 mcg—96
Folic Acid and Creatine as Therapeutic Approaches to Lower Blood Arsenic: A Randomized Controlled Trial
2015 · FA400 continued, second phase · Adults aged 20–65 in Bangladesh selected for drinking from a well with arsenic above 50 μg/L; both folate-deficient and folate-sufficient participants
400 mcg24 weeks77
Myoinositol plus α-lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study
2021 · Control group · Women aged 18–44 with gestational diabetes mellitus and a singleton pregnancy
400 mcg60 days60
Effect of myo-inositol supplementation on ICSI outcomes among poor ovarian responder patients: A randomized controlled trial
2020 · Group B · Poor responder patients undergoing ICSI; age and sex details not reported
400 mcg—56
Low-Dose folic acid supplementation decreases plasma homocysteine concentrations: a randomised trial
2000 · 500 microg folic acid per day · Healthy women aged 18–40 years
500 mcg4 weeks45
Randomized clinical trial of folate supplementation in patients with peripheral arterial disease
2009 · folic acid · People with peripheral arterial disease (PAD); age and sex not reported
400 mcg16 weeks45
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes
2011 · control group · Women with gestational diabetes treated with diet
400 mcg8 weeks45
Genomic DNA methylation changes in response to folic acid supplementation in a population-based intervention study among women of reproductive age
2011 · 400 µg/day folic acid group · Women of reproductive age; mean age 30.7 years in the analyzed sample; not pregnant or breastfeeding and without chronic disease
400 mcg26 weeks45
Genomic DNA methylation changes in response to folic acid supplementation in a population-based intervention study among women of reproductive age
2011 · 4,000 µg/day folic acid group · Women of reproductive age; mean age 29.9 years in the analyzed sample; not pregnant or breastfeeding and without chronic disease
4 mg26 weeks45
Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial
1999 · 500 microgram/d group · Healthy women aged 18–40 years
500 mcg4 weeks45
The impact of a standardized micronutrient supplementation on PCOS-typical parameters: a randomized controlled trial
2019 · Control group · Women aged 19–35 with polycystic ovary syndrome (PCOS)
400 mcg90 days30
The effects of high and low doses of folic acid on oxidation of protein levels during pregnancy: a randomized double-blind clinical trial
2017 · Group 2 (0.5 mg/day folic acid) · Pregnant women, from before pregnancy through the 36th week of pregnancy
500 mcg—23
Human milk oligosaccharide composition following supplementation with folic acid vs (6S)-5-methyltetrahydrofolic acid during pregnancy and mediation by human milk folate forms
2024 · Folic acid group · Pregnant women recruited at 8–21 weeks’ gestation in Vancouver, Canada; no diagnosed condition stated
600 mcg16 weeks20
The potential adding therapeutic effect of pentoxifylline and/or folic acid for chronic kidney disease patients: randomized controlled trial
2025 · FA group · Adults aged 18–60 with stable stage 3–5 chronic kidney disease
500 mcg26 weeks20
Effect of Myo-Inositol Treatment on Serum Asprosin Levels of Pregnant Women: A Prospective Randomized Controlled Pilot Study
2025 · Group 2 · Pregnant women aged 18–40 without the stated exclusion conditions
400 mcg21 weeks20
Low-dose folic acid supplementation reduces plasma levels of the cardiovascular risk factor homocysteine in postmenopausal women
2000 · group receiving folic acid · postmenopausal women
500 mcg4 weeks18
Folic acid and vitamin B(12) supplementation lowers plasma homocysteine but has no effect on serum bone turnover markers in elderly women: a randomized, double-blind, placebo-controlled trial
2013 · vitamin group · Women aged 65–93 years with homocysteine levels greater than 10 μmol/L
800 mcg120 days17
Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma
2005 · folic acid supplement · Patients with histologically confirmed colorectal adenoma
400 mcg10 weeks15
Short-term folate supplementation in physiological doses has no effect on ESR1 and MLH1 methylation in colonic mucosa of individuals with adenoma
2012 · folic acid group · Individuals with colorectal adenoma; age and sex not specified
400 mcg10 weeks15
Stability of the human sperm DNA methylome to folic acid fortification and short-term supplementation
2017 · supplement containing folic acid · Men with no history of infertility; age range not reported
400 mcg90 days10
Impact of folic acid supplementation on the epigenetic profile in healthy unfortified individuals - a randomized intervention trial
2024 · 400 μg folic acid · Healthy men aged 23–61 years with normal baseline folate levels
400 mcg8 weeks9
Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized, factorial design, placebo-controlled trial
1999 · B group vitamins alone · Men aged 30–49 with plasma homocysteine concentration ≥8.34 μmol/L
1 mg8 weeks—
Low-dose folic acid supplementation does not influence plasma methionine concentrations in young non-pregnant women
1999 · 500 micrograms folic acid each day · Young non-pregnant women
500 mcg4 weeks—
Randomized trial of folic acid supplementation and serum homocysteine levels
2001 · 0.4 mg/d folic acid · Patients with ischemic heart disease; age and sex not specified
400 mcg90 days—
Randomized trial of folic acid supplementation and serum homocysteine levels
2001 · 0.6 mg/d folic acid · Patients with ischemic heart disease; age and sex not specified
600 mcg90 days—
Optimization of dietary folate or low-dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults, irrespective of the methylenetetrahydrofolate reductase (C677T) genotype
2001 · daily 400-microg folic acid supplement plus natural diet · Healthy adults; 42 of each MTHFR genotype
400 mcg120 days—
5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women
2002 · folic acid · healthy young women
400 mcg8 weeks—
The effect of folic acid supplementation on plasma homocysteine in an elderly population
2002 · 400 microg folic acid group · Adults aged 65–75 years
400 mcg6 weeks—
The effect of folic acid supplementation on plasma homocysteine in an elderly population
2002 · 600 microg folic acid group · Adults aged 65–75 years
600 mcg6 weeks—
Effect of riboflavin supplementation on plasma homocysteine in elderly people with low riboflavin status
2002 · Folic acid group (Part 2, first phase) · Healthy elderly people with sub-optimal riboflavin status
400 mcg6 weeks—
Low-dose folic acid lowers plasma homocysteine levels in women of child-bearing age
2002 · 400 microg/day folic acid group · Premenopausal women of child-bearing age
400 mcg10 weeks—
Effect of low doses of 5-methyltetrahydrofolate and folic acid on plasma homocysteine in healthy subjects with or without the 677C-->T polymorphism of methylenetetrahydrofolate reductase
2002 · Folic acid · Healthy subjects, including wild-type and homozygous carriers of the MTHFR 677C-->T polymorphism
400 mcg7 weeks—
Weekly high-dose folic Acid supplementation is effective in lowering serum homocysteine concentrations in women
2003 · weekly folic acid group · Healthy women of childbearing age
400 mcg12 weeks—
Weekly high-dose folic Acid supplementation is effective in lowering serum homocysteine concentrations in women
2003 · daily folic acid group · Healthy women of childbearing age
400 mcg12 weeks—
Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study
2003 · 400 micro g folic acid · Healthy men and women aged 50–75 years
400 mcg12 weeks—
Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study
2003 · 600 micro g folic acid · Healthy men and women aged 50–75 years
600 mcg12 weeks—
Supplementation with micronutrients in addition to iron and folic acid does not further improve the hematologic status of pregnant women in rural Nepal
2003 · folic acid alone · Pregnant women in rural Nepal
400 mcg——
Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women
2004 · 400 micro g folic acid · healthy women
400 mcg24 weeks—
[6S]5-methyltetrahydrofolate or folic acid supplementation and absorption and initial elimination of folate in young and middle-aged adults
2005 · folic acid supplementation · Healthy young and middle-aged adults
400 mcg5 weeks—
Effect of folic acid treatment on carotid intima-media thickness of patients with coronary disease
2007 · Group A · Patients with coronary disease and homocysteine levels ≥9 micromol/L; normal vitamin B12 values
2.5 mg3 years—
Effect of folate supplementation on N-terminal pro-brain natriuretic peptide
2007 · 0.4 mg FA daily · Healthy adults, median age 57 years
400 mcg8 weeks—
High- but not low-dose folic acid improves endothelial function in coronary artery disease
2006 · 400 microg folic acid group · Patients with coronary artery disease; age and sex not reported
400 mcg6 weeks—
Folic acid supplementation lowers blood arsenic
2007 · folic acid group · Bangladeshi adults selected for low plasma folate; pregnant people and people with cobalamin deficiency were excluded
400 mcg12 weeks—
Comparison study on the effect of prenatal administration of high dose and low dose folic acid
2009 · group 2 (low dose) · nulliparous pregnant women
500 mcg——
A dose-finding trial of the effect of long-term folic acid intervention: implications for food fortification policy
2011 · 0.4 mg/d folic acid · Patients with ischemic heart disease and healthy volunteers; ages and sex not specified
400 mcg26 weeks—
Effect of folic acid intervention on ALT concentration in hypertensives without known hepatic disease: a randomized, double-blind, controlled trial
2012 · low FA group · Chinese adults with mild or moderate essential hypertension and no known hepatic disease
400 mcg8 weeks—
Folic acid supplementation does not reduce intracellular homocysteine, and may disturb intracellular one-carbon metabolism
2013 · folic acid group · Volunteers; age and sex not specified
500 mcg8 weeks—
Effects of combined enalapril and folic acid therapy on the serum uric acid levels in hypertensive patients: a multicenter, randomized, double-blind, parallel-controlled clinical trial
2015 · low-FA group · Adults aged 27–75 with mild to moderate hypertension in China
400 mcg8 weeks—
Supplementation with Folic Acid, but Not Creatine, Increases Plasma Betaine, Decreases Plasma Dimethylglycine, and Prevents a Decrease in Plasma Choline in Arsenic-Exposed Bangladeshi Adults
2016 · FA400 · Arsenic-exposed adults aged 24–55 in Bangladesh
400 mcg12 weeks—
Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces serum homocysteine concentrations in older adults
2018 · Folic acid group · Healthy adults aged 50–65 with normal serum folate who had not used B-vitamin supplements for 6 months
400 mcg4 weeks—
Gene-specific DNA methylation in newborns in response to folic acid supplementation during the second and third trimesters of pregnancy: epigenetic analysis from a randomized controlled trial
2018 · ongoing folic acid supplementation · Pregnant women receiving supplementation during the second and third trimesters; newborn cord blood was analyzed
400 mcg——
Folic acid supplementation enhances arsenic methylation: results from a folic acid and creatine supplementation randomized controlled trial in Bangladesh
2019 · 400 μg folic acid group · Bangladeshi participants exposed to arsenic through drinking water; the majority were folate sufficient
400 mcg24 weeks—
Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid
1995 · 2.5 mg folic acid group · Patients with acute myocardial infarction; age and sex not reported
2.5 mg6 weeks—
Vitamin requirements for the treatment of hyperhomocysteinemia in humans
1994 · folic acid · men with hyperhomocysteinemia
650 mcg6 weeks—
Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers
1998 · 0.5 mg folic acid · Healthy volunteers without hyperhomocysteinemia
500 mcg——
Plasma homocyst(e)ine concentrations in pregnant and nonpregnant women with controlled folate intake
1998 · 850 microg/day folate intake · Women in the second trimester of pregnancy and young, healthy nonpregnant women
730 mcg12 weeks—
Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women
1998 · 400 microg folic acid · Female volunteers of childbearing age
400 mcg4 weeks—
Antenatal Multiple Micronutrient Supplementation Compared to Iron-Folic Acid Affects Micronutrient Status but Does Not Eliminate Deficiencies in a Randomized Controlled Trial Among Pregnant Women of Rural Bangladesh
2019 · IFA · Pregnant women aged 12–45 years in rural Bangladesh
600 mcg165 days777
Impact of Preconception Micronutrient Supplementation on Anemia and Iron Status during Pregnancy and Postpartum: A Randomized Controlled Trial in Rural Vietnam
2016 · IFA (iron and folic acid) · Women aged 18–40 planning pregnancy in rural Vietnam; no specific diagnosed condition required
400 mcg56 weeks518
A Prenatal Multiple Micronutrient Supplement Produces Higher Maternal Vitamin B-12 Concentrations and Similar Folate, Ferritin, and Zinc Concentrations as the Standard 60-mg Iron Plus 400-μg Folic Acid Supplement in Rural Bangladeshi Women
2016 · Fe30F · Pregnant women in rural Bangladesh enrolled before 14 weeks of pregnancy
400 mcg114 days213
Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh
2020 · IFA · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified
600 mcg—157
Effect of Combined Treatment With Folic Acid, Vitamin B(6), and Vitamin B(12) on Plasma Biomarkers of Inflammation and Endothelial Dysfunction in Women
2018 · Folic Acid/B6/B12 · Adult women at increased cardiovascular risk, with pre-existing cardiovascular disease or at least three coronary risk factors
2.5 mg2665 days150
Weekly iron-folic acid supplements containing 2.8 mg folic acid are associated with a lower risk of neural tube defects than the current practice of 0.4 mg: a randomised controlled trial in Malaysia
2020 · 2.8 mg folic acid group · Women aged 18–45 years, predominantly 18–21, non-pregnant and not planning pregnancy
400 mcg16 weeks111
Consumption of multiple micronutrients or small-quantity lipid-based nutrient supplements containing iodine at the recommended dose during pregnancy, compared with iron and folic acid, does not affect women's urinary iodine concentration in rural Malawi: a secondary outcome analysis of the iLiNS DYAD trial
2021 · MMN group · Pregnant women enrolled at no more than 20 completed weeks of pregnancy in rural Malawi
400 mcg—106
Long-term effect of low-dose folic acid intake: potential effect of mandatory fortification on the prevention of neural tube defects
2011 · 140 μg folic acid group · Women aged 18–40 years; reproductive-aged women
140 mcg40 weeks49
Folate status of reproductive age women and neural tube defect risk: the effect of long-term folic acid supplementation at doses of 140 µg and 400 µg per day
2011 · 140 μg folic acid/day · Healthy reproductive-age women aged 18–40 years; not pregnant or lactating and not planning pregnancy in the next 12 months
140 mcg40 weeks49
Functionality of endogenous folates from rye and orange juice using human in vivo model
2002 · fortified wheat bread and apple juice group · Healthy human volunteers aged 20–66 years
188 mcg4 weeks31
Optimum dose of oral folic acid supplementation in transfusion-dependent thalassemia: a randomized controlled trial
2022 · Group 1 · Children aged 5–18 years with transfusion-dependent thalassemia
5 mg39 weeks30
Bioavailability of food folates is 80% of that of folic acid
2007 · Group A · Healthy adults; age and sex not reported
58 mcg4 weeks29
Folic acid absorption in patients infected with the human immunodeficiency virus
1991 · oral folic acid absorption study · people with HIV infection; age and sex not reported
5 mg1 day25
Human milk unmetabolized folic acid is increased following supplementation with synthetic folic acid as compared to (6S)-5-methyltetrahydrofolic acid
2023 · folic acid · Pregnant women aged 19–42 years with singleton pregnancies, continuing supplementation through approximately 1 week postpartum
600 mcg24 weeks21
Effects of folic acid on epithelial apoptosis and expression of Bcl-2 and p53 in premalignant gastric lesions
2005 · treatment group · Patients with premalignant gastric lesions, including colonic-type intestinal metaplasia or mild to moderate dysplasia; age and sex not reported
30 mg90 days19
Determining bioavailability of food folates in a controlled intervention study
2004 · folic acid group · men; age and health status not specified
200 mcg30 days18
Relative bioavailability of iron and folic acid from a new powdered supplement compared to a traditional tablet in pregnant women
2009 · Powdered Supplement · Healthy pregnant women aged 18–45 years, at 24–32 weeks’ gestation
600 mcg1 day18
Study of wheat breakfast rolls fortified with folic acid. The effect on folate status in women during a 3-month intervention
2002 · group H · healthy women; age not reported
355 mcg12 weeks15
Study of wheat breakfast rolls fortified with folic acid. The effect on folate status in women during a 3-month intervention
2002 · group L · healthy women; age not reported
166 mcg12 weeks14
Postpartum folic acid supplementation of adolescents: impact on maternal folate and zinc status and milk composition
1995 · folic acid supplement lactating (SL) · Breastfeeding adolescents aged 14–19 years postpartum
300 mcg12 weeks14
Folate bioavailability from breads and a meal assessed with a human stable-isotope area under the curve and ileostomy model
2010 · Whole-meal bread containing labeled folic acid · Healthy ileostomists; age and sex not reported
200 mcg1 day8
Folate bioavailability from breads and a meal assessed with a human stable-isotope area under the curve and ileostomy model
2010 · Fortified breakfast meal containing labeled folic acid · Healthy ileostomists; age and sex not reported
200 mcg1 day8
Folic acid handling by the human gut: implications for food fortification and supplementation
2014 · 13C5-folic acid · Adults aged 44–61 with stable liver cirrhosis and an in situ TIPSS
220 mcg1 day6
School-administered weekly iron-folate supplements improve hemoglobin and ferritin concentrations in Malaysian adolescent girls
1999 · 60 mg Fe plus 3.5 mg folic acid weekly · Adolescent girls with hemoglobin 80–119.9 g/L (group A, mild-to-moderate anemia) and 120–130 g/L (group B, borderline anemia); otherwise healthy
500 mcg22 weeks—
School-administered weekly iron-folate supplements improve hemoglobin and ferritin concentrations in Malaysian adolescent girls
1999 · 120 mg Fe plus 3.5 mg folic acid weekly · Adolescent girls with hemoglobin 80–119.9 g/L (group A, mild-to-moderate anemia) and 120–130 g/L (group B, borderline anemia); otherwise healthy
500 mcg22 weeks—
Effect of folic acid and vitamin C supplementation on folate status and homocysteine level: a randomised controlled trial in Italian smoker-blood donors
2002 · A: folic acid · Italian repeat blood donors who smoked more than 15 cigarettes per day; age and sex not specified
5 mg45 days—
Assessment of three levels of folic acid on serum folate and plasma homocysteine: a randomised placebo-controlled double-blind dietary intervention trial
2002 · 100 microg folic acid group · Men and women aged 29–90 years with plasma total homocysteine ≥10 micromol/L
100 mcg4 weeks—
Assessment of three levels of folic acid on serum folate and plasma homocysteine: a randomised placebo-controlled double-blind dietary intervention trial
2002 · 200 microg folic acid group · Men and women aged 29–90 years with plasma total homocysteine ≥10 micromol/L
200 mcg4 weeks—
Assessment of three levels of folic acid on serum folate and plasma homocysteine: a randomised placebo-controlled double-blind dietary intervention trial
2002 · 300 microg folic acid group · Men and women aged 29–90 years with plasma total homocysteine ≥10 micromol/L
300 mcg4 weeks—
Increases in blood folate indices are similar in women of childbearing age supplemented with [6S]-5-methyltetrahydrofolate and folic acid
2002 · Folic acid group · Women aged 18–49 years of childbearing age
100 mcg24 weeks—
Acute absorption of folic acid from a fortified low-fat spread
2003 · A: fortified spread and placebo tablet · Male volunteers aged 31.8 ± 13.2 years
200 mcg1 day—
Acute absorption of folic acid from a fortified low-fat spread
2003 · B: placebo spread and folic acid tablet · Male volunteers aged 31.8 ± 13.2 years
200 mcg1 day—
Pharmacokinetic study on the utilisation of 5-methyltetrahydrofolate and folic acid in patients with coronary artery disease
2004 · 5 mg folic acid · Patients with coronary artery disease who were homozygous for the 677C→T MTHFR mutation
5 mg1 day—
Zinc plus beta-carotene supplementation of pregnant women is superior to beta-carotene supplementation alone in improving vitamin A status in both mothers and infants
2004 · zinc · Pregnant women; age and specific condition not stated
400 mcg——
Folic acid fortified milk increases blood folate and lowers homocysteine concentration in women of childbearing age
2005 · fortified milk · Non-pregnant women aged 18–47 years
375 mcg12 weeks—
Bioavailability of folic acid from fortified pasteurised and UHT-treated milk in humans
2005 · Pasteurised milk fortified with folic acid · Healthy, free-living adults aged 18–49 years
200 mcg4 weeks—
Bioavailability of folic acid from fortified pasteurised and UHT-treated milk in humans
2005 · UHT-treated milk fortified with folic acid · Healthy, free-living adults aged 18–49 years
200 mcg4 weeks—
Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability
2008 · 0.4 mg folic acid with green tea · Healthy volunteers; age and sex not specified
400 mcg1 day—
Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability
2008 · 0.4 mg folic acid with black tea · Healthy volunteers; age and sex not specified
400 mcg1 day—
Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability
2008 · 5 mg folic acid with water · Healthy volunteers; age and sex not specified
5 mg1 day—
Gender and body size affect the response of erythrocyte folate to folic acid treatment
2008 · 50 microg/d folic acid, 12-wk trial · men and women; age and health condition not reported
50 mcg12 weeks—
Gender and body size affect the response of erythrocyte folate to folic acid treatment
2008 · 100 microg/d folic acid, 12-wk trial · men and women; age and health condition not reported
100 mcg12 weeks—
Gender and body size affect the response of erythrocyte folate to folic acid treatment
2008 · 200 microg/d folic acid, 12-wk trial · men and women; age and health condition not reported
200 mcg12 weeks—
Folate status and homocysteine response to folic acid doses and withdrawal among young Chinese women in a large-scale randomized double-blind trial
2008 · 100 microg 1 time/d · Young Chinese women not exposed to other sources of folic acid
100 mcg26 weeks—
Folate status and homocysteine response to folic acid doses and withdrawal among young Chinese women in a large-scale randomized double-blind trial
2008 · 25 microg 4 times/d · Young Chinese women not exposed to other sources of folic acid
100 mcg26 weeks—
Steady state folate concentrations achieved with 5 compared with 1.1 mg folic acid supplementation among women of childbearing age
2009 · 5 mg folic acid group · Nonpregnant women aged 18–45 years who did not take folic acid supplements
5 mg30 weeks—
Effects of folic acid supplementation on serum folate and plasma homocysteine concentrations in older adults: a dose-response trial
2010 · 100 μg/day folic acid · Adults aged 60–90 years; healthy older adults
100 mcg6 weeks—
MTHFR 677C->T genotype is associated with folate and homocysteine concentrations in a large, population-based, double-blind trial of folic acid supplementation
2011 · 100 μg/d folic acid · Northern Chinese women of childbearing age
100 mcg26 weeks—
The effects of folic acid on markers of endothelial function in patients with type 1 diabetes mellitus
2012 · folic acid · Type 1 diabetic patients aged 5–20 years
5 mg8 weeks—
Response of serum and red blood cell folate concentrations to folic acid supplementation depends on methylenetetrahydrofolate reductase C677T genotype: results from a crossover trial
2013 · 200 μg folic acid · Adults aged 18–69 years without chronic disease or diseases known to interfere with folate metabolism
200 mcg12 weeks—
Iron-containing micronutrient supplementation of Chinese women with no or mild anemia during pregnancy improved iron status but did not affect perinatal anemia
2014 · IFA group · Pregnant nulliparous women aged 20 years or older, enrolled by 20 weeks’ gestation, with hemoglobin at least 100 g/L and no or mild anemia
400 mcg——
Iron-containing micronutrient supplementation of Chinese women with no or mild anemia during pregnancy improved iron status but did not affect perinatal anemia
2014 · MM group · Pregnant nulliparous women aged 20 years or older, enrolled by 20 weeks’ gestation, with hemoglobin at least 100 g/L and no or mild anemia
400 mcg——
Pregnancy-induced changes in the long-term pharmacokinetics of 1.1 mg vs. 5 mg folic acid: a randomized clinical trial
2015 · 5 mg (high dose) · Pregnant women who were not previously taking folic acid
5 mg——
Minimum effective dose of folic acid for food fortification to prevent neural-tube defects
1997 · 100 micrograms/day group · Women with red-cell folate concentrations between 150 and 400 micrograms/L
100 mcg26 weeks—
Minimum effective dose of folic acid for food fortification to prevent neural-tube defects
1997 · 200 micrograms/day group · Women with red-cell folate concentrations between 150 and 400 micrograms/L
200 mcg26 weeks—
Folate status response to controlled folate intake in pregnant women
1997 · 330 microg/d synthetic folic acid group · Pregnant women in their second trimester and nonpregnant women; the abstract does not give the number in this dose group
330 mcg12 weeks—
Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease
1998 · Cereal providing 499 microg of folic acid daily · Men and women with coronary artery disease
499 mcg——
Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease
1998 · Cereal providing 665 microg of folic acid daily · Men and women with coronary artery disease
665 mcg——
Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial
2012 · UFT/LV group · Adults aged 20–80 with resected stage III colon adenocarcinoma
75 mg25 weeks748
Impact of Preconception Micronutrient Supplementation on Anemia and Iron Status during Pregnancy and Postpartum: A Randomized Controlled Trial in Rural Vietnam
2016 · Multiple micronutrients (MM) · Women aged 18–40 planning pregnancy in rural Vietnam; no specific diagnosed condition required
400 mcg56 weeks508
Provision of Lipid-Based Nutrient Supplements to Mothers During Pregnancy and 6 Months Postpartum and to Their Infants from 6 to 18 Months Promotes Infant Gut Microbiota Diversity at 18 Months of Age but Not Microbiota Maturation in a Rural Malawian Setting: Secondary Outcomes of a Randomized Trial
2020 · MMN group · Pregnant women aged 15 years or older, enrolled at 20 or more weeks of gestation; mothers and infants in the MMN group, with no direct infant supplementation
400 mcg548 days291
Daily Folic Acid and/or Vitamin B12 Supplementation Between 6 and 30 Months of Age and Cardiometabolic Risk Markers After 6-7 Years: A Follow-Up of a Randomized Controlled Trial
2023 · Folic acid only · Children aged 6–30 months at enrollment
150 mcg180 days204
The Effect of High Dose Folic Acid throughout Pregnancy on Homocysteine (Hcy) Concentration and Pre-Eclampsia: A Randomized Clinical Trial
2016 · Group 1 (Low dose) · Healthy nulliparous pregnant women aged 20–30 years with singleton pregnancies
500 mcg—200
Prenatal nutrition supplementation and growth biomarkers in preadolescent Bangladeshi children: A birth cohort study
2022 · Fe30F · Pregnant women in rural Bangladesh; age and sex beyond pregnancy not specified
400 mcg—189
Prenatal nutrition supplementation and growth biomarkers in preadolescent Bangladeshi children: A birth cohort study
2022 · MM · Pregnant women in rural Bangladesh; age and sex beyond pregnancy not specified
400 mcg—162
Consumption of multiple micronutrients or small-quantity lipid-based nutrient supplements containing iodine at the recommended dose during pregnancy, compared with iron and folic acid, does not affect women's urinary iodine concentration in rural Malawi: a secondary outcome analysis of the iLiNS DYAD trial
2021 · LNS group · Pregnant women enrolled at no more than 20 completed weeks of pregnancy in rural Malawi
400 mcg—107
Plasma Methylmalonic Acid Concentration in Folic Acid-Supplemented Depressed Patients with Low or Marginal Vitamin B-12: A Randomized Trial
2021 · Folic acid · Adults with moderate to severe depression, aged about 46 years, with low or marginal serum vitamin B-12 (150–280 ng/L)
5 mg12 weeks92
Folic acid treatment normalizes NOS-dependence of vascular tone in the metabolic syndrome
2011 · folic acid treatment · Obese subjects with and without metabolic syndrome
5 mg4 weeks75
A Randomized Trial of Short-term Treatment with Folic Acid to Reduce the Oxidative Stress of Patients with Chronic Kidney Disease
2021 · folic acid treatment · Adults with chronic kidney disease stages 3a and 3b
5 mg90 days66
Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke: effect of combined therapy with folic acid and mecobalamine
2002 · folic acid group · Japanese patients with ischemic stroke in the convalescent stage
5 mg8 weeks64
The effect of folic acid supplementation on carotid intima-media thickness in patients with cardiovascular risk: a randomized, placebo-controlled trial
2010 · group I · Patients with at least one cardiovascular risk factor
5 mg78 weeks53
Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial
2016 · Control group · Adults with stage 1 essential hypertension and hyper-homocysteinemia (HCys ≥15 μmol/L), without a history of cardiovascular or cerebrovascular disease; mean age 62.8 years, 63.5% male
5 mg60 days52
Low-Dose folic acid supplementation decreases plasma homocysteine concentrations: a randomised trial
2000 · 500 microg folic acid every second day (250 microg/day) · Healthy women aged 18–40 years
250 mcg4 weeks50
Short-term high-dose folic acid does not alter markers of endothelial cell damage in patients with coronary heart disease
2004 · folic acid · Patients with coronary heart disease and normal serum creatinine
5 mg6 weeks50
Evaluation of the deoxyuridine suppression test by using whole blood samples from folic acid-supplemented subjects
1990 · F group · Women with cervical dysplasia; age range not reported
10 mg26 weeks50
Folic acid effect on homocysteine, sortilin levels and glycemic control in type 2 diabetes mellitus patients
2022 · folic acid group · Adults aged 45–75 with type 2 diabetes mellitus
5 mg12 weeks50
Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial
1999 · 250 microgram/d group · Healthy women aged 18–40 years
250 mcg4 weeks50
Genomic DNA methylation changes in response to folic acid supplementation in a population-based intervention study among women of reproductive age
2011 · 100 µg/day folic acid group · Women of reproductive age; mean age 30.6 years in the analyzed sample; not pregnant or breastfeeding and without chronic disease
100 mcg26 weeks45
Different doses of oral folic acid for homocysteine-lowering therapy in patients on hemodialysis: a randomized controlled trial
2009 · group 1 · Adults on hemodialysis
5 mg60 days40
Different doses of oral folic acid for homocysteine-lowering therapy in patients on hemodialysis: a randomized controlled trial
2009 · group 2 · Adults on hemodialysis
15 mg60 days40
Homocysteine lowering by folate-rich diet or pharmacological supplementations in subjects with moderate hyperhomocysteinemia
2013 · Folic acid · Adults aged 18–60 with moderate hyperhomocysteinemia
200 mcg13 weeks37
Prospective evaluation of folic acid supplementation on plasma homocysteine concentrations during weight reduction: a randomized, double-blinded, placebo-controlled study in obese women
2005 · folic acid supplementation · Obese women, mean age 41 years, participating in a weight-reduction program
5 mg12 weeks36
Homocysteine--a treatable risk factor for allograft vascular disease after heart transplantation?
2001 · folic acid · Heart transplant recipients, mean age 55.0 years; 61 of the 69 participants were male
5 mg90 days34
Effect of different doses of folic acid on serum homocysteine level in patients on hemodialysis
2011 · 5 mg/d folic acid · Adults on maintenance hemodialysis; mean age 57.6 years; 17 women and 14 men completed all phases
5 mg4 weeks31
Effect of different doses of folic acid on serum homocysteine level in patients on hemodialysis
2011 · 10 mg/d folic acid · Adults on maintenance hemodialysis; mean age 57.6 years; 17 women and 14 men completed all phases
10 mg4 weeks31
Effect of different doses of folic acid on serum homocysteine level in patients on hemodialysis
2011 · 15 mg/d folic acid · Adults on maintenance hemodialysis; mean age 57.6 years; 17 women and 14 men completed all phases
15 mg4 weeks31
[Effects of intervention therapy of methylcobalamin and folic acid on plasma homocysteine concentration and homocysteine thiolactonases/paraoxonase activity in patients with type 2 diabetes mellitus]
2007 · Group II · Patients with type 2 diabetes mellitus
5 mg12 weeks30
Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes
2008 · Group II · Patients with type 2 diabetes; age and sex not specified
5 mg2 weeks30
The Effects of Folate Supplementation on Carotid Intima-Media Thickness and Metabolic Status in Patients with Metabolic Syndrome
2016 · group A · Overweight adults aged 40–85 with type 2 diabetes, coronary heart disease, and metabolic syndrome
5 mg12 weeks30
Folate supplementation in peritoneal dialysis patients with normal erythrocyte folate: effect on plasma homocysteine
2001 · oral folate · Peritoneal dialysis patients with hyperhomocysteinemia (>15 micromol/l) and normal folate status (erythrocyte folate >600 nmol/l)
5 mg60 days29
Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial
2014 · Folate-5 · Women aged 18–40 years with obesity and polycystic ovary syndrome
5 mg8 weeks27
Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients
2003 · 5 mg per day · Chronic hemodialysis patients
5 mg1 year26
Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients
2003 · 15 mg per day · Chronic hemodialysis patients
15 mg1 year25
Fenofibrate-induced hyperhomocysteinemia may be prevented by folate co-administration
2003 · fenofibrate in combination with folate · Adults with total cholesterol ≥6 mmol/L and triglycerides <5 mmol/L, normal blood pressure and glucose, and no clinical vascular or metabolic disease; mean age 54.9 years
10 mg90 days24
Effect of Folic Acid, Betaine, Vitamin B₆, and Vitamin B12 on Homocysteine and Dimethylglycine Levels in Middle-Aged Men Drinking White Wine
2016 · Folate group · Healthy men aged 37–65 years who were moderate alcohol consumers
5 mg4 weeks24
No effect of folic acid on markers of endothelial dysfunction or inflammation in patients with type 2 diabetes mellitus and mild hyperhomocysteinaemia
2004 · folic acid · Patients with type 2 diabetes mellitus and mild hyperhomocysteinaemia (homocysteine ≥14 micromol/L)
5 mg26 weeks23
The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial
2014 · folate-5 · Women aged 18–40 with polycystic ovary syndrome who were overweight or obese
5 mg8 weeks23
The effects of high and low doses of folic acid on oxidation of protein levels during pregnancy: a randomized double-blind clinical trial
2017 · Group 1 (5 mg/day folic acid) · Pregnant women, from before pregnancy through the 36th week of pregnancy
5 mg—23
Homocysteine-lowering therapy and early progression of transplant vasculopathy: a prospective, randomized, IVUS-based study
2005 · 15 mg/day of 5-methyl-tetrahydrofolate · De novo heart transplant recipients
15 mg1 year22
Effect of folate supplementation on DNA methylation of rectal mucosa in patients with colonic adenomas: correlation with nutrient intake
1998 · folate supplementation · 20 patients with resected colonic adenomas
5 mg—20
Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial
2005 · group 3 · Women with polycystic ovarian syndrome treated with metformin; age not reported
348 mcg90 days20
[Hyperhomocysteinemia and treatment with antiepileptic drugs. Effects of different doses of folic acid]
2005 · 5.2 mg folic acid group · Adults with hyperhomocysteinemia receiving antiepileptic drugs
5.2 mg90 days20
The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level
2005 · HT + FA · Healthy postmenopausal women, mean age 52 years
5 mg90 days20
Effect of folate supplementation on serum homocysteine and plasma total antioxidant capacity in hypercholesterolemic adults under lovastatin treatment: a double-blind randomized controlled clinical trial
2009 · Group A · Adults with newly diagnosed hypercholesterolemia
5 mg8 weeks20
Randomized controlled trial of the effect of short-term coadministration of methylcobalamin and folate on serum ADMA concentration in patients receiving long-term hemodialysis
2010 · folate group · Patients undergoing long-term hemodialysis
15 mg3 weeks20
Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial
2018 · DCI treatment · Pregnant women with gestational diabetes mellitus
400 mcg8 weeks20
The potential adding therapeutic effect of pentoxifylline and/or folic acid for chronic kidney disease patients: randomized controlled trial
2025 · PTX + FA group · Adults aged 18–60 with stable stage 3–5 chronic kidney disease
500 mcg26 weeks20
[Hyperhomocysteinemia and treatment with antiepileptic drugs. Effects of different doses of folic acid]
2005 · 0.2 mg folic acid group · Adults with hyperhomocysteinemia receiving antiepileptic drugs
200 mcg90 days18
Vitamin B(6) supplementation improves pro-inflammatory responses in patients with rheumatoid arthritis
2010 · control · Patients with rheumatoid arthritis
5 mg12 weeks15
A pilot study of folic acid supplementation for improving homocysteine levels, cognitive and depressive status in eating disorders
2013 · supplemented group (SG) · Patients with eating disorders and low folate intake; mean age 24.2 years; sex not specified
10 mg26 weeks12
Folic acid mediated attenuation of loss of heterozygosity of DCC tumor suppressor gene in the colonic mucosa of patients with colorectal adenomas
2003 · folic acid group · Patients with colorectal adenomas; age and sex not specified
5 mg1 year10
Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome
2008 · Group B · Overweight patients with polycystic ovary syndrome; age and sex details not stated
200 mcg12 weeks10
Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation
2002 · group I · Haemodialysis patients with chronic renal failure and hyperhomocysteinaemia
15 mg3 weeks7
Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients
1999 · Folic acid 5 mg daily without betaine · Adults with end-stage renal disease receiving maintenance haemodialysis
5 mg12 weeks—
Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients
1999 · Folic acid 5 mg daily (40-week phase) · Adults with end-stage renal disease receiving maintenance haemodialysis
5 mg40 weeks—
Low-dose folic acid supplementation does not influence plasma methionine concentrations in young non-pregnant women
1999 · 500 micrograms folic acid and placebo tablets on alternate days · Young non-pregnant women
250 mcg4 weeks—
Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study
2000 · 15 mg/d folic acid group · Hemodialysis patients with hyperhomocysteinemia
15 mg4 weeks—
Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study
2000 · 30 mg/d folic acid group · Hemodialysis patients with hyperhomocysteinemia
30 mg4 weeks—
Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study
2000 · 60 mg/d folic acid group · Hemodialysis patients with hyperhomocysteinemia
60 mg4 weeks—
A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease
2000 · folic acid · Adults receiving hemodialysis or continuous ambulatory peritoneal dialysis with end-stage renal disease
5 mg90 days—
A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH)
2000 · vitamins alone group · Patients with primary hypercholesterolaemia; age and sex not reported
2 mg6 weeks—
Effects of folate supplementation on two provisional molecular markers of colon cancer: a prospective, randomized trial
2001 · folate · people with adenomas after polypectomy; age and sex not specified
5 mg1 year—
Randomized trial of folic acid supplementation and serum homocysteine levels
2001 · 0.2 mg/d folic acid · Patients with ischemic heart disease; age and sex not specified
200 mcg90 days—
Concomitant supplemental vitamin A enhances the response to weekly supplemental iron and folic acid in anemic teenagers in urban Bangladesh
2001 · iron + folic acid · Teenage women in urban Bangladesh with hemoglobin concentrations of 80–120 g/L
500 mcg12 weeks—
Folate supplementation prevents plasma homocysteine increase after fenofibrate therapy
2001 · fenofibrate plus folic acid · Patients with mixed hyperlipidemia
5 mg9 weeks—
The effect of folic acid supplementation on plasma homocysteine in an elderly population
2002 · 50 microg folic acid group · Adults aged 65–75 years
50 mcg6 weeks—
The effect of folic acid supplementation on plasma homocysteine in an elderly population
2002 · 100 microg folic acid group · Adults aged 65–75 years
100 mcg6 weeks—
The effect of folic acid supplementation on plasma homocysteine in an elderly population
2002 · 200 microg folic acid group · Adults aged 65–75 years
200 mcg6 weeks—
Randomized trial of methylcobalamin and folate effects on homocysteine in hemodialysis patients
2002 · Group B · Chronic hemodialysis patients without previous vitamin supplementation
10 mg120 days—
Low-dose folic acid lowers plasma homocysteine levels in women of child-bearing age
2002 · 100 microg/day folic acid group · Premenopausal women of child-bearing age
100 mcg10 weeks—
Low-dose folic acid lowers plasma homocysteine levels in women of child-bearing age
2002 · 200 microg/day folic acid group · Premenopausal women of child-bearing age
200 mcg10 weeks—
Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease
2002 · 0.2 mg folic acid · People with a history of myocardial infarction or unstable angina
200 mcg——
Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo-controlled study
2003 · Folic acid group · Healthy volunteers; age and sex not specified
100 mcg24 weeks—
Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study
2003 · 50 micro g folic acid · Healthy men and women aged 50–75 years
50 mcg12 weeks—
Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study
2003 · 100 micro g folic acid · Healthy men and women aged 50–75 years
100 mcg12 weeks—
Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study
2003 · 200 micro g folic acid · Healthy men and women aged 50–75 years
200 mcg12 weeks—
Bioavailability of oral vs. subcutaneous low-dose methotrexate in patients with Crohn's disease
2003 · Orally with 5 mg folic acid · Patients with stable Crohn's disease; age and sex not stated
5 mg7 days—
Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine
2003 · F+F group · Patients with combined hyperlipidemia; age and sex not specified
5 mg9 weeks—
Effects of folic acid supplementation on inflammatory and thrombogenic markers in chronic smokers. A randomised controlled trial
2003 · folic acid · Healthy chronic cigarette smokers; mean age 37.8 years; sex not specified
5 mg4 weeks—
Folic acid supplement decreases the homocysteine increasing effect of filtered coffee. A randomised placebo-controlled study
2003 · folic acid group · Healthy, nonsmoking men and women aged 29–65 years
200 mcg4 weeks—
The methylenetetrahydrofolate reductase C677T polymorphism is a major determinant of coffee-induced increase of plasma homocysteine: a randomized placebo controlled study
2004 · 200 microg folic acid group · Healthy, non-smoking men and women aged 29–65 years
200 mcg4 weeks—
Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial
2005 · vitamin therapy · Patients with recent transient ischemic attack or stroke; age and sex not reported
2 mg26 weeks—
Sustained homocysteine-lowering effect over time of folic acid-based multivitamin therapy in stroke patients despite increasing folate status in the population
2005 · active VITATOPS medication · Patients with stroke or transient ischemic attack
2 mg26 weeks—
L-folic acid supplementation in healthy postmenopausal women: effect on homocysteine and glycolipid metabolism
2005 · L-folic acid · Healthy, normoinsulinemic postmenopausal women
7.5 mg8 weeks—
Decrease of carotid intima-media thickness in patients at risk to cerebral ischemia after supplementation with folic acid, Vitamins B6 and B12
2005 · treatment group · Adults aged 60 ± 8 years with carotid intima-media thickness ≥1 mm and at risk of cerebral ischemia
2.5 mg1 year—
Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease
2005 · folic acid plus vitamin B-12 · Adults aged 65 years or older with ischemic vascular disease
2.5 mg1 year—
Folate co-administration improves the effectiveness of fenofibrate to decrease the lipoprotein oxidation and endothelial dysfunction surrogates
2006 · Fenofibrate combined with folate · Subjects with hypercholesterolemia; age and sex not reported
10 mg——
No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk
2006 · Study II: folic acid · Patients with type 2 diabetes and mild hyperhomocysteinaemia; ages and sex not stated
5 mg26 weeks—
Milk folate secretion is not impaired during iron deficiency in humans
2006 · multivitamin with iron · Breast-feeding mothers; age not reported
400 mcg——
Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients
2006 · Control group · Chronic hemodialysis patients with hyperhomocysteinemia; age and sex not specified
5 mg26 weeks—
Effect of folate supplementation on N-terminal pro-brain natriuretic peptide
2007 · 5.0 mg FA daily · Healthy adults, median age 57 years
5 mg8 weeks—
High- but not low-dose folic acid improves endothelial function in coronary artery disease
2006 · 5 mg folic acid group · Patients with coronary artery disease; age and sex not reported
5 mg6 weeks—
Folic acid does not improve endothelial function in obese children and adolescents
2007 · folic acid group · Obese children and adolescents; mean age 13.3 years; no diabetes
5 mg8 weeks—
Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease
2007 · folic acid · Patients with hyperhomocysteinaemia and coronary artery disease; age and sex not reported
5 mg8 weeks—
Comparison study on the effect of prenatal administration of high dose and low dose folic acid
2009 · group one (high dose) · nulliparous pregnant women
5 mg——
Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial
2009 · B-vitamin therapy · Adults with a history of ischemic stroke
2 mg1461 days—
Role of folic acid in atherosclerosis after kidney transplant: a double-blind, randomized, placebo-controlled clinical trial
2009 · folic acid group · Kidney transplant recipients; age and sex range not specified
5 mg26 weeks—
Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients
2009 · group I (only folic acid) · Hemodialysis patients; age and sex not reported
5 mg8 weeks—
Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients
2009 · group III (only folic acid) · Hemodialysis patients; age and sex not reported
15 mg8 weeks—
Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India
2010 · B0 F200 (no vitamin B12, 200 μg folic acid) · Children and adults from rural families in India; participants included children (mean age 9 years), mothers and fathers
200 mcg1 year—
Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial
2010 · B-vitamin group · People with type 1 or type 2 diabetes and a clinical diagnosis of diabetic nephropathy
2.5 mg3 years—
A comparison of iron and folate with folate alone in hematologic recovery of children treated for acute malaria
2010 · folate alone group · Children aged 6–60 months with smear-positive malaria and anemia (hematocrit <33%)
5 mg4 weeks—
A dose-finding trial of the effect of long-term folic acid intervention: implications for food fortification policy
2011 · 0.2 mg/d folic acid · Patients with ischemic heart disease and healthy volunteers; ages and sex not specified
200 mcg26 weeks—
Effect of folic acid supplementation on homocysteine, serum total antioxidant capacity, and malondialdehyde in patients with type 2 diabetes mellitus
2011 · folic acid group · men with type 2 diabetes
5 mg8 weeks—
Effects of prenatal micronutrient and early food supplementation on maternal hemoglobin, birth weight, and infant mortality among children in Bangladesh: the MINIMat randomized trial
2012 · 30 mg iron and 400 μg folic acid; early food invitation · Pregnant women in poor communities in Bangladesh
400 mcg——
Effects of prenatal micronutrient and early food supplementation on maternal hemoglobin, birth weight, and infant mortality among children in Bangladesh: the MINIMat randomized trial
2012 · 30 mg iron and 400 μg folic acid; usual food invitation · Pregnant women in poor communities in Bangladesh
400 mcg——
Effects of prenatal micronutrient and early food supplementation on maternal hemoglobin, birth weight, and infant mortality among children in Bangladesh: the MINIMat randomized trial
2012 · MMS containing 15 micronutrients, including 30 mg iron and 400 μg folic acid; early food invitation · Pregnant women in poor communities in Bangladesh
400 mcg——
Effects of prenatal micronutrient and early food supplementation on maternal hemoglobin, birth weight, and infant mortality among children in Bangladesh: the MINIMat randomized trial
2012 · MMS containing 15 micronutrients, including 30 mg iron and 400 μg folic acid; usual food invitation · Pregnant women in poor communities in Bangladesh
400 mcg——
The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis
2016 · Group A, t1: folic acid (B9) · Hemodialysis patients with C677T MTHFR genotypes
10 mg60 days—
The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis
2016 · Group B, t2: folic acid (B9) · Hemodialysis patients with C677T MTHFR genotypes
10 mg60 days—
Comparative Study of the Effects of Tamoxifen Citrate and Folate on Semen Quality of the Infertile Male with Semen Abnormality
2015 · Folate · Infertile men with semen abnormalities
5 mg90 days—
Acceptability and Utilization of Three Nutritional Supplements during Pregnancy: Findings from a Longitudinal, Mixed-Methods Study in Niger
2018 · MMN group · Pregnant women enrolled before 30 weeks’ gestation in rural Niger
400 mcg26 weeks—
The Inclusion of Folic Acid in Weekly Iron-Folic Acid Supplements Confers no Additional Benefit on Anemia Reduction in Nonpregnant Women: A Randomized Controlled Trial in Malaysia
2021 · 60 mg Fe with 2.8 mg folic acid · Nonpregnant women aged 18–45 years in Malaysia
400 mcg16 weeks—
Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid
1995 · 10 mg folic acid group · Patients with acute myocardial infarction; age and sex not reported
10 mg6 weeks—
No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients
1998 · 5 mg folic acid (phase 1) · Haemodialysis patients with hyperhomocysteinaemia; age and sex not reported
5 mg12 weeks—
No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients
1998 · 5 mg folic acid (phase 2) · Haemodialysis patients with hyperhomocysteinaemia; age and sex not reported
5 mg40 weeks—
No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients
1998 · 15 mg folic acid (phase 3; all patients) · Haemodialysis patients with hyperhomocysteinaemia; age and sex not reported
15 mg4 weeks—
Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers
1998 · 5 mg folic acid · Healthy volunteers without hyperhomocysteinemia
5 mg——
Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy
1998 · 5 mg folic acid alone daily · Peritoneal dialysis patients with hyperhomocysteinemia
5 mg12 weeks—
Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy
1998 · 5 mg folic acid daily · Peritoneal dialysis patients with hyperhomocysteinemia
5 mg40 weeks—
Plasma homocyst(e)ine concentrations in pregnant and nonpregnant women with controlled folate intake
1998 · 450 microg/day folate intake · Women in the second trimester of pregnancy and young, healthy nonpregnant women
330 mcg12 weeks—
Effects of an Iodine-Containing Prenatal Multiple Micronutrient on Maternal and Infant Iodine Status and Thyroid Function: A Randomized Trial in The Gambia
2020 · FeFol · Pregnant women aged 18–45 years in rural West Kiang, The Gambia, with moderate iodine deficiency
400 mcg—219
A Prenatal Multiple Micronutrient Supplement Produces Higher Maternal Vitamin B-12 Concentrations and Similar Folate, Ferritin, and Zinc Concentrations as the Standard 60-mg Iron Plus 400-μg Folic Acid Supplement in Rural Bangladeshi Women
2016 · Fe60F · Pregnant women in rural Bangladesh enrolled before 14 weeks of pregnancy
400 mcg114 days216
Impact of nutritional supplementation during pregnancy on antibody responses to diphtheria-tetanus-pertussis vaccination in infants: A randomised trial in The Gambia
2019 · MMN · Pregnant women aged 18–45 years, enrolled before 20 weeks’ gestation in rural Gambia
400 mcg186 days179
Impact of nutritional supplementation during pregnancy on antibody responses to diphtheria-tetanus-pertussis vaccination in infants: A randomised trial in The Gambia
2019 · FeFol · Pregnant women aged 18–45 years, enrolled before 20 weeks’ gestation in rural Gambia
400 mcg186 days178
A community-based randomized controlled trial providing weekly iron-folic acid supplementation increased serum- ferritin, -folate and hemoglobin concentration of adolescent girls in southern Ethiopia
2021 · WIFAS · Apparently healthy adolescent girls aged 10–19 years in southern Ethiopia
57.1 mcg90 days113
Weekly iron-folic acid supplements containing 2.8 mg folic acid are associated with a lower risk of neural tube defects than the current practice of 0.4 mg: a randomised controlled trial in Malaysia
2020 · 0.4 mg folic acid group · Women aged 18–45 years, predominantly 18–21, non-pregnant and not planning pregnancy
57.1 mcg16 weeks110
Small-Quantity Lipid-Based Nutrient Supplements Do Not Affect Plasma or Milk Retinol Concentrations Among Malawian Mothers, or Plasma Retinol Concentrations among Young Malawian or Ghanaian Children in Two Randomized Trials
2021 · IFA (Malawi mothers) · Women aged over 15 years, pregnant at enrollment (≤20 weeks), in Malawi
400 mcg—105
Consumption of multiple micronutrients or small-quantity lipid-based nutrient supplements containing iodine at the recommended dose during pregnancy, compared with iron and folic acid, does not affect women's urinary iodine concentration in rural Malawi: a secondary outcome analysis of the iLiNS DYAD trial
2021 · iron–folic acid group (IFA) · Pregnant women enrolled at no more than 20 completed weeks of pregnancy in rural Malawi
400 mcg—104
Serum Concentrations of Folate Forms Following Supplementation of Multimicronutrients with 400 µg or 800 µg Mix of (6S)-5-Methyltetrahydrofolate and Folic Acid (1:1) in Women of Childbearing Age
2024 · 800 µg group · Nonpregnant women aged 18–45 years in good physical and mental health
400 mcg8 weeks101
Serum Concentrations of Folate Forms Following Supplementation of Multimicronutrients with 400 µg or 800 µg Mix of (6S)-5-Methyltetrahydrofolate and Folic Acid (1:1) in Women of Childbearing Age
2024 · 400 µg group · Nonpregnant women aged 18–45 years in good physical and mental health
200 mcg8 weeks100
Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study
2022 · intervention (myo-inositol) · Pregnant women aged at least 16 years with a singleton pregnancy at 12+0 to 15+6 weeks’ gestation and high risk of gestational diabetes
400 mcg—99
Supplementation during pregnancy with small-quantity lipid-based nutrient supplements or multiple micronutrients, compared with iron and folic acid, increases women's urinary iodine concentration in semiurban Ghana: A randomized controlled trial
2018 · IFA group · Pregnant women aged 18 years or older, enrolled at 20 weeks of gestation or earlier, in semiurban Ghana
400 mcg—94
Maternal multiple micronutrient supplementation in rural Pakistan increased some milk micronutrient concentrations, but not infant growth, at three-months postpartum: a randomized controlled trial substudy
2025 · Standard of care · Adolescent and young mothers aged 15–23 years in rural Pakistan; mothers in the substudy were breastfeeding infants aged about 3 months
400 mcg—89
Weekly vitamin A and iron supplementation during pregnancy increases vitamin A concentration of breast milk but not iron status in Indonesian lactating women
2001 · weekly iron and folic acid group · Pregnant Indonesian women; age and specific health conditions not stated
71.4 mcg—88
Weekly vitamin A and iron supplementation during pregnancy increases vitamin A concentration of breast milk but not iron status in Indonesian lactating women
2001 · weekly vitamin A, iron, and folic acid group · Pregnant Indonesian women; age and specific health conditions not stated
71.4 mcg—82
mRNA Levels of Placental Iron and Zinc Transporter Genes Are Upregulated in Gambian Women with Low Iron and Zinc Status
2017 · FeFol group · Pregnant women aged 18–45 years with singleton pregnancies under 20 weeks in rural Gambia
400 mcg184 days75
Bread cofortified with folic acid and vitamin B-12 improves the folate and vitamin B-12 status of healthy older people: a randomized controlled trial
2008 · bread fortified with folic acid and vitamin B-12 · Men and women aged 50–75 years described as healthy older people
138 mcg12 weeks72
Effect of iron supplementation on serum zinc status of lactating women in Addis Ababa, Ethiopia
2005 · daily iron-supplemented group · Anaemic lactating women in urban slum communities of Addis Ababa
400 mcg90 days71
Effect of iron supplementation on serum zinc status of lactating women in Addis Ababa, Ethiopia
2005 · weekly iron-supplemented group · Anaemic lactating women in urban slum communities of Addis Ababa
57.1 mcg90 days71
Double-blind, placebo-controlled trial comparing effects of supplementation of two micronutrient sprinkles on fatty acid status in Cambodian infants
2007 · iron/folate · Cambodian infants aged 6 months at enrolment
150 mcg1 year68
Maternal serum unmetabolized folic acid concentration following multivitamin and mineral supplementation with or without folic acid after 12 weeks gestation: A randomized controlled trial
2024 · Control 800 µg FA/day · Pregnant women with singleton pregnancies, enrolled at 12–16 weeks’ gestation and intending to continue a folic-acid-containing supplement; maternal age averaged 31 years
800 mcg—52
A pilot randomised controlled trial to reduce colorectal cancer risk markers associated with B-vitamin deficiency, insulin resistance and colonic inflammation
2005 · treatment arm · Adults aged 44–80 with previously resected colonic adenomatous polyps or intramucosal carcinoma
3 mg4 weeks50
Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes
2000 · nonsmokers receiving vitamin cocktail · Male nonsmokers selected for low fruit and vegetable intake
400 mcg90 days38
Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes
2000 · smokers receiving vitamin cocktail · Male smokers selected for low fruit and vegetable intake
400 mcg90 days37
Folic acid causes higher prevalence of detectable unmetabolized folic acid in serum than B-complex: a randomized trial
2016 · B-complex · Elderly people
400 mcg23 days27
Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid
2002 · Folic acid group · Adults with chronic stable hemodialysis and hyperhomocysteinemia
15 mg12 weeks24
Folic acid enrichment of bread does not appear to affect zinc absorption in young women
2001 · A · Healthy women aged 22–33 years
17 mcg1 day15
Folic acid enrichment of bread does not appear to affect zinc absorption in young women
2001 · B · Healthy women aged 22–33 years
144 mcg1 day15
Folic acid enrichment of bread does not appear to affect zinc absorption in young women
2001 · D · Healthy women aged 22–33 years
144 mcg1 day15
Adding zinc to prenatal iron and folate supplements improves maternal and neonatal zinc status in a Peruvian population
1999 · Prenatal supplements with zinc · Pregnant women in a shantytown in Lima, Peru, beginning supplementation between gestation weeks 10 and 24
250 mcg——
Adding zinc to prenatal iron and folate supplements improves maternal and neonatal zinc status in a Peruvian population
1999 · Prenatal supplements without zinc · Pregnant women in a shantytown in Lima, Peru, beginning supplementation between gestation weeks 10 and 24
250 mcg——
Changes in iron status during pregnancy in peruvian women receiving prenatal iron and folic acid supplements with or without zinc
2000 · Iron and folic acid · Pregnant women in Peru, from 10–24 weeks gestation to 4 weeks postpartum
250 mcg——
Changes in iron status during pregnancy in peruvian women receiving prenatal iron and folic acid supplements with or without zinc
2000 · Iron, folic acid, and zinc · Pregnant women in Peru, from 10–24 weeks gestation to 4 weeks postpartum
250 mcg——
Effect of folic acid and vitamin C supplementation on folate status and homocysteine level: a randomised controlled trial in Italian smoker-blood donors
2002 · C: folic acid plus vitamin C · Italian repeat blood donors who smoked more than 15 cigarettes per day; age and sex not specified
5 mg45 days—
Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study
2002 · Vitamin B(12), folic acid, and vitamin B(6) · Patients aged 38–80 years undergoing coronary angiography
800 mcg12 weeks—
Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study
2002 · Vitamin B(12) and folic acid · Patients aged 38–80 years undergoing coronary angiography
800 mcg12 weeks—
Plasma vitamin B6 vitamers before and after oral vitamin B6 treatment: a randomized placebo-controlled study
2003 · Group A · Patients aged 38–80 years undergoing coronary angiography
800 mcg12 weeks—
Zinc plus beta-carotene supplementation of pregnant women is superior to beta-carotene supplementation alone in improving vitamin A status in both mothers and infants
2004 · beta-carotene · Pregnant women; age and specific condition not stated
400 mcg——
Bioavailability of food folates is 80% of that of folic acid
2007 · Group B · Healthy adults; age and sex not reported
150 mcg4 weeks—
Bioavailability of food folates is 80% of that of folic acid
2007 · Group C · Healthy adults; age and sex not reported
249 mcg4 weeks—
Bioavailability of food folates is 80% of that of folic acid
2007 · Group D · Healthy adults; age and sex not reported
347 mcg4 weeks—
Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial
2007 · FO with MTHF · Pregnant women from gestation week 22 until delivery
400 mcg——
A randomised double-blind study comparing sodium feredetate with ferrous fumarate in anaemia in pregnancy
2007 · Group A · Pregnant women at 12–26 weeks’ gestation with iron-deficiency anaemia
3 mg75 days—
A randomised double-blind study comparing sodium feredetate with ferrous fumarate in anaemia in pregnancy
2007 · Group B · Pregnant women at 12–26 weeks’ gestation with iron-deficiency anaemia
3 mg75 days—
A randomised double-blind study comparing sodium feredetate with ferrous fumarate in anaemia in pregnancy
2007 · Group C · Pregnant women at 12–26 weeks’ gestation with iron-deficiency anaemia
3 mg75 days—
Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability
2008 · 5 mg folic acid with green tea · Healthy volunteers; age and sex not specified
5 mg1 day—
Supplementation with a multivitamin containing 800 microg of folic acid shortens the time to reach the preventive red blood cell folate concentration in healthy women
2009 · verum group · Healthy females; age not reported
800 mcg16 weeks—
Concentrations of unmetabolized folic acid and primary folate forms in plasma after folic acid treatment in older adults
2011 · folic acid treatment group · Older adults, median age 82 years; sex and health condition not specified
5 mg3 weeks—
Vitamin B12 supplementation during pregnancy and postpartum improves B12 status of both mothers and infants but vaccine response in mothers only: a randomized clinical trial in Bangladesh
2016 · B12 supplementation · Bangladeshi pregnant women aged 18–35 years, 11–14 weeks pregnant, with hemoglobin <110 g/L
400 mcg——
Effects of a lipid-based nutrient supplement during pregnancy and lactation on maternal plasma fatty acid status and lipid profile: Results of two randomized controlled trials
2017 · iron and folic acid (IFA) · Pregnant women in Ghana and Malawi; Ghana participants were at least 18 years old, and Malawi participants were at least 15 years old
400 mcg——
Effect of Nutritional Interventions on Micronutrient Status in Pregnant Malawian Women with Moderate Malnutrition: A Randomized, Controlled Trial
2018 · CSB+IFA · Pregnant Malawian women aged 16–38 with moderate malnutrition
400 mcg10 weeks—
Multi-Micronutrient Fortified Rice Improved Serum Zinc and Folate Concentrations of Cambodian School Children. A Double-Blinded Cluster-Randomized Controlled Trial
2019 · NutriRice · Cambodian schoolchildren, approximately 4–12 years old, including children with zinc deficiency
160 mcg26 weeks—
Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease
1998 · Cereal providing 127 microg of folic acid daily · Men and women with coronary artery disease
127 mcg——
One year B-vitamins increases serum and whole blood folate forms and lowers plasma homocysteine in older Germans
2015 · B-vitamin supplementation · Older German adults, mean age 67 years
500 mcg1 year—
Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS
2014 · D-chiro-inositol group · Women with PCOS and menstrual irregularities
400 mcg26 weeks25
Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study
2013 · Group B · Overweight patients with polycystic ovary syndrome; age and sex not specified
200 mg12 weeks10
Effectiveness of routine antihelminthic treatment on anaemia in pregnancy in Rufiji District, Tanzania: a cluster randomised controlled trial
2011 · control arm · Pregnant women attending antenatal care in Rufiji District, Tanzania
5 mg—1,605
Effectiveness of routine antihelminthic treatment on anaemia in pregnancy in Rufiji District, Tanzania: a cluster randomised controlled trial
2011 · study arm · Pregnant women attending antenatal care in Rufiji District, Tanzania
5 mg—1,475
Effectiveness of weekly vitamin A (10,000 IU) and iron (60 mg) supplementation for adolescent boys and girls through schools in rural and urban East Java, Indonesia
2004 · Fe group · Adolescent boys and girls aged 12–15 years attending junior high schools in rural and urban East Java, Indonesia
35.7 mcg14 weeks978
Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial
2023 · intervention · Women planning pregnancy; generally healthy, recruited before conception
400 mcg—870
Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial
2023 · control · Women planning pregnancy; generally healthy, recruited before conception
400 mcg—859
Antenatal Multiple Micronutrient Supplementation Compared to Iron-Folic Acid Affects Micronutrient Status but Does Not Eliminate Deficiencies in a Randomized Controlled Trial Among Pregnant Women of Rural Bangladesh
2019 · MM · Pregnant women aged 12–45 years in rural Bangladesh
600 mcg165 days749
The impact of zinc and folic acid supplementation on sperm DNA methylation: results from the folic acid and zinc supplementation randomized clinical trial (FAZST)
2022 · FAZ group · Men aged 18 or older in couples seeking fertility treatment
5 mg26 weeks713
Effects of lipid-based nutrient supplements or multiple micronutrient supplements compared with iron and folic acid supplements during pregnancy on maternal haemoglobin and iron status
2018 · IFA group · Pregnant Malawian women aged over 15 years, enrolled at up to 20 gestational weeks
400 mcg—460
Maternal cortisol and stress are associated with birth outcomes, but are not affected by lipid-based nutrient supplements during pregnancy: an analysis of data from a randomized controlled trial in rural Malawi
2015 · IFA · Pregnant women aged 15–49 years in rural Malawi, enrolled at up to 20 weeks of gestation
400 mcg—413
Impact of small-quantity lipid-based nutrient supplement on hemoglobin, iron status and biomarkers of inflammation in pregnant Ghanaian women
2017 · IFA · Pregnant women in a semi-urban setting in Ghana
400 mcg—349
Provision of Lipid-Based Nutrient Supplements to Mothers During Pregnancy and 6 Months Postpartum and to Their Infants from 6 to 18 Months Promotes Infant Gut Microbiota Diversity at 18 Months of Age but Not Microbiota Maturation in a Rural Malawian Setting: Secondary Outcomes of a Randomized Trial
2020 · IFA group · Pregnant women aged 15 years or older, enrolled at 20 or more weeks of gestation; mothers and infants in the IFA group, with no direct infant supplementation
400 mcg548 days290
The effectiveness of weekly iron supplementation in pregnant women of rural northern Malawi
2000 · daily iron/folate group · Pregnant women living in rural Malawi
250 mcg10 weeks211
The Effect of High Dose Folic Acid throughout Pregnancy on Homocysteine (Hcy) Concentration and Pre-Eclampsia: A Randomized Clinical Trial
2016 · Group 2 (High dose) · Healthy nulliparous pregnant women aged 20–30 years with singleton pregnancies
5 mg—210
The effectiveness of weekly iron supplementation in pregnant women of rural northern Malawi
2000 · weekly iron/folate group · Pregnant women living in rural Malawi
71.4 mcg10 weeks202
Prenatal nutrition supplementation and growth biomarkers in preadolescent Bangladeshi children: A birth cohort study
2022 · Fe60F · Pregnant women in rural Bangladesh; age and sex beyond pregnancy not specified
400 mcg—184
Daily Folic Acid and/or Vitamin B12 Supplementation Between 6 and 30 Months of Age and Cardiometabolic Risk Markers After 6-7 Years: A Follow-Up of a Randomized Controlled Trial
2023 · Vitamin B12 and folic acid · Children aged 6–30 months at enrollment
150 mcg180 days184
Impact of nutritional supplementation during pregnancy on antibody responses to diphtheria-tetanus-pertussis vaccination in infants: A randomised trial in The Gambia
2019 · PE + MMN · Pregnant women aged 18–45 years, enrolled before 20 weeks’ gestation in rural Gambia
400 mcg186 days182
Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh
2020 · MM · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified
600 mcg—176
Impact of nutritional supplementation during pregnancy on antibody responses to diphtheria-tetanus-pertussis vaccination in infants: A randomised trial in The Gambia
2019 · PE · Pregnant women aged 18–45 years, enrolled before 20 weeks’ gestation in rural Gambia
400 mcg186 days170
A prospective, partially randomized study of pregnancy outcomes and hematologic responses to oral and intramuscular iron treatment in moderately anemic pregnant women
2004 · Daily oral iron group · Pregnant women with moderate anemia
500 mcg—148
Impact of anaemia prophylaxis in pregnancy on maternal haemoglobin, serum ferritin & birth weight
1991 · study group · Pregnant women at 16–24 weeks of gestation
500 mcg100 days137
Daily supplementation of a multiple micronutrient powder improves folate but not thiamine, riboflavin, or vitamin B(12) status among young Laotian children: a randomized controlled trial
2022 · micronutrient powder group (MNP) · Children aged 6–23 months in rural Lao PDR; no disease-based selection, with high prevalence of undernutrition and micronutrient deficiencies
150 mcg36 weeks130
Lowering plasma homocysteine concentrations of older men and women with folate, vitamin B-12, and vitamin B-6 does not affect the proportion of (n-3) long chain polyunsaturated fatty acids in plasma phosphatidylcholine
2008 · vitamin group · Men and women aged 65 years or older with plasma homocysteine concentrations of at least 13 micromol/L
1 mg2 years127
The effect of Lactiplantibacillus plantarum 299v together with a low dose of iron on iron status in healthy pregnant women: A randomized clinical trial
2021 · Lp group · Healthy, non-anemic pregnant women aged 18–42 years, with singleton pregnancies and iron-replete status at enrollment
60 mcg—120
Influence of folic acid and vitamin B12 supplementation on arsenic methylation: A double-blinded, placebo-controlled trial in Bangladeshi children
2024 · FA + B12 supplementation group · Children aged 8–11 years in Bangladesh exposed to drinking-water arsenic above 50 μg/L
400 mcg12 weeks118
Relative efficacy of weekly and two differing doses of daily iron-folate supplementation in improving hemoglobin in mild and moderately anemic children between 3 and 5 years of age: a cluster randomized trial
2013 · Daily dose doubled (B) · Children aged 3–5 years with mild or moderate anemia (hemoglobin 7–10 g/dL)
200 mcg100 days114
Relative efficacy of weekly and two differing doses of daily iron-folate supplementation in improving hemoglobin in mild and moderately anemic children between 3 and 5 years of age: a cluster randomized trial
2013 · NNACP daily dose (A) · Children aged 3–5 years with mild or moderate anemia (hemoglobin 7–10 g/dL)
100 mcg100 days112
Relative efficacy of weekly and two differing doses of daily iron-folate supplementation in improving hemoglobin in mild and moderately anemic children between 3 and 5 years of age: a cluster randomized trial
2013 · Weekly dose (C) · Children aged 3–5 years with mild or moderate anemia (hemoglobin 7–10 g/dL)
28.6 mcg100 days110
Multiple micronutrient supplementation improves vitamin B₁₂ and folate concentrations of HIV infected children in Uganda: a randomized controlled trial
2011 · Multiple micronutrient supplementation (MMS) · HIV-infected children aged 1–5 years
40 mcg26 weeks104
Betaine and choline status modify the effects of folic acid and creatine supplementation on arsenic methylation in a randomized controlled trial of Bangladeshi adults
2021 · creatine+400FA · Adults aged 24–55 in Bangladesh exposed to arsenic through household drinking water
400 mcg12 weeks104
Effect of oral zinc supplementation on copper and haemoglobin levels in pregnant women
1994 · Gp B (zinc treated group) · Pregnant women in different trimesters of pregnancy
10 mg—104
Folic Acid and Creatine as Therapeutic Approaches to Lower Blood Arsenic: A Randomized Controlled Trial
2015 · Creatine plus FA400, first phase · Adults aged 20–65 in Bangladesh selected for drinking from a well with arsenic above 50 μg/L; both folate-deficient and folate-sufficient participants
400 mcg12 weeks103
Low-Dose Creatine Supplementation Lowers Plasma Guanidinoacetate, but Not Plasma Homocysteine, in a Double-Blind, Randomized, Placebo-Controlled Trial
2015 · Cr+FA group · Bangladeshi adults
400 mcg12 weeks103
The Folic Acid and Creatine Trial: Treatment Effects of Supplementation on Arsenic Methylation Indices and Metabolite Concentrations in Blood in a Bangladeshi Population
2023 · creatine + 400FA · Adults aged 20–65 years in Bangladesh exposed to arsenic in drinking water; men and women, recruited independent of folate status
400 mcg12 weeks103
Antenatal iron supplements consumed daily produce oxidative stress in contrast to weekly supplementation in Mexican non-anemic women
2012 · daily supplementation · Pregnant non-anemic women; 30% were iron-deficient at week 20; ages and sex beyond pregnancy not specified
400 mcg8 weeks100
Effectiveness of Health Information Package Program on Knowledge and Compliance among Pregnant Women with Anemia: A Randomized Controlled Trial
2022 · intervention group · Pregnant women aged 18–45 years with anemia, at 14–16 weeks of gestation and with hemoglobin <11 g/dL and hematocrit <30%.
500 mcg90 days98
Effectiveness of Health Information Package Program on Knowledge and Compliance among Pregnant Women with Anemia: A Randomized Controlled Trial
2022 · control group · Pregnant women aged 18–45 years with anemia, at 14–16 weeks of gestation and with hemoglobin <11 g/dL and hematocrit <30%.
500 mcg90 days98
Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment
2021 · B-vitamin group · Men and women, mean age 77.6 years, with mild cognitive impairment
800 mcg2 years95
Red blood cell metallothionein as an indicator of zinc status during pregnancy
2008 · supplement without zinc · Pregnant women in coastal Peru, enrolled at 10–16 weeks gestation and considered low risk, carrying a singleton fetus
250 mcg—86
Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial
2015 · high-dose B vitamin supplementation · Adults aged 70 years or older with mild cognitive impairment
800 mcg2 years85
The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis
2008 · Vitamins · People with a history of stroke or transient ischemic attack; age range and sex not restricted
2 mg4 years83
Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease
2003 · Daily multivitamin therapy · Adults with end-stage renal disease receiving hemodialysis and with hyperhomocysteinemia
1 mg4 weeks81
Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease
2003 · Daily multivitamin therapy with added vitamin B12 · Adults with end-stage renal disease receiving hemodialysis and with hyperhomocysteinemia
1 mg4 weeks81
Timing of folic acid/vitamin B12 supplementation and hematologic toxicity during first-line treatment of patients with nonsquamous non-small cell lung cancer using pemetrexed-based chemotherapy: The PEMVITASTART randomized trial
2019 · immediate arm (IA) · Adults with locally advanced or metastatic nonsquamous non-small cell lung cancer receiving pemetrexed-based chemotherapy
1 mg18 weeks81
Timing of folic acid/vitamin B12 supplementation and hematologic toxicity during first-line treatment of patients with nonsquamous non-small cell lung cancer using pemetrexed-based chemotherapy: The PEMVITASTART randomized trial
2019 · delayed arm (DA) · Adults with locally advanced or metastatic nonsquamous non-small cell lung cancer receiving pemetrexed-based chemotherapy
1 mg18 weeks80
Homocysteine-lowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trial
2003 · Folic acid plus vitamin B6 treatment · Healthy adults who were siblings of patients with premature atherosclerotic disease
5 mg2 years78
Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo-controlled, randomized trial
2004 · vitamin-treated group · Healthy siblings of patients with premature atherosclerotic disease; mean age 46.0 years; sex not specified
5 mg2 years78
mRNA Levels of Placental Iron and Zinc Transporter Genes Are Upregulated in Gambian Women with Low Iron and Zinc Status
2017 · PE group · Pregnant women aged 18–45 years with singleton pregnancies under 20 weeks in rural Gambia
400 mcg184 days76
mRNA Levels of Placental Iron and Zinc Transporter Genes Are Upregulated in Gambian Women with Low Iron and Zinc Status
2017 · MMN group · Pregnant women aged 18–45 years with singleton pregnancies under 20 weeks in rural Gambia
400 mcg184 days75
mRNA Levels of Placental Iron and Zinc Transporter Genes Are Upregulated in Gambian Women with Low Iron and Zinc Status
2017 · PE+MMN group · Pregnant women aged 18–45 years with singleton pregnancies under 20 weeks in rural Gambia
400 mcg184 days75
Red blood cell metallothionein as an indicator of zinc status during pregnancy
2008 · supplement with zinc · Pregnant women in coastal Peru, enrolled at 10–16 weeks gestation and considered low risk, carrying a singleton fetus
250 mcg—72
Daily versus weekly iron supplementation and prevention of iron deficiency anaemia in lactating women
2003 · daily supplementation group · Lactating anaemic mothers in urban slum communities; age range and sex beyond lactating mothers not stated
400 mcg—71
Double-blind, placebo-controlled trial comparing effects of supplementation with two different combinations of micronutrients delivered as sprinkles on growth, anemia, and iron deficiency in cambodian infants
2006 · MMN · Infants aged 6 months living in Kompong Chhnang Province, Cambodia
150 mcg1 year68
Double-blind, placebo-controlled trial comparing effects of supplementation with two different combinations of micronutrients delivered as sprinkles on growth, anemia, and iron deficiency in cambodian infants
2006 · FFA · Infants aged 6 months living in Kompong Chhnang Province, Cambodia
150 mcg1 year68
Double-blind, placebo-controlled trial comparing effects of supplementation of two micronutrient sprinkles on fatty acid status in Cambodian infants
2007 · mineral/micronutrient (MMN) · Cambodian infants aged 6 months at enrolment
150 mcg1 year68
Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke: effect of combined therapy with folic acid and mecobalamine
2002 · combined vitamin B(12) and folic acid group · Japanese patients with ischemic stroke in the convalescent stage
5 mg8 weeks64
Supplementation with antioxidant micronutrients in pregnant women with obesity: a randomized controlled trial
2024 · Intervention group · Pregnant women with obesity (BMI ≥30 kg/m²)
800 mcg—64
Effects of folic acid and vitamin B complex on serum C-reactive protein and albumin levels in stable hemodialysis patients
2007 · Folic acid and vitamin B complex · Adults receiving maintenance hemodialysis; age and sex range not reported
5 mg90 days61
Weekly iron folate supplementation in adolescent girls--an effective nutritional measure for the management of iron deficiency anaemia
2013 · Daily IFA Supplementation Group · Adolescent girls aged 10–19 years with anaemia (haemoglobin <12 g/dL)
1.5 mg90 days60
Myoinositol plus α-lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study
2021 · Treated group · Women aged 18–44 with gestational diabetes mellitus and a singleton pregnancy
400 mcg60 days60
Effect of oral zinc supplementation on copper and haemoglobin levels in pregnant women
1994 · Gp A (untreated control group) · Pregnant women in different trimesters of pregnancy
10 mg—58
Weekly iron as a safe alternative to daily supplementation for nonanemic pregnant women
2006 · Daily supplementation (DS) · Pregnant women with singleton pregnancies, at gestational week 20, with hemoglobin >115 g/L; nonanemic
200 mcg16 weeks56
Effect of myo-inositol supplementation on ICSI outcomes among poor ovarian responder patients: A randomized controlled trial
2020 · Group A · Poor responder patients undergoing ICSI; age and sex details not reported
400 mcg—56
Intermittent iron supplementation regimens are able to maintain safe maternal hemoglobin concentrations during pregnancy in Venezuela
2004 · weekly (WS) · Pregnant women at 10–30 weeks of gestation
71.4 mcg14 weeks52
Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure/function in coronary artery disease
2022 · Folic acid + vitamins B12, B6 · Adults with suspected coronary artery disease undergoing angiography for stable angina; mean age 61.2 years, 71.5% male
800 mcg1387 days52
Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure/function in coronary artery disease
2022 · Folic acid + vitamin B12 · Adults with suspected coronary artery disease undergoing angiography for stable angina; mean age 61.2 years, 71.5% male
800 mcg1387 days52
A combination of iron and retinol supplementation benefits iron status, IL-2 level and lymphocyte proliferation in anemic pregnant women
2010 · Group IF · Anemic pregnant women with hemoglobin 80 to less than 110 g/L
400 mcg60 days46
A combination of iron and retinol supplementation benefits iron status, IL-2 level and lymphocyte proliferation in anemic pregnant women
2010 · Group IR · Anemic pregnant women with hemoglobin 80 to less than 110 g/L
400 mcg60 days46
Efficacy of different strategies to treat anemia in children: a randomized clinical trial
2010 · Iron plus folic acid supplement (IFS) · Children aged 6–42 months with anemia in rural communities in Mexico
37.5 mcg120 days42
Impact of daily versus weekly hematinic supplementation on anemia in pregnant women
2002 · Group I (daily therapy) · Pregnant women; age range and anemia status not specified
500 g14 weeks40
Impact of daily versus weekly hematinic supplementation on anemia in pregnant women
2002 · Group II (weekly therapy) · Pregnant women; age range and anemia status not specified
71.4 g14 weeks40
[Impact of adding folic acid, vitamin B(12) and probucol to standard antihypertensive medication on plasma homocysteine and asymmetric dimethylarginine levels of essential hypertension patients]
2012 · group 2 · Patients with essential hypertension; age and sex not reported
5 mg12 weeks40
[Impact of adding folic acid, vitamin B(12) and probucol to standard antihypertensive medication on plasma homocysteine and asymmetric dimethylarginine levels of essential hypertension patients]
2012 · group 3 · Patients with essential hypertension; age and sex not reported
5 mg12 weeks40
Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure
2002 · Folic acid and pyridoxine without glycine betaine · Patients with chronic renal failure who were folate and pyridoxine replete
5 mg90 days36
Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure
2002 · Folic acid, pyridoxine, and glycine betaine · Patients with chronic renal failure who were folate and pyridoxine replete
5 mg90 days36
Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance
2005 · All patients receiving vitamin therapy · Haemodialysis patients with end-stage renal disease; age and sex not reported
5 mg24 weeks35
An open-label, randomized, parallel-group comparative study of the efficacy of sorghum bicolor extract in preoperative anemia
2017 · test group · Patients with preoperative anemia booked for myomectomy; age and sex details not stated
5 mg3 weeks34
[Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial]
2005 · Supraphysiological daily-dose regimen · Adults with stable maintenance hemodialysis (mean age 68 years; 48% male)
15 mg1 year33
Effect of B vitamins-fortified foods on primary school children in Beijing
2006 · B vitamin compound supplementation group · Normal primary school children aged 9–11 years
130 mcg—33
An open-label, randomized, parallel-group comparative study of the efficacy of sorghum bicolor extract in preoperative anemia
2017 · control group · Patients with preoperative anemia booked for myomectomy; age and sex details not stated
5 mg3 weeks32
A phase I study of pemetrexed (LY231514) supplemented with folate and vitamin B12 in Japanese patients with solid tumours
2006 · Pemetrexed dose-escalation cohorts receiving folate and vitamin B12 supplementation · Japanese adults aged 20–75 with incurable solid tumours
500 mcg—31
Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults
1998 · supplemented group · Young Australian adults aged 18–32 years; males and females; not folate deficient, with 4.4% vitamin B12 deficient
700 mcg26 weeks31
[Effects of intervention therapy of methylcobalamin and folic acid on plasma homocysteine concentration and homocysteine thiolactonases/paraoxonase activity in patients with type 2 diabetes mellitus]
2007 · Group IV · Patients with type 2 diabetes mellitus
5 mg12 weeks30
Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes
2008 · Group III · Patients with type 2 diabetes; age and sex not specified
5 mg2 weeks30
A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels
2019 · Natural vitamin B complex (group N) · Healthy adults; age range and sex not specified
690 mcg6 weeks30
A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels
2019 · Synthetic vitamin B complex (group S) · Healthy adults; age range and sex not specified
690 mcg6 weeks30
Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation
2005 · open therapy with vitamins · Adults with ischemic heart disease and plasma homocysteine at least 15.0 micromol/L
5 mg90 days29
Preliminary results of the effect of treatment of hyperhomocysteinemia and its relationship with inflammation, coagulation status, and endothelial function after renal transplantation
2005 · Hyperhomocysteinemia patients treated with folic acid and vitamin B12 · Renal transplant recipients with hyperhomocysteinemia
10 mg90 days29
The impact of folate status and folic acid supplementation on the micronucleus frequency in human erythrocytes
2006 · folic acid, vitamin B12 and vitamin B6 supplementation group · Both-sex participants without folate deficiency; age not reported
800 mcg7 days29
Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients
2003 · group A · Adults with hyperhomocysteinemia who were stable renal-transplant recipients
5 mg26 weeks28
[Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial]
2005 · Daily renal multivitamin regimen · Adults with stable maintenance hemodialysis (mean age 68 years; 48% male)
5 mg1 year27
Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients
2004 · Group A · Hemodialysis patients with hyperhomocysteinemia; age and sex not reported
15 mg—26
Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
2000 · FA group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis
15 mg12 weeks25
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Folic acid group · Adults with chronic, stable hyperhomocysteinemia receiving maintenance hemodialysis
15 mg12 weeks25
Inositol for the prevention of neural tube defects: a pilot randomised controlled trial
2016 · inositol+FA group · Women aged 18–40 planning pregnancy, with a history of a previous neural tube defect-affected pregnancy
5 mg—25
Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
2001 · Folic acid group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis
15 mg12 weeks24
Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients
2004 · Group B · Hemodialysis patients with hyperhomocysteinemia; age and sex not reported
15 mg—24
Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial
2006 · B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset
5 mg2 weeks24
Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial
2006 · Antioxidant vitamins plus B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset
5 mg2 weeks24
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes
2011 · study group · Women with gestational diabetes treated with diet
400 mcg8 weeks24
Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients
1999 · group 1 · Chronic, stable renal transplant recipients; age and sex not stated
2.4 mg12 weeks20
Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients
1999 · group 2 · Chronic, stable renal transplant recipients; age and sex not stated
400 mcg12 weeks20
Randomized controlled trial of the effect of short-term coadministration of methylcobalamin and folate on serum ADMA concentration in patients receiving long-term hemodialysis
2010 · methylcobalamin group · Patients undergoing long-term hemodialysis
15 mg3 weeks20
Vitamin B(6) supplementation improves pro-inflammatory responses in patients with rheumatoid arthritis
2010 · vitamin B(6) · Patients with rheumatoid arthritis
5 mg12 weeks20
Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial
2018 · MI treatment · Pregnant women with gestational diabetes mellitus
400 mcg8 weeks20
Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial
2018 · MI plus DCI treatment · Pregnant women with gestational diabetes mellitus
400 mcg8 weeks20
Effect of Myo-Inositol Treatment on Serum Asprosin Levels of Pregnant Women: A Prospective Randomized Controlled Pilot Study
2025 · Group 1 · Pregnant women aged 18–40 without the stated exclusion conditions
400 mcg21 weeks20
Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation
2002 · vitamin supplementation · Male volunteers aged 40 years or younger; nine matched pairs received vitamins, including hyperhomocysteinemic and normohomocysteinemic subjects
600 mcg8 weeks18
[Treatment of hyperhomocysteinemia and endothelial dysfunction in renal-transplant recipients with vitamin B]
2005 · vitamin treatment (group A) · Stable hyperhomocysteinemic renal-transplant recipients
5 mg26 weeks18
Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial
2020 · DHA treatment arm · Cognitively unimpaired men and women aged 55 years and older with a first-degree family history of dementia
800 mcg26 weeks18
The effects of gum arabic oral treatment on the metabolic profile of chronic renal failure patients under regular haemodialysis in Central Sudan
2008 · group B · Patients with chronic renal failure receiving regular haemodialysis; age and sex not reported
5 mg90 days14
Nutritional status-dependent DNA methylation modifications on adipose tissue in systemic lupus erythematosus women following folic acid and vitamin B12 supplementation: a randomized double-blind placebo-controlled trial
2026 · excess-body-weight intervention group · Women aged 18–45 with inactive systemic lupus erythematosus and excess body weight (BMI ≥25 kg/m²)
400 mcg12 weeks14
Nutritional status-dependent DNA methylation modifications on adipose tissue in systemic lupus erythematosus women following folic acid and vitamin B12 supplementation: a randomized double-blind placebo-controlled trial
2026 · normal-weight intervention group · Women aged 18–45 with inactive systemic lupus erythematosus and normal weight (BMI 18.5–24.9 kg/m²)
400 mcg12 weeks11
Effect of multivitamins on plasma homocysteine and folate levels in patients on hemodialysis
1999 · Nephro-Vite Rx · Adults with chronic kidney disease receiving hemodialysis who were not taking vitamin or folate supplements
1 mg3 weeks11
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Renal transplant recipients · Renal transplant recipients with hyperhomocysteinemia
2.4 mg12 weeks10
Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome
2008 · Group A · Overweight patients with polycystic ovary syndrome; age and sex details not stated
200 mcg12 weeks10
Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study
2013 · Group A · Overweight patients with polycystic ovary syndrome; age and sex not specified
200 mg12 weeks10
Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease
2004 · folic acid combined with vitamin B(12) · Patients with coronary artery disease and at least 70% stenosis of one major coronary artery
5 mg12 weeks9
Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation
2002 · group II · Haemodialysis patients with chronic renal failure and hyperhomocysteinaemia
15 mg3 weeks7
Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation
2002 · group III · Haemodialysis patients with chronic renal failure and hyperhomocysteinaemia
15 mg3 weeks7
Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial
1997 · folic acid plus vitamin B12 · Clinically stable renal transplant recipients
5 mg—7
Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial
1997 · vitamin B6, folic acid, and vitamin B12 · Clinically stable renal transplant recipients
5 mg—7
Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients
1999 · Folic acid 5 mg daily with betaine · Adults with end-stage renal disease receiving maintenance haemodialysis
5 mg12 weeks—
Folate administration reduces circulating homocysteine levels in NIDDM patients on long-term metformin treatment
1998 · folate group · Adults treated with metformin for at least 1 year; 26 had NIDDM and 2 had hyperlipidaemia. Baseline homocysteine was within the reference range.
250 mcg12 weeks—
Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients
2000 · iron group · Critically ill anemic adults admitted to a multidisciplinary intensive care unit
1 mg2 weeks—
Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients
2000 · EPO group · Critically ill anemic adults admitted to a multidisciplinary intensive care unit
1 mg2 weeks—
Anthelminthic treatment and haemoglobin concentrations during pregnancy
2000 · iron-folate supplements · Pregnant women in Sierra Leone
5 mg——
Changes in markers of anemia and iron metabolism and how they are influenced by antianemics in postpartum period
2001 · second group · Women after spontaneous delivery; age and postpartum condition details not reported
350 mcg60 days—
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Hemodialysis patients receiving folic acid · Hemodialysis patients with hyperhomocysteinemia and baseline total homocysteine comparable to the renal transplant recipients
15 mg12 weeks—
Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia
2001 · 0 mg folic acid group · Adults with hyper-homocyst(e)inemia receiving hemodialysis for end-stage renal disease
1 mg4 weeks—
Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete
2001 · Vitamin B-6 supplementation group · Healthy adults aged 63–80 years; folate- and riboflavin-replete, with no vitamin B-12 deficiency
400 mcg12 weeks—
Albendazole therapy and reduced decline in haemoglobin concentration during pregnancy (Sierra Leone)
2001 · iron-folate supplements · Pregnant women in Sierra Leone
5 mg——
The effect of weekly iron supplementation on anaemia and on iron deficiency among female tea pluckers in Bangladesh
2001 · weekly iron supplementation · Adult female tea pluckers in Bangladesh
28.6 mg24 weeks—
Concomitant supplemental vitamin A enhances the response to weekly supplemental iron and folic acid in anemic teenagers in urban Bangladesh
2001 · iron + folic acid + vitamin A · Teenage women in urban Bangladesh with hemoglobin concentrations of 80–120 g/L
500 mcg12 weeks—
Vitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrate
2001 · fenofibrate plus vitamins · men with hyperlipidemia
650 mcg6 weeks—
Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour
2002 · Folic acid, riboflavin, and vitamin B12 without vitamin B6 · Adults with stable coronary artery disease; mean age 60.1 years; 29.8% women
2.5 mg12 weeks—
Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12
2002 · Group 3 · Chronic haemodialysis patients; age and sex not specified
6.43 mg26 weeks—
A randomised trial in Mali of the effectiveness of weekly iron supplements given by teachers on the haemoglobin concentrations of schoolchildren
2002 · weekly iron tablets · Schoolchildren aged 6–19 years in rural community schools in Kolondieba district, Mali
35.7 mcg10 weeks—
Randomized trial of methylcobalamin and folate effects on homocysteine in hemodialysis patients
2002 · Group A · Chronic hemodialysis patients without previous vitamin supplementation
10 mg120 days—
Effect of homocysteine reduction by B-vitamin supplementation on markers of clotting activation
2002 · high-dose B-vitamin supplements · Healthy volunteers with homocysteine >16 μmol/L or ≤16 μmol/L
5 mg8 weeks—
Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease
2002 · folic acid/cobalamin treated group · Patients with coronary artery disease and hyperhomocysteinemia, plasma homocysteine ≥16 micromol/L; age and sex not reported
5 mg26 weeks—
Effect of riboflavin supplementation on plasma homocysteine in elderly people with low riboflavin status
2002 · Folic acid and riboflavin group (Part 2, second phase) · Healthy elderly people with sub-optimal riboflavin status
400 mcg12 weeks—
Reduction of plasma homocysteine and serum methylmalonate concentrations in apparently healthy elderly subjects after treatment with folic acid, vitamin B12 and vitamin B6: a randomised trial
2003 · B-vitamin treatment · Community-dwelling apparently healthy adults aged 70–93 years; median age 76 years
800 mcg120 days—
Supplementation with micronutrients in addition to iron and folic acid does not further improve the hematologic status of pregnant women in rural Nepal
2003 · folic acid plus iron · Pregnant women in rural Nepal
400 mcg——
Mineral water fortified with folic acid, vitamins B6, B12, D and calcium improves folate status and decreases plasma homocysteine concentration in men and women
2004 · Fortified mineral water · Free-living men and women without folate deficiency or elevated homocysteine
563 mcg8 weeks—
Breakfast cereal fortified with folic acid, vitamin B-6, and vitamin B-12 increases vitamin concentrations and reduces homocysteine concentrations: a randomized trial
2004 · Fortified cereal group · Volunteers aged 50–85 years without the listed medical conditions who did not regularly use multiple or B-vitamin supplements or highly fortified breakfast cereal
440 mcg12 weeks—
Randomized controlled trial of prenatal zinc supplementation and fetal bone growth
2004 · supplements containing 60 mg Fe and 250 microg folic acid, without 25 mg Zn · Pregnant women in Peru, enrolled at 10–16 weeks of gestation
250 mcg——
Randomized controlled trial of prenatal zinc supplementation and fetal bone growth
2004 · supplements containing 60 mg Fe and 250 microg folic acid, with 25 mg Zn · Pregnant women in Peru, enrolled at 10–16 weeks of gestation
250 mcg——
Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention
2004 · group B · Patients with suspected coronary artery disease; age and sex not stated
5.8 mg90 days—
Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia
2004 · group 2 · Patients with metabolic syndrome; age range and sex not reported
5 mg30 days—
Zinc plus beta-carotene supplementation of pregnant women is superior to beta-carotene supplementation alone in improving vitamin A status in both mothers and infants
2004 · beta-carotene plus zinc · Pregnant women; age and specific condition not stated
400 mcg——
The effect of homocysteine reduction by B-vitamin supplementation on markers of endothelial dysfunction
2004 · B-vitamins · Healthy volunteers, including hyperhomocysteinemic and normohomocysteinemic participants
5 mg8 weeks—
Efficacy of B vitamins in lowering homocysteine in older men: maximal effects for those with B12 deficiency and hyperhomocysteinemia
2006 · Vitamin group · Community-dwelling men aged 75 years or older
2 mg2 years—
Effects of short-term folic acid and/or riboflavin supplementation on serum folate and plasma total homocysteine concentrations in young Japanese male subjects
2006 · FAR group · Healthy Japanese men aged 20–29 years
800 mcg2 weeks—
No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk
2006 · Study I: B vitamins · Siblings of patients with clinical atherosclerotic disease and postmethionine hyperhomocysteinaemia; ages and sex not stated
5 mg1 year—
Short-term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster-randomised trial
2006 · daily group · Children aged 3–6 years in a kindergarten in northern China
150 mcg13 weeks—
Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients
2006 · Treatment group · Chronic hemodialysis patients with hyperhomocysteinemia; age and sex not specified
15 mg26 weeks—
Effect of fortified spread on homocysteine concentration in apparently healthy volunteers
2007 · spread 1 · Apparently healthy adult volunteers; 50% male; age range not reported
200 mcg6 weeks—
Effect of fortified spread on homocysteine concentration in apparently healthy volunteers
2007 · spread 2 · Apparently healthy adult volunteers; 50% male; age range not reported
400 mcg6 weeks—
Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease
2007 · A: folic acid/vitamin B12/vitamin B6 · Adults aged 38–80 with suspected coronary artery disease
800 mcg26 weeks—
Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease
2007 · B: folic acid/vitamin B12 · Adults aged 38–80 with suspected coronary artery disease
800 mcg26 weeks—
Folic acid and vitamin B-12 supplementation does not favorably influence uracil incorporation and promoter methylation in rectal mucosa DNA of subjects with previous colorectal adenomas
2007 · folic acid plus vitamin B-12 · People with a history of colorectal adenoma and MTHFR CC or TT genotype
5 mg26 weeks—
Treatment of hyperhomocysteinemia and endothelial dysfunction in renal transplant recipients with B vitamins in the Chinese population
2008 · folate treatment · Chinese renal transplant recipients with hyperhomocysteinemia; age and sex not reported
5 mg26 weeks—
Effect of homocysteine-lowering therapy on arterial elasticity and metabolic parameters in metformin-treated diabetic patients
2008 · group 1 · Adults with diabetes treated with high-dose metformin
1 mg120 days—
Serum biomarkers for atrophic gastritis and antibodies against Helicobacter pylori in the elderly: Implications for vitamin B12, folic acid and iron status and response to oral vitamin therapy
2008 · oral vitamin treatment · Community-dwelling adults, mean age 76 years
800 mcg120 days—
Weekly may be as efficacious as daily folic acid supplementation in improving folate status and lowering serum homocysteine concentrations in Guatemalan women
2008 · weekly 5000 microg folic acid group · Healthy reproductive-aged women in Guatemala
714 mcg12 weeks—
Weekly may be as efficacious as daily folic acid supplementation in improving folate status and lowering serum homocysteine concentrations in Guatemalan women
2008 · weekly 2800 microg folic acid group · Healthy reproductive-aged women in Guatemala
400 mcg12 weeks—
Weekly may be as efficacious as daily folic acid supplementation in improving folate status and lowering serum homocysteine concentrations in Guatemalan women
2008 · daily 400 microg folic acid group · Healthy reproductive-aged women in Guatemala
400 mcg12 weeks—
Weekly may be as efficacious as daily folic acid supplementation in improving folate status and lowering serum homocysteine concentrations in Guatemalan women
2008 · daily 200 microg folic acid group · Healthy reproductive-aged women in Guatemala
200 mcg12 weeks—
The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability
2009 · vitamin supplementation · patients diagnosed with migraine with aura; age and sex not reported
2 mg26 weeks—
Leaf concentrate as an alternative to iron and folic acid supplements for anaemic adolescent girls: a randomised controlled trial in India
2010 · Fe and folic acid (IFA) · Anaemic adolescent girls aged 14–18 years
500 mcg90 days—
Leaf concentrate as an alternative to iron and folic acid supplements for anaemic adolescent girls: a randomised controlled trial in India
2010 · Leaf concentrate (LC) · Anaemic adolescent girls aged 14–18 years
13 mcg90 days—
Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients
2009 · group II (folic acid and vitamin B12) · Hemodialysis patients; age and sex not reported
5 mg8 weeks—
Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients
2009 · group IV (folic acid and vitamin B12) · Hemodialysis patients; age and sex not reported
15 mg8 weeks—
Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations
2010 · vitamins group · Healthy adults aged 65 years or older with elevated homocysteine (>13 micromol/l)
1 mg2 years—
Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India
2010 · B2 F200 (2 μg vitamin B12 and 200 μg folic acid) · Children and adults from rural families in India; participants included children (mean age 9 years), mothers and fathers, with common vitamin B12 deficiency and elevated homocysteine
200 mcg1 year—
Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India
2010 · B10 F200 (10 μg vitamin B12 and 200 μg folic acid) · Children and adults from rural families in India; participants included children (mean age 9 years), mothers and fathers, with common vitamin B12 deficiency and elevated homocysteine
200 mcg1 year—
Community-level micronutrient fortification of school lunch meals improved vitamin A, folate, and iron status of schoolchildren in Himalayan villages of India
2010 · multiple micronutrients (treatment group) · Schoolchildren aged 6–10 years in Himalayan villages of India
225 mcg240 days—
Supplementation of iron alone and combined with vitamins improves haematological status, erythrocyte membrane fluidity and oxidative stress in anaemic pregnant women
2010 · group IF · Pregnant women with anaemia
400 mcg60 days—
A comparison of iron and folate with folate alone in hematologic recovery of children treated for acute malaria
2010 · iron plus folate group · Children aged 6–60 months with smear-positive malaria and anemia (hematocrit <33%)
5 mg4 weeks—
Patterns of compliance with prenatal iron supplementation among Peruvian women
2014 · Iron and folate without zinc · Pregnant women enrolled at 10–24 weeks of gestation and followed through 4 weeks postpartum
250 mcg——
Patterns of compliance with prenatal iron supplementation among Peruvian women
2014 · Iron, folate, and zinc · Pregnant women enrolled at 10–24 weeks of gestation and followed through 4 weeks postpartum
250 mcg——
Effects of prenatal micronutrient and early food supplementation on maternal hemoglobin, birth weight, and infant mortality among children in Bangladesh: the MINIMat randomized trial
2012 · 60 mg iron and 400 μg folic acid; early food invitation · Pregnant women in poor communities in Bangladesh
400 mcg——
Effects of prenatal micronutrient and early food supplementation on maternal hemoglobin, birth weight, and infant mortality among children in Bangladesh: the MINIMat randomized trial
2012 · 60 mg iron and 400 μg folic acid; usual food invitation · Pregnant women in poor communities in Bangladesh
400 mcg——
Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment
2013 · B-vitamin treatment · Elderly adults with mild cognitive impairment and increased dementia risk
800 mcg2 years—
The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine
2013 · Folic acid plus vitamin B12 plus vitamin B6 · Adults with suspected or established coronary artery disease who underwent coronary angiography; median age 60 years
800 mcg316 days—
The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine
2013 · Folic acid plus vitamin B12 · Adults with suspected or established coronary artery disease who underwent coronary angiography; median age 60 years
800 mcg316 days—
Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome
2016 · Group A · Women of reproductive age with polycystic ovarian syndrome undergoing IVF
400 mcg——
Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome
2016 · Group B · Women of reproductive age with polycystic ovarian syndrome undergoing IVF
400 mcg——
The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis
2016 · Group A, t3: folic acid plus vitamin B12 · Hemodialysis patients with C677T MTHFR genotypes
10 mg60 days—
The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis
2016 · Group B, t3: vitamin B12 plus folic acid · Hemodialysis patients with C677T MTHFR genotypes
10 mg60 days—
Supplementation with Folic Acid, but Not Creatine, Increases Plasma Betaine, Decreases Plasma Dimethylglycine, and Prevents a Decrease in Plasma Choline in Arsenic-Exposed Bangladeshi Adults
2016 · Creatine plus FA400 · Arsenic-exposed adults aged 24–55 in Bangladesh
400 mcg12 weeks—
Lipid-Based Nutrient Supplements During Pregnancy and Lactation Did Not Affect Human Milk Oligosaccharides and Bioactive Proteins in a Randomized Trial
2017 · IFA group · Pregnant women over 15 years old, enrolled at no more than 20 weeks’ gestation, in Malawi; continued postpartum for the breast-milk assessment
400 mcg——
Acceptability and Utilization of Three Nutritional Supplements during Pregnancy: Findings from a Longitudinal, Mixed-Methods Study in Niger
2018 · IFA group · Pregnant women enrolled before 30 weeks’ gestation in rural Niger
400 mcg26 weeks—
Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial
2019 · folic acid + vitamin B12 + vitamin B6 · Adults with suspected coronary artery disease who underwent coronary angiography; mean age about 61 years, 69.8% male
800 mcg165 weeks—
Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial
2019 · folic acid + vitamin B12 · Adults with suspected coronary artery disease who underwent coronary angiography; mean age about 61 years, 69.8% male
800 mcg165 weeks—
Folic acid supplementation enhances arsenic methylation: results from a folic acid and creatine supplementation randomized controlled trial in Bangladesh
2019 · 400 μg folic acid plus 3 g creatine group · Bangladeshi participants exposed to arsenic through drinking water; the majority were folate sufficient
400 mcg24 weeks—
Influence of Dietary Supplementation for Hyperhomocysteinemia Treatments
2020 · oxifolic · Adults aged 48 ± 14 years, men and women, with moderate hyperhomocysteinemia
300 mcg90 days—
Impact of daily-supervised administration of a package of iron and folic acid and vitamin B(12) on hemoglobin levels among adolescent girls (12-19 years): a cluster randomized control trial
2021 · Experimental group-IFA with vitamin B12 · Adolescent girls aged 12–19 years with mild or moderate anemia
500 mcg90 days—
Impact of daily-supervised administration of a package of iron and folic acid and vitamin B(12) on hemoglobin levels among adolescent girls (12-19 years): a cluster randomized control trial
2021 · Control group-IFA · Adolescent girls aged 12–19 years with mild or moderate anemia
500 mcg90 days—
The Inclusion of Folic Acid in Weekly Iron-Folic Acid Supplements Confers no Additional Benefit on Anemia Reduction in Nonpregnant Women: A Randomized Controlled Trial in Malaysia
2021 · 60 mg Fe with 0.4 mg folic acid · Nonpregnant women aged 18–45 years in Malaysia
57.1 mcg16 weeks—
Low-dose daily folic acid (400 μg) supplementation does not affect regulation of folate transporters found present throughout the terminal ileum and colon of humans: a randomized clinical trial
2024 · 400 μg folic acid group · Adults
400 mcg16 weeks—
The ameliorative effect of myo-inositol on apoptosis-related genes expression in cumulus cells of women with polycystic ovary syndrome undergoing ICSI and its relationship with the quality of oocyte and embryo
2025 · MYO group · Infertile women with PCOS undergoing ICSI; age range and sex beyond women not reported
2 mg6 weeks—
Vitamin requirements for the treatment of hyperhomocysteinemia in humans
1994 · combination of folic acid, vitamin B-12 and vitamin B-6 · men with hyperhomocysteinemia
650 mcg6 weeks—
Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia
1993 · daily vitamin supplement · Apparently healthy men with moderate hyperhomocysteinemia
1 mg6 weeks—
Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents
1997 · daily supplementation group · female Indonesian high-school adolescents
250 mcg90 days—
Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents
1997 · weekly supplementation group (60 mg Fe) · female Indonesian high-school adolescents
71.4 mg90 days—
Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents
1997 · weekly supplementation group (120 mg Fe) · female Indonesian high-school adolescents
71.4 mg90 days—
No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients
1998 · 5 mg folic acid plus 4 g betaine (phase 1) · Haemodialysis patients with hyperhomocysteinaemia; age and sex not reported
5 mg12 weeks—
Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers
1998 · high-dose multivitamin supplements · Patients with a history of recurrent venous thrombosis and hyperhomocysteinemic healthy volunteers
5 mg——
Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy
1998 · 5 mg folic acid and 4 g betaine daily · Peritoneal dialysis patients with hyperhomocysteinemia
5 mg12 weeks—
Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women
1998 · 400 microg folic acid + 6 microg vitamin B-12 · Female volunteers of childbearing age
400 mcg4 weeks—
Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women
1998 · 400 microg folic acid + 400 microg vitamin B-12 · Female volunteers of childbearing age
400 mcg4 weeks—
Randomized, double-blind, placebo-controlled trial of selenium supplements among HIV-infected pregnant women in Tanzania: effects on maternal and child outcomes
2008 · selenium group · Pregnant women aged about 27.5 years on average, at 12–27 weeks of gestation, living with HIV in Dar es Salaam, Tanzania
1.05 mg—456
Effects of prenatal micronutrient and early food supplementation on metabolic status of the offspring at 4.5 years of age. The MINIMat randomized trial in rural Bangladesh
2016 · MMS · Pregnant women in rural Bangladesh; offspring assessed at 4.5 years
400 mcg—439
Maternal cortisol and stress are associated with birth outcomes, but are not affected by lipid-based nutrient supplements during pregnancy: an analysis of data from a randomized controlled trial in rural Malawi
2015 · LNS · Pregnant women aged 15–49 years in rural Malawi, enrolled at up to 20 weeks of gestation
400 mcg—418
Maternal cortisol and stress are associated with birth outcomes, but are not affected by lipid-based nutrient supplements during pregnancy: an analysis of data from a randomized controlled trial in rural Malawi
2015 · MMN · Pregnant women aged 15–49 years in rural Malawi, enrolled at up to 20 weeks of gestation
400 mcg—415
Micronutrient Sprinkles reduce anemia among 9- to 24-mo-old children when delivered through an integrated health and nutrition program in rural Haiti
2007 · Sprinkles-WSB (S-WSB) · Children aged 9–24 months in rural Haiti receiving take-home fortified wheat-soy blend rations
160 mcg60 days254
A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia
2019 · UNIMMAP tablet · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population
400 mcg12 weeks105
A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia
2019 · drink powder · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population
800 mcg12 weeks93
Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial
2016 · Normocis 400® group · Adults with stage 1 essential hypertension and hyper-homocysteinemia (HCys ≥15 μmol/L), without a history of cardiovascular or cerebrovascular disease; mean age 62.8 years, 63.5% male
400 mcg60 days52
Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial
2014 · Intervention (Armolipid Plus/AP) · Men and women older than 18 years with mild-moderate hypercholesterolemia and elevated LDL-c, candidates for lifestyle intervention without hypolipemic drug treatment
200 mcg12 weeks51
Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD
2009 · Treatment group · Adults with stage 2 to 4 chronic kidney disease and creatinine clearance of 15 to 70 mL/min/1.73 m²
5 mg2 years47
Effects of low-dose B vitamins plus betaine supplementation on lowering homocysteine concentrations among Chinese adults with hyperhomocysteinemia: a randomized, double-blind, controlled preliminary clinical trial
2023 · supplement group · Chinese adults aged 18–65 with hyperhomocysteinemia (blood homocysteine 15–100 μmol/L)
400 mcg12 weeks44
Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome
2006 · test group · Patients with metabolic syndrome; age and sex not specified
150 mcg90 days36
The impact of a standardized micronutrient supplementation on PCOS-typical parameters: a randomized controlled trial
2019 · Multinutrient supplementation group · Women aged 19–35 with polycystic ovary syndrome (PCOS)
800 mcg90 days30
Plasma trimethylamine-N-oxide following supplementation with vitamin D or D plus B vitamins
2017 · vitamin D + B arm · Participants; age, sex, and health condition not specified
500 mcg1 year25
A Mixed Flavonoid-Fish Oil Supplement Induces Immune-Enhancing and Anti-Inflammatory Transcriptomic Changes in Adult Obese and Overweight Women-A Randomized Controlled Trial
2016 · Q-Mix · Women aged 40–70 years who were overweight or obese (BMI ≥25 kg/m²), without the listed major diseases
400 mcg10 weeks24
Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial
2019 · Nutraceutical B · Adults aged 18–75 with elevated serum cholesterol not requiring statins or statin-intolerant; people with cardiovascular disease and uncontrolled diabetes were excluded.
200 mcg6 weeks23
Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product
2017 · Active nutraceutical · Adults with impaired fasting glucose, ages 54.6 ± 11.3 years on average; men and women
300 mcg8 weeks20
Effects of baked products enriched with n-3 fatty acids, folates, β-glucans, and tocopherol in patients with mild mixed hyperlipidemia
2012 · active diet · Adults with mild plasma lipid abnormalities (mild mixed hyperlipidemia)
1.6 mg30 days16
High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients
1996 · Supraphysiologic-dose B-vitamin supplementation · Hyperhomocysteinemic dialysis patients
15 mg8 weeks15
Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate-advanced chronic renal failure
2006 · FA-15 · Adults aged 45–71 years with moderate-severe chronic renal failure
15 mg180 days9
Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate-advanced chronic renal failure
2006 · FA-5 · Adults aged 45–71 years with moderate-severe chronic renal failure
5 mg180 days8
Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized, factorial design, placebo-controlled trial
1999 · B vitamins with antioxidant vitamins · Men aged 30–49 with plasma homocysteine concentration ≥8.34 μmol/L
1 mg8 weeks—
Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia
2001 · 5 mg folic acid group · Adults with hyper-homocyst(e)inemia receiving hemodialysis for end-stage renal disease
6 mg4 weeks—
Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia
2001 · 20 mg folic acid group · Adults with hyper-homocyst(e)inemia receiving hemodialysis for end-stage renal disease
21 mg4 weeks—
Prophylactic iron supplementation in pregnant women in Norway
2001 · 15 mg iron daily · Non-anaemic pregnant women, allocated at about 10 weeks of pregnancy
100 mcg——
Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour
2002 · Folic acid, riboflavin, and vitamin B12 with vitamin B6 · Adults with stable coronary artery disease; mean age 60.1 years; 29.8% women
2.5 mg12 weeks—
Supplementation with micronutrients in addition to iron and folic acid does not further improve the hematologic status of pregnant women in rural Nepal
2003 · folic acid plus iron and zinc · Pregnant women in rural Nepal
400 mcg——
Supplementation with micronutrients in addition to iron and folic acid does not further improve the hematologic status of pregnant women in rural Nepal
2003 · folic acid plus iron, zinc and multiple micronutrients · Pregnant women in rural Nepal
400 mcg——
Folate therapy and in-stent restenosis after coronary stenting
2004 · folate group · Patients who had undergone successful coronary stenting
1.2 mg26 weeks—
Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention
2004 · group A · Patients with suspected coronary artery disease; age and sex not stated
5.8 mg90 days—
Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins
2005 · All subjects · Adults with chronic kidney disease in MDRD Study A (GFR 25–55 mL/min/1.73 m²) or Study B (GFR 13–24 mL/min/1.73 m²)
1 mg1 year—
No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease
2006 · B-vitamin group · Patients with symptomatic peripheral arterial occlusive disease and elevated homocysteine levels
5 mg6 weeks—
One year B and D vitamins supplementation improves metabolic bone markers
2013 · group A · Healthy adults older than 54 years
500 mcg1 year—
Co-administration of methyl donors along with guanidinoacetic acid reduces the incidence of hyperhomocysteinaemia compared with guanidinoacetic acid administration alone
2013 · GAA with methyl donors group · Healthy male and female volunteers
600 mcg8 weeks—
Effects of mixed dietary supplements on total plasma homocysteine concentrations (tHcy): a randomized, double-blind, placebo-controlled trial
2012 · supplement group · hospitalized, acutely ill older patients recovering from acute illness; sex and age range not stated
200 mcg6 weeks—
One-carbon metabolites and telomere length in a prospective and randomized study of B- and/or D-vitamin supplementation
2017 · group A · Adults older than 54 years; no specific condition stated
500 mcg1 year—
Multimicronutrient and omega-3 fatty acid supplementation reduces low-grade inflammation in older participants: An exploratory study
2025 · multimicronutrient and n-3 PUFA supplementation · Healthy, physically active older adults; mean age 75.6 ± 3.9 years; sex not specified
400 mcg12 weeks—
Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS
2014 · Myo-inositol group · Women with PCOS and menstrual irregularities
400 mcg26 weeks25
The effectiveness of inositol and metformin on infertile polycystic ovary syndrome women with resistant to letrozole
2019 · Group III · Infertile women with polycystic ovary syndrome who did not ovulate after letrozole treatment
400 mcg90 days—
Vitamin B12 Supplementation in Addition to Folic Acid and Iron Improves Hematological and Biochemical Markers in Pregnancy: A Randomized Controlled Trial
2020 · intervention group · Healthy, nonanemic pregnant women; age and sex details beyond pregnancy not reported
5 mg100 days—
Vitamin B12 Supplementation in Addition to Folic Acid and Iron Improves Hematological and Biochemical Markers in Pregnancy: A Randomized Controlled Trial
2020 · control group · Healthy, nonanemic pregnant women; age and sex details beyond pregnancy not reported
5 mg100 days—
Effect of antenatal multiple micronutrient supplementation on anthropometry and blood pressure in mid-childhood in Nepal: follow-up of a double-blind randomised controlled trial
2014 · control group (iron and folic acid supplement) · Pregnant women attending antenatal care in Nepal; no specific age range or deficiency criterion stated
400 mcg—600
Effects of prenatal micronutrient and early food supplementation on metabolic status of the offspring at 4.5 years of age. The MINIMat randomized trial in rural Bangladesh
2016 · Fe30F · Pregnant women in rural Bangladesh; offspring assessed at 4.5 years
400 mcg—458
Effects of prenatal micronutrient and early food supplementation on metabolic status of the offspring at 4.5 years of age. The MINIMat randomized trial in rural Bangladesh
2016 · Fe60F · Pregnant women in rural Bangladesh; offspring assessed at 4.5 years
400 mcg—454
Effect of prenatal micronutrient-fortified balanced energy-protein supplementation on maternal and newborn body composition: A sub-study from the MISAME-III randomized controlled efficacy trial in rural Burkina Faso
2023 · Control · Pregnant women aged 15–40 years, enrolled before 21 completed weeks of gestation; maternal and newborn body composition were assessed postpartum
400 mcg—440
Sex-Specific Associations between One-Carbon Metabolism Indices and Posttranslational Histone Modifications in Arsenic-Exposed Bangladeshi Adults
2017 · 800 µg FA/day · Adults aged 20–65 exposed to household well-water arsenic ≥50 µg/L
800 mcg12 weeks154
Sex-Specific Associations between One-Carbon Metabolism Indices and Posttranslational Histone Modifications in Arsenic-Exposed Bangladeshi Adults
2017 · 3 g creatine + 400 µg FA/day · Adults aged 20–65 exposed to household well-water arsenic ≥50 µg/L
400 mcg12 weeks104
Small-Quantity Lipid-Based Nutrient Supplements Do Not Affect Plasma or Milk Retinol Concentrations Among Malawian Mothers, or Plasma Retinol Concentrations among Young Malawian or Ghanaian Children in Two Randomized Trials
2021 · IFA (Ghana mothers) · Women aged 18 years or older, pregnant at enrollment (≤20 weeks), in Ghana
400 mcg—97
The effects of gum arabic oral treatment on the metabolic profile of chronic renal failure patients under regular haemodialysis in Central Sudan
2008 · group C (control group) · Patients with chronic renal failure receiving regular haemodialysis; age and sex not reported
5 mg90 days10
Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation
2004 · folic acid, vitamin B12, and vitamin B6 group · Patients undergoing coronary angiography
800 mcg1 year—
Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation
2004 · folic acid and vitamin B12 group · Patients undergoing coronary angiography
800 mcg1 year—
Baseline plasma total homocysteine and adenoma recurrence: results from a double blind randomized clinical trial of aspirin and folate supplementation
2010 · folic acid supplementation group · Adults aged 21–80 with a history of colorectal adenomas
1 mg3 years—
Preconception Micronutrient Supplementation with Iron and Folic Acid Compared with Folic Acid Alone Affects Linear Growth and Fine Motor Development at 2 Years of Age: A Randomized Controlled Trial in Vietnam
2017 · FA group · Women in Vietnam receiving preconception supplementation; age and health status not stated
400 mcg——
The myo-inositol effect on the oocyte quality and fertilization rate among women with polycystic ovary syndrome undergoing assisted reproductive technology cycles: a randomized clinical trial
2019 · control group · infertile women with PCOS undergoing assisted reproductive technology cycles; age not reported
400 mg30 days—
Defining the plasma folate concentration associated with the red blood cell folate concentration threshold for optimal neural tube defects prevention: a population-based, randomized trial of folic acid supplementation
2019 · 25 μg 4 times a day · Women of reproductive age in northern China; nonpregnant; no diagnosed condition specified for those eligible for supplementation
100 mcg26 weeks—
Defining the plasma folate concentration associated with the red blood cell folate concentration threshold for optimal neural tube defects prevention: a population-based, randomized trial of folic acid supplementation
2019 · 100 μg 1 time a day · Women of reproductive age in northern China; nonpregnant; no diagnosed condition specified for those eligible for supplementation
100 mcg26 weeks—
Defining the plasma folate concentration associated with the red blood cell folate concentration threshold for optimal neural tube defects prevention: a population-based, randomized trial of folic acid supplementation
2019 · 100 μg 4 times a day · Women of reproductive age in northern China; nonpregnant; no diagnosed condition specified for those eligible for supplementation
400 mcg26 weeks—
Defining the plasma folate concentration associated with the red blood cell folate concentration threshold for optimal neural tube defects prevention: a population-based, randomized trial of folic acid supplementation
2019 · 400 μg 1 time a day · Women of reproductive age in northern China; nonpregnant; no diagnosed condition specified for those eligible for supplementation
400 mcg26 weeks—
Defining the plasma folate concentration associated with the red blood cell folate concentration threshold for optimal neural tube defects prevention: a population-based, randomized trial of folic acid supplementation
2019 · 4000 μg 1 time a day · Women of reproductive age in northern China; nonpregnant; no diagnosed condition specified for those eligible for supplementation
4 mg26 weeks—
Defining the plasma folate concentration associated with the red blood cell folate concentration threshold for optimal neural tube defects prevention: a population-based, randomized trial of folic acid supplementation
2019 · 4000 μg 1 time per week · Women of reproductive age in northern China; nonpregnant; no diagnosed condition specified for those eligible for supplementation
571 mcg26 weeks—
Fortified balanced energy-protein supplementation during pregnancy and lactation and infant growth in rural Burkina Faso: A 2 × 2 factorial individually randomized controlled trial
2023 · Prenatal and postnatal IFA only supplementation · Pregnant women aged 15–40 years in rural Burkina Faso who continued into lactation
400 mcg——